26909-37-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis
67656-30-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis
83219-99-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism
66-71-7	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00524|Butirosin and neomycin biosynthesis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus
81276-02-0	KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway
71-55-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05016|Huntington's disease; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus
79-00-5	KEGG:01100|Metabolic pathways; KEGG:00250|Alanine, aspartate and glutamate metabolism
72-23-1	KEGG:04960|Aldosterone-regulated sodium reabsorption
80558-61-8	KEGG:04020|Calcium signaling pathway
37786-00-8	KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway
75-34-3	KEGG:00980|Metabolism of xenobiotics by cytochrome P450
564-32-9	KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis
39227-28-6	KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM)
130495-35-1	KEGG:04930|Type II diabetes mellitus; KEGG:04940|Type I diabetes mellitus
634-90-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450
127003-40-1	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction
96-18-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05323|Rheumatoid arthritis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway
95-94-3	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450
124043-51-2	KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption
120-82-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism
81-54-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism
53-70-3	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway
66772-14-3	KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer
85233-19-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04270|Vascular smooth muscle contraction; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation
139890-68-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway
99-56-9	KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:03320|PPAR signaling pathway
96-12-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04912|GnRH signaling pathway; KEGG:00480|Glutathione metabolism
99-54-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
540-59-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism
149-45-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway
99-51-4	KEGG:05200|Pathways in cancer; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04640|Hematopoietic cell lineage
113669-21-9	KEGG:05219|Bladder cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04010|MAPK signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04623|Cytosolic DNA-sensing pathway
534-25-8	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection
111001-48-0	KEGG:01100|Metabolic pathways
67675-13-2	KEGG:00480|Glutathione metabolism; KEGG:00590|Arachidonic acid metabolism
6542-05-8	KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04930|Type II diabetes mellitus; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption
2422-79-9	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
524-42-5	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
106-99-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450
6640-24-0	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04540|Gap junction
472-86-6	KEGG:04976|Bile secretion
145757-47-7	KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05162|Measles
61805-96-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
75321-20-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway
28979-44-4	KEGG:05323|Rheumatoid arthritis; KEGG:04060|Cytokine-cytokine receptor interaction
5204-88-6	KEGG:01100|Metabolic pathways
31385-09-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
15532-75-9	KEGG:04080|Neuroactive ligand-receptor interaction
81276-03-1	KEGG:05218|Melanoma; KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:05221|Acute myeloid leukemia; KEGG:04666|Fc gamma R-mediated phagocytosis
76150-91-9	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04114|Oocyte meiosis; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00120|Primary bile acid biosynthesis; KEGG:00500|Starch and sucrose metabolism; KEGG:00920|Sulfur metabolism
138932-35-1	KEGG:04080|Neuroactive ligand-receptor interaction
81-64-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
123-91-1	KEGG:04110|Cell cycle
108614-26-2	KEGG:04080|Neuroactive ligand-receptor interaction
162054-19-5	KEGG:04210|Apoptosis; KEGG:05140|Leishmaniasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity
130-15-4	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes
85539-83-9	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04310|Wnt signaling pathway
88337-96-6	KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05020|Prion diseases; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
75414-43-6	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:05146|Amoebiasis
83-56-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction
73945-47-8	KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
2243-62-1	KEGG:00980|Metabolism of xenobiotics by cytochrome P450
112648-68-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04971|Gastric acid secretion; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00562|Inositol phosphate metabolism
61854-83-9	KEGG:04973|Carbohydrate digestion and absorption; KEGG:04742|Taste transduction
42397-64-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:00983|Drug metabolism - other enzymes
822-06-0	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:00232|Caffeine metabolism; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
92593-91-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:05221|Acute myeloid leukemia; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis
1228-73-5	KEGG:00561|Glycerolipid metabolism
21466-08-0	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:00140|Steroid hormone biosynthesis; KEGG:05162|Measles
630-56-8	KEGG:05152|Tuberculosis; KEGG:00591|Linoleic acid metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:00983|Drug metabolism - other enzymes
70761-64-7	KEGG:05219|Bladder cancer; KEGG:05213|Endometrial cancer; KEGG:05200|Pathways in cancer; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway
611-59-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00232|Caffeine metabolism
90780-52-2	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04514|Cell adhesion molecules (CAMs)
116360-82-8	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
230-46-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
1449-05-4	KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04973|Carbohydrate digestion and absorption; KEGG:00590|Arachidonic acid metabolism; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00562|Inositol phosphate metabolism
42397-65-9	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
81705-06-8	KEGG:00140|Steroid hormone biosynthesis
379-68-0	KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis
88378-35-2	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04730|Long-term depression; KEGG:04810|Regulation of actin cytoskeleton
52946-22-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04120|Ubiquitin mediated proteolysis
60965-80-2	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04660|T cell receptor signaling pathway
1614-12-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:00590|Arachidonic acid metabolism
1606-67-3	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04060|Cytokine-cytokine receptor interaction
4238-71-5	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism
106-94-5	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04540|Gap junction; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway
2921-20-2	KEGG:03320|PPAR signaling pathway
62938-14-1	KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis
64644-62-8	KEGG:04973|Carbohydrate digestion and absorption; KEGG:04742|Taste transduction
27451-36-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
678-39-7	KEGG:00140|Steroid hormone biosynthesis
506-52-5	KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04020|Calcium signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04970|Salivary secretion; KEGG:05146|Amoebiasis; KEGG:00330|Arginine and proline metabolism
86-48-6	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
41294-56-8	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:05146|Amoebiasis
16331-64-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04146|Peroxisome
5315-79-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00920|Sulfur metabolism; KEGG:00514|Other types of O-glycan biosynthesis
709-49-9	KEGG:05160|Hepatitis C; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:04670|Leukocyte transendothelial migration
2498-77-3	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
832-69-9	KEGG:04110|Cell cycle; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00030|Pentose phosphate pathway
90-15-3	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:00590|Arachidonic acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00920|Sulfur metabolism; KEGG:00514|Other types of O-glycan biosynthesis
86-57-7	KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04145|Phagosome; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation
108-03-2	KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:03320|PPAR signaling pathway
5522-43-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00970|Aminoacyl-tRNA biosynthesis
3391-86-4	KEGG:04080|Neuroactive ligand-receptor interaction
86390-77-4	KEGG:04975|Fat digestion and absorption
579-07-7	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
842-07-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes
50370-56-4	KEGG:05012|Parkinson's disease; KEGG:04976|Bile secretion
131384-80-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:04650|Natural killer cell mediated cytotoxicity
79551-86-3	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
3424-82-6	KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04020|Calcium signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04144|Endocytosis
38380-05-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04010|MAPK signaling pathway; KEGG:04722|Neurotrophin signaling pathway
35065-28-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04970|Salivary secretion; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04310|Wnt signaling pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00020|Citrate cycle (TCA cycle)
38379-99-6	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04930|Type II diabetes mellitus; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation; KEGG:04730|Long-term depression; KEGG:04114|Oocyte meiosis
131-55-5	KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis
950-99-2	KEGG:04115|p53 signaling pathway; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:04010|MAPK signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00340|Histidine metabolism
613-67-2	KEGG:04080|Neuroactive ligand-receptor interaction
26581-81-7	KEGG:05416|Viral myocarditis; KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04510|Focal adhesion; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04512|ECM-receptor interaction; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC)
2706-56-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05020|Prion diseases
13217-66-8	KEGG:04975|Fat digestion and absorption; KEGG:04977|Vitamin digestion and absorption
1675-54-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:04672|Intestinal immune network for IgA production
2971-36-0	KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04350|TGF-beta signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04510|Focal adhesion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis; KEGG:05414|Dilated cardiomyopathy
3296-90-0	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00983|Drug metabolism - other enzymes
92891-93-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05416|Viral myocarditis; KEGG:05216|Thyroid cancer
1222-87-3	KEGG:00564|Glycerophospholipid metabolism
306-83-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
2127-03-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04360|Axon guidance
17711-16-9	KEGG:05160|Hepatitis C; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis
146724-94-9	KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:00380|Tryptophan metabolism; KEGG:05143|African trypanosomiasis; KEGG:04670|Leukocyte transendothelial migration
38380-08-4	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04930|Type II diabetes mellitus; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04730|Long-term depression
32598-14-4	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
38380-07-3	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
31508-00-6	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04114|Oocyte meiosis; KEGG:04514|Cell adhesion molecules (CAMs)
57117-31-4	KEGG:05200|Pathways in cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
87-87-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis
119212-33-8	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton
80809-81-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway
38411-22-2	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis
50585-41-6	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
51207-31-9	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:04520|Adherens junction; KEGG:00480|Glutathione metabolism; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00520|Amino sugar and nucleotide sugar metabolism
76543-16-3	KEGG:04370|VEGF signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04510|Focal adhesion
76543-15-2	KEGG:00140|Steroid hormone biosynthesis; KEGG:04370|VEGF signaling pathway; KEGG:04510|Focal adhesion
87420-41-5	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04630|Jak-STAT signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
87173-03-3	KEGG:05145|Toxoplasmosis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05144|Malaria
771-97-1	KEGG:05016|Huntington's disease; KEGG:04146|Peroxisome
2687-25-4	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
6956-96-3	KEGG:04110|Cell cycle; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:01100|Metabolic pathways; KEGG:04610|Complement and coagulation cascades; KEGG:04510|Focal adhesion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis; KEGG:03030|DNA replication; KEGG:03420|Nucleotide excision repair
13394-86-0	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia
118876-58-7	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
3848-24-6	KEGG:00561|Glycerolipid metabolism
104121-92-8	KEGG:04920|Adipocytokine signaling pathway; KEGG:04976|Bile secretion
2437-79-8	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis
68138-65-8	KEGG:05416|Viral myocarditis; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04975|Fat digestion and absorption; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs)
120225-54-9	KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04930|Type II diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:04912|GnRH signaling pathway
7012-37-5	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis
35065-27-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04530|Tight junction; KEGG:00564|Glycerophospholipid metabolism; KEGG:05217|Basal cell carcinoma
37680-73-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:00983|Drug metabolism - other enzymes
95-95-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS)
118-79-6	KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis
88-06-2	KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis
1836-77-7	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway
95-80-7	KEGG:04110|Cell cycle; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:05322|Systemic lupus erythematosus; KEGG:00380|Tryptophan metabolism; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00240|Pyrimidine metabolism
25515-43-9	KEGG:05210|Colorectal cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
89-02-1	KEGG:04210|Apoptosis; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation
143134-35-4	KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction
121-14-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:00270|Cysteine and methionine metabolism; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00970|Aminoacyl-tRNA biosynthesis; KEGG:00340|Histidine metabolism; KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:00240|Pyrimidine metabolism; KEGG:03022|Basal transcription factors; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:04710|Circadian rhythm - mammal; KEGG:00563|Glycosylphosphatidylinositol(GPI)-anchor biosynthesis; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:03440|Homologous recombination; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:03015|mRNA surveillance pathway; KEGG:00670|One carbon pool by folate; KEGG:00770|Pantothenate and CoA biosynthesis; KEGG:00640|Propanoate metabolism; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:03020|RNA polymerase; KEGG:00600|Sphingolipid metabolism; KEGG:03040|Spliceosome; KEGG:04962|Vasopressin-regulated water reabsorption
80466-34-8	KEGG:00051|Fructose and mannose metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:00052|Galactose metabolism
474-73-7	KEGG:01100|Metabolic pathways; KEGG:03320|PPAR signaling pathway; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00120|Primary bile acid biosynthesis; KEGG:04977|Vitamin digestion and absorption
154447-36-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04512|ECM-receptor interaction; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05414|Dilated cardiomyopathy
99697-24-2	KEGG:04210|Apoptosis; KEGG:04115|p53 signaling pathway; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04940|Type I diabetes mellitus; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
2295-31-0	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05152|Tuberculosis; KEGG:05020|Prion diseases; KEGG:05216|Thyroid cancer; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway
7724-15-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
35693-99-3	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis
38444-81-4	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
490-79-9	KEGG:01100|Metabolic pathways; KEGG:04146|Peroxisome; KEGG:00480|Glutathione metabolism; KEGG:00920|Sulfur metabolism
110-13-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:01100|Metabolic pathways; KEGG:04010|MAPK signaling pathway; KEGG:04810|Regulation of actin cytoskeleton
2140-46-7	KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04976|Bile secretion; KEGG:00120|Primary bile acid biosynthesis
133310-38-0	KEGG:03410|Base excision repair
823-40-5	KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:03320|PPAR signaling pathway
618-80-4	KEGG:05010|Alzheimer's disease; KEGG:05016|Huntington's disease; KEGG:05012|Parkinson's disease; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:00071|Fatty acid metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00920|Sulfur metabolism; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00190|Oxidative phosphorylation
84-60-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
118790-71-9	KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05146|Amoebiasis
581-42-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00232|Caffeine metabolism
606-20-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:00270|Cysteine and methionine metabolism; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00500|Starch and sucrose metabolism; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00970|Aminoacyl-tRNA biosynthesis; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:00240|Pyrimidine metabolism; KEGG:03022|Basal transcription factors; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:00563|Glycosylphosphatidylinositol(GPI)-anchor biosynthesis; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03015|mRNA surveillance pathway; KEGG:00670|One carbon pool by folate; KEGG:00770|Pantothenate and CoA biosynthesis; KEGG:00640|Propanoate metabolism; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:00600|Sphingolipid metabolism; KEGG:03040|Spliceosome; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:00052|Galactose metabolism; KEGG:00650|Butanoate metabolism; KEGG:00510|N-Glycan biosynthesis; KEGG:00760|Nicotinate and nicotinamide metabolism; KEGG:00910|Nitrogen metabolism; KEGG:04330|Notch signaling pathway; KEGG:00072|Synthesis and degradation of ketone bodies
6485-57-0	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04360|Axon guidance
2607-52-5	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:04520|Adherens junction; KEGG:04670|Leukocyte transendothelial migration; KEGG:04612|Antigen processing and presentation; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05100|Bacterial invasion of epithelial cells
128-39-2	KEGG:00910|Nitrogen metabolism
576-26-1	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00910|Nitrogen metabolism
87-62-7	KEGG:00982|Drug metabolism - cytochrome P450
85138-49-4	KEGG:02010|ABC transporters
5405-53-8	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
20380-11-4	KEGG:05010|Alzheimer's disease; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04020|Calcium signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:04976|Bile secretion; KEGG:04975|Fat digestion and absorption; KEGG:00120|Primary bile acid biosynthesis; KEGG:04672|Intestinal immune network for IgA production
126005-94-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis
1745-81-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
126861-72-1	KEGG:00920|Sulfur metabolism
105650-23-5	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:05216|Thyroid cancer; KEGG:04722|Neurotrophin signaling pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00590|Arachidonic acid metabolism
77094-11-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
77500-04-0	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04010|MAPK signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04662|B cell receptor signaling pathway; KEGG:04722|Neurotrophin signaling pathway
68006-83-7	KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:00920|Sulfur metabolism
76180-96-6	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05211|Renal cell carcinoma; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:00232|Caffeine metabolism; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04530|Tight junction; KEGG:04360|Axon guidance; KEGG:05217|Basal cell carcinoma
35572-78-2	KEGG:05219|Bladder cancer; KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00330|Arginine and proline metabolism
712-30-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:04650|Natural killer cell mediated cytotoxicity
143800-82-2	KEGG:01100|Metabolic pathways; KEGG:00270|Cysteine and methionine metabolism
6323-99-5	KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton
26148-68-5	KEGG:01100|Metabolic pathways; KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
90-41-5	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton
153-78-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00232|Caffeine metabolism; KEGG:04722|Neurotrophin signaling pathway
95-55-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome
109-12-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450
137-07-5	KEGG:05322|Systemic lupus erythematosus; KEGG:04610|Complement and coagulation cascades; KEGG:05150|Staphylococcus aureus infection
90-04-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes
613-13-8	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
53847-30-6	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton
95034-25-6	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction
41098-69-5	KEGG:01100|Metabolic pathways; KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
107-09-5	KEGG:04270|Vascular smooth muscle contraction; KEGG:00230|Purine metabolism
18263-25-7	KEGG:05200|Pathways in cancer; KEGG:00830|Retinol metabolism; KEGG:04920|Adipocytokine signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:05143|African trypanosomiasis; KEGG:04977|Vitamin digestion and absorption
78-92-2	KEGG:04080|Neuroactive ligand-receptor interaction
4170-30-3	KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04144|Endocytosis; KEGG:04672|Intestinal immune network for IgA production; KEGG:00561|Glycerolipid metabolism
1977-08-8	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04540|Gap junction
689-98-5	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04144|Endocytosis
693-07-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:00590|Arachidonic acid metabolism; KEGG:03410|Base excision repair
95-48-7	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00590|Arachidonic acid metabolism
134665-72-8	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05215|Prostate cancer; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis
185915-33-7	KEGG:04350|TGF-beta signaling pathway; KEGG:04144|Endocytosis
19192-40-6	KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:04520|Adherens junction; KEGG:04670|Leukocyte transendothelial migration
118869-52-6	KEGG:01100|Metabolic pathways; KEGG:00670|One carbon pool by folate
95-50-1	KEGG:05200|Pathways in cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:00380|Tryptophan metabolism; KEGG:05216|Thyroid cancer; KEGG:04660|T cell receptor signaling pathway
110-80-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00524|Butirosin and neomycin biosynthesis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04973|Carbohydrate digestion and absorption; KEGG:00100|Steroid biosynthesis; KEGG:04340|Hedgehog signaling pathway
149-57-5	KEGG:03320|PPAR signaling pathway
505-57-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:00480|Glutathione metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00052|Galactose metabolism
124489-20-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00232|Caffeine metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
1214-47-7	KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:05221|Acute myeloid leukemia; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway
1126-61-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00983|Drug metabolism - other enzymes; KEGG:00533|Glycosaminoglycan biosynthesis - keratan sulfate
362-05-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00920|Sulfur metabolism; KEGG:00514|Other types of O-glycan biosynthesis
1232-80-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
362-06-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
818-61-1	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
583-92-6	KEGG:01100|Metabolic pathways
68-11-1	KEGG:04080|Neuroactive ligand-receptor interaction
60423-21-4	KEGG:05010|Alzheimer's disease; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05211|Renal cell carcinoma; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04662|B cell receptor signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:03010|Ribosome; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05130|Pathogenic Escherichia coli infection; KEGG:04142|Lysosome
10312-83-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:00071|Fatty acid metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism
579-75-9	KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
1504-74-1	KEGG:05140|Leishmaniasis
362-07-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04510|Focal adhesion; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
75987-08-5	KEGG:04146|Peroxisome
78263-90-8	KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway
2498-76-2	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
12108-13-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis
2531-84-2	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer
135-19-3	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04976|Bile secretion; KEGG:00590|Arachidonic acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
5307-14-2	KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:03320|PPAR signaling pathway
91-23-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:00590|Arachidonic acid metabolism
13177-29-2	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
607-57-8	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:00270|Cysteine and methionine metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:03050|Proteasome; KEGG:03010|Ribosome; KEGG:00983|Drug metabolism - other enzymes
88-75-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
79-46-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway
88-72-2	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:05217|Basal cell carcinoma
2463-53-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:00620|Pyruvate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism
111-80-8	KEGG:04978|Mineral absorption
19750-45-9	KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04660|T cell receptor signaling pathway
18390-00-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:04010|MAPK signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:05146|Amoebiasis
90-43-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer
1575-72-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
100045-68-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
2409-55-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05016|Huntington's disease; KEGG:04146|Peroxisome
1948-33-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05020|Prion diseases; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04520|Adherens junction; KEGG:00480|Glutathione metabolism; KEGG:02010|ABC transporters
68170-97-8	KEGG:03320|PPAR signaling pathway
155450-08-1	KEGG:04972|Pancreatic secretion; KEGG:05110|Vibrio cholerae infection
148-53-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
95-47-6	KEGG:04115|p53 signaling pathway; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04380|Osteoclast differentiation
100828-16-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus
83003-12-7	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
136982-36-0	KEGG:04080|Neuroactive ligand-receptor interaction
4339-71-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway
76-62-0	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
150336-90-6	KEGG:04080|Neuroactive ligand-receptor interaction
1968-05-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis
70-40-6	KEGG:00920|Sulfur metabolism
358-72-5	KEGG:04060|Cytokine-cytokine receptor interaction
14047-09-7	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
21232-47-3	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
32598-13-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:00071|Fatty acid metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04614|Renin-angiotensin system
123594-64-9	KEGG:05210|Colorectal cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04540|Gap junction; KEGG:04660|T cell receptor signaling pathway
81226-60-0	KEGG:04080|Neuroactive ligand-receptor interaction
32774-16-6	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:04660|T cell receptor signaling pathway
57465-28-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:00330|Arginine and proline metabolism; KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00910|Nitrogen metabolism; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism
95896-78-9	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
95-76-1	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism
129075-56-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:04930|Type II diabetes mellitus; KEGG:04950|Maturity onset diabetes of the young
5707-55-1	KEGG:00010|Glycolysis / Gluconeogenesis
10597-60-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma
6515-38-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:00564|Glycerophospholipid metabolism
79755-43-4	KEGG:04080|Neuroactive ligand-receptor interaction
34883-41-5	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis
146255-66-5	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway
1158-10-7	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
95906-67-5	KEGG:05223|Non-small cell lung cancer; KEGG:05222|Small cell lung cancer; KEGG:05416|Viral myocarditis; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:03320|PPAR signaling pathway; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04512|ECM-receptor interaction; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs)
154453-18-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway
128714-76-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
81485-25-8	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway
14114-46-6	KEGG:04080|Neuroactive ligand-receptor interaction
156177-65-0	KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04660|T cell receptor signaling pathway
50722-38-8	KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05140|Leishmaniasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
3544-24-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04950|Maturity onset diabetes of the young; KEGG:03410|Base excision repair
2693-46-1	KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
103680-47-3	KEGG:04080|Neuroactive ligand-receptor interaction
108-43-0	KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04630|Jak-STAT signaling pathway; KEGG:05310|Asthma
117620-77-6	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00380|Tryptophan metabolism
6736-58-9	KEGG:05210|Colorectal cancer
102052-95-9	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04310|Wnt signaling pathway; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:05217|Basal cell carcinoma
109-55-7	KEGG:04978|Mineral absorption
99-65-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis; KEGG:03050|Proteasome; KEGG:04360|Axon guidance
25521-33-9	KEGG:04976|Bile secretion; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption
6561-58-6	KEGG:03320|PPAR signaling pathway
621-42-1	KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:01100|Metabolic pathways; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00120|Primary bile acid biosynthesis
13345-21-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00920|Sulfur metabolism; KEGG:00514|Other types of O-glycan biosynthesis
577-85-5	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:00140|Steroid hormone biosynthesis; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:00380|Tryptophan metabolism; KEGG:05216|Thyroid cancer; KEGG:04320|Dorso-ventral axis formation; KEGG:04650|Natural killer cell mediated cytotoxicity
21616-46-6	KEGG:01100|Metabolic pathways; KEGG:00790|Folate biosynthesis
82413-20-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00983|Drug metabolism - other enzymes
55406-53-6	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04610|Complement and coagulation cascades
54048-10-1	KEGG:04610|Complement and coagulation cascades; KEGG:04810|Regulation of actin cytoskeleton
1531-25-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00983|Drug metabolism - other enzymes
147402-53-7	KEGG:04080|Neuroactive ligand-receptor interaction
5142-23-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:04150|mTOR signaling pathway; KEGG:04140|Regulation of autophagy
488-17-5	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
40642-83-9	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism
108-99-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
480-19-3	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:02010|ABC transporters; KEGG:00330|Arginine and proline metabolism
99-61-6	KEGG:00561|Glycerolipid metabolism
892-21-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
504-88-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:04146|Peroxisome; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway
81790-82-1	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05223|Non-small cell lung cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation; KEGG:05332|Graft-versus-host disease; KEGG:04660|T cell receptor signaling pathway
501-52-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
108-38-3	KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction
151070-83-6	KEGG:04080|Neuroactive ligand-receptor interaction
71441-28-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05152|Tuberculosis; KEGG:04920|Adipocytokine signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles
34284-75-8	KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:04670|Leukocyte transendothelial migration
63608-11-7	KEGG:01100|Metabolic pathways; KEGG:04146|Peroxisome
101-77-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00120|Primary bile acid biosynthesis; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00020|Citrate cycle (TCA cycle); KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:03440|Homologous recombination; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03015|mRNA surveillance pathway; KEGG:00640|Propanoate metabolism; KEGG:00600|Sphingolipid metabolism; KEGG:03040|Spliceosome; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:03060|Protein export
613-33-2	KEGG:00982|Drug metabolism - cytochrome P450
101-68-8	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:00232|Caffeine metabolism; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05150|Staphylococcus aureus infection; KEGG:00983|Drug metabolism - other enzymes; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
107430-51-3	KEGG:05200|Pathways in cancer
64603-91-4	KEGG:04080|Neuroactive ligand-receptor interaction
28664-35-9	KEGG:04080|Neuroactive ligand-receptor interaction
127686-49-1	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction
28322-02-3	KEGG:04115|p53 signaling pathway; KEGG:03320|PPAR signaling pathway
1742-95-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:03450|Non-homologous end-joining
19406-51-0	KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:04020|Calcium signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:05162|Measles; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:00230|Purine metabolism; KEGG:03013|RNA transport; KEGG:04530|Tight junction; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00970|Aminoacyl-tRNA biosynthesis; KEGG:00240|Pyrimidine metabolism; KEGG:00670|One carbon pool by folate; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:03040|Spliceosome
2835-68-9	KEGG:05200|Pathways in cancer
25747-40-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:04370|VEGF signaling pathway
123-30-8	KEGG:04210|Apoptosis; KEGG:04141|Protein processing in endoplasmic reticulum
6283-24-5	KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:04670|Leukocyte transendothelial migration
1852-61-5	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer
104-94-9	KEGG:04110|Cell cycle; KEGG:04115|p53 signaling pathway; KEGG:00232|Caffeine metabolism; KEGG:00760|Nicotinate and nicotinamide metabolism
611-95-0	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
92-67-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00232|Caffeine metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions
106-40-1	KEGG:01100|Metabolic pathways; KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
99-73-0	KEGG:05140|Leishmaniasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
106-47-8	KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
2051-62-9	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis
100-00-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
5304-59-6	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis
7400-08-0	KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:00920|Sulfur metabolism
106-44-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:05323|Rheumatoid arthritis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04670|Leukocyte transendothelial migration; KEGG:04514|Cell adhesion molecules (CAMs)
106-46-7	KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04010|MAPK signaling pathway; KEGG:00380|Tryptophan metabolism
133208-93-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:04976|Bile secretion; KEGG:00983|Drug metabolism - other enzymes
120-21-8	KEGG:00830|Retinol metabolism; KEGG:04950|Maturity onset diabetes of the young
6203-18-5	KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:00380|Tryptophan metabolism; KEGG:00071|Fatty acid metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism
81405-11-0	KEGG:04620|Toll-like receptor signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
123-07-9	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04730|Long-term depression; KEGG:04660|T cell receptor signaling pathway
17427-08-6	KEGG:05016|Huntington's disease; KEGG:05012|Parkinson's disease
29343-52-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:04672|Intestinal immune network for IgA production; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:03420|Nucleotide excision repair; KEGG:03410|Base excision repair; KEGG:04710|Circadian rhythm - mammal; KEGG:03440|Homologous recombination
99-93-4	KEGG:04910|Insulin signaling pathway; KEGG:00500|Starch and sucrose metabolism
150-76-5	KEGG:04141|Protein processing in endoplasmic reticulum
2086-86-4	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
20426-12-4	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
1076-38-6	KEGG:04370|VEGF signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04510|Focal adhesion; KEGG:04670|Leukocyte transendothelial migration; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells
81608-60-8	KEGG:05214|Glioma; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04012|ErbB signaling pathway; KEGG:03010|Ribosome
5976-61-4	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis
3131-23-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
138-85-2	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04660|T cell receptor signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
110025-28-0	KEGG:04012|ErbB signaling pathway
18344-42-8	KEGG:00051|Fructose and mannose metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:00052|Galactose metabolism
66592-72-1	KEGG:00830|Retinol metabolism
68392-35-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00240|Pyrimidine metabolism; KEGG:03008|Ribosome biogenesis in eukaryotes
60113-82-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
24579-14-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism
64584-34-5	KEGG:04020|Calcium signaling pathway
540-37-4	KEGG:01100|Metabolic pathways; KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
32954-58-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways
832-01-9	KEGG:04110|Cell cycle; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04114|Oocyte meiosis
91-44-1	KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma
316-49-4	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
452-86-8	KEGG:04210|Apoptosis; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis
19438-60-9	KEGG:04060|Cytokine-cytokine receptor interaction
36507-31-0	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
2747-05-9	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04612|Antigen processing and presentation; KEGG:00983|Drug metabolism - other enzymes
120685-11-2	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05020|Prion diseases; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04310|Wnt signaling pathway; KEGG:04971|Gastric acid secretion; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection
2581-34-2	KEGG:01100|Metabolic pathways
100-01-6	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
555-16-8	KEGG:00561|Glycerolipid metabolism
100-14-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
5339-26-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
100-02-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00232|Caffeine metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00920|Sulfur metabolism; KEGG:00514|Other types of O-glycan biosynthesis
830-03-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:00983|Drug metabolism - other enzymes; KEGG:00561|Glycerolipid metabolism; KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism
104-03-0	KEGG:01100|Metabolic pathways; KEGG:00983|Drug metabolism - other enzymes
2635-84-9	KEGG:00983|Drug metabolism - other enzymes
131549-85-4	KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma
99-99-0	KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection
64091-91-4	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:03050|Proteasome; KEGG:03010|Ribosome; KEGG:00590|Arachidonic acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00330|Arginine and proline metabolism
104-40-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04260|Cardiac muscle contraction; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:04975|Fat digestion and absorption; KEGG:05310|Asthma
1806-26-4	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:00920|Sulfur metabolism; KEGG:00450|Selenocompound metabolism
57716-89-9	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04350|TGF-beta signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04660|T cell receptor signaling pathway
33532-44-4	KEGG:00051|Fructose and mannose metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:00052|Galactose metabolism
38030-57-8	KEGG:05219|Bladder cancer; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04510|Focal adhesion; KEGG:04512|ECM-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
62702-55-0	KEGG:05200|Pathways in cancer; KEGG:05130|Pathogenic Escherichia coli infection
1821-12-1	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05162|Measles; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04612|Antigen processing and presentation; KEGG:03040|Spliceosome
106-50-3	KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00232|Caffeine metabolism; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
92-69-3	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04114|Oocyte meiosis; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
645-56-7	KEGG:05219|Bladder cancer; KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05020|Prion diseases; KEGG:04930|Type II diabetes mellitus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05216|Thyroid cancer; KEGG:04320|Dorso-ventral axis formation; KEGG:00480|Glutathione metabolism
140-66-9	KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05152|Tuberculosis; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04978|Mineral absorption; KEGG:04510|Focal adhesion; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction
622-58-2	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
128095-54-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
106-87-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:04530|Tight junction; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC)
100-43-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
106-42-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism
213252-19-8	KEGG:03320|PPAR signaling pathway
63741-13-9	KEGG:04350|TGF-beta signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction
3317-61-1	KEGG:04145|Phagosome
17528-72-2	KEGG:01100|Metabolic pathways; KEGG:04020|Calcium signaling pathway; KEGG:00330|Arginine and proline metabolism
29347-89-5	KEGG:01100|Metabolic pathways; KEGG:00670|One carbon pool by folate; KEGG:00790|Folate biosynthesis
153570-58-2	KEGG:04080|Neuroactive ligand-receptor interaction
117570-53-3	KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:02010|ABC transporters
480-11-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
21392-57-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05140|Leishmaniasis; KEGG:05146|Amoebiasis; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:05217|Basal cell carcinoma
3469-78-1	KEGG:04020|Calcium signaling pathway
156680-74-9	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
74885-09-9	KEGG:04080|Neuroactive ligand-receptor interaction
79955-27-4	KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
26172-55-4	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05332|Graft-versus-host disease; KEGG:04672|Intestinal immune network for IgA production
1820-81-1	KEGG:03410|Base excision repair
1214-79-5	KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04976|Bile secretion
153042-42-3	KEGG:04020|Calcium signaling pathway; KEGG:04146|Peroxisome; KEGG:00330|Arginine and proline metabolism
72255-35-7	KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
624-00-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04660|T cell receptor signaling pathway
81517-87-5	KEGG:01100|Metabolic pathways
491-78-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
1953-54-4	KEGG:00920|Sulfur metabolism
53660-23-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
85379-09-5	KEGG:04080|Neuroactive ligand-receptor interaction
484-20-8	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:04914|Progesterone-mediated oocyte maturation
2319-96-2	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
14172-53-3	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
134-35-0	KEGG:04977|Vitamin digestion and absorption; KEGG:00670|One carbon pool by folate
2457-80-9	KEGG:05146|Amoebiasis; KEGG:04510|Focal adhesion; KEGG:04512|ECM-receptor interaction; KEGG:04974|Protein digestion and absorption
34661-85-3	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction
107254-86-4	KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05146|Amoebiasis
136623-01-3	KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction
96861-65-3	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
1428-95-1	KEGG:04141|Protein processing in endoplasmic reticulum
72873-74-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05160|Hepatitis C; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04660|T cell receptor signaling pathway
146535-11-7	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
91300-60-6	KEGG:05016|Huntington's disease; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
88070-98-8	KEGG:05145|Toxoplasmosis; KEGG:00590|Arachidonic acid metabolism
3301-79-9	KEGG:02010|ABC transporters
2642-98-0	KEGG:05219|Bladder cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:04012|ErbB signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04540|Gap junction
467-13-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
163163-23-3	KEGG:04974|Protein digestion and absorption
56305-04-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04672|Intestinal immune network for IgA production
37515-51-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
18003-33-3	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
2208-41-5	KEGG:00920|Sulfur metabolism
33458-93-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:05217|Basal cell carcinoma
115039-00-4	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
316-14-3	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
2381-39-7	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
63041-90-7	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
7496-02-8	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
2784-73-8	KEGG:01100|Metabolic pathways; KEGG:00983|Drug metabolism - other enzymes
2498-66-0	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
72617-60-8	KEGG:00980|Metabolism of xenobiotics by cytochrome P450
73536-69-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04380|Osteoclast differentiation; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity
131403-76-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:04976|Bile secretion
129468-28-6	KEGG:04080|Neuroactive ligand-receptor interaction
127191-86-0	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
127191-85-9	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
115453-82-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
194-59-2	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
74938-11-7	KEGG:04080|Neuroactive ligand-receptor interaction
575-03-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00590|Arachidonic acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
93-35-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
6665-86-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:04976|Bile secretion; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes
112953-11-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton
566-28-9	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00120|Primary bile acid biosynthesis
5725-89-3	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00380|Tryptophan metabolism
2541-69-7	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
578-76-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
20268-51-3	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
2942-42-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:04080|Neuroactive ligand-receptor interaction
157622-55-4	KEGG:04080|Neuroactive ligand-receptor interaction
148589-13-3	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04270|Vascular smooth muscle contraction
41941-66-6	KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04742|Taste transduction
54364-02-2	KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:03320|PPAR signaling pathway; KEGG:04730|Long-term depression; KEGG:04742|Taste transduction
80206-91-3	KEGG:04060|Cytokine-cytokine receptor interaction
273-40-5	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05162|Measles
53696-59-6	KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
31356-94-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway
150418-07-8	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:05146|Amoebiasis
68206-94-0	KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:00330|Arginine and proline metabolism
27415-26-5	KEGG:05140|Leishmaniasis
73179-96-1	KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04630|Jak-STAT signaling pathway
2381-31-9	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
88847-89-6	KEGG:01100|Metabolic pathways; KEGG:00270|Cysteine and methionine metabolism; KEGG:00590|Arachidonic acid metabolism; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:00450|Selenocompound metabolism
65167-83-1	KEGG:03320|PPAR signaling pathway
84-11-7	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00590|Arachidonic acid metabolism; KEGG:00561|Glycerolipid metabolism
1839-11-8	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:03320|PPAR signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage
59262-86-1	KEGG:00230|Purine metabolism
514-85-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04976|Bile secretion; KEGG:00071|Fatty acid metabolism
60203-57-8	KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:03320|PPAR signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:00480|Glutathione metabolism
144598-75-4	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04540|Gap junction
104195-61-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05216|Thyroid cancer; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway
130465-45-1	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction
108605-62-5	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
71751-41-2	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04610|Complement and coagulation cascades; KEGG:05130|Pathogenic Escherichia coli infection
118931-00-3	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction
480-44-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
2627-69-2	KEGG:04115|p53 signaling pathway
77337-76-9	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04540|Gap junction
56180-94-0	KEGG:04910|Insulin signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04920|Adipocytokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction
37517-30-9	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:04660|T cell receptor signaling pathway
89796-99-6	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway
82-86-0	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
208-96-8	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
152-72-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
30560-19-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism
75-07-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:00071|Fatty acid metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:00040|Pentose and glucuronate interconversions; KEGG:04672|Intestinal immune network for IgA production; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00340|Histidine metabolism; KEGG:05217|Basal cell carcinoma; KEGG:00410|beta-Alanine metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism
53-96-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04530|Tight junction; KEGG:02010|ABC transporters; KEGG:04514|Cell adhesion molecules (CAMs)
103-90-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00120|Primary bile acid biosynthesis; KEGG:00500|Starch and sucrose metabolism; KEGG:00920|Sulfur metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00970|Aminoacyl-tRNA biosynthesis; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04977|Vitamin digestion and absorption; KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03022|Basal transcription factors; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:04710|Circadian rhythm - mammal; KEGG:00563|Glycosylphosphatidylinositol(GPI)-anchor biosynthesis; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:03440|Homologous recombination; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:03015|mRNA surveillance pathway; KEGG:00670|One carbon pool by folate; KEGG:00770|Pantothenate and CoA biosynthesis; KEGG:00640|Propanoate metabolism; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:03020|RNA polymerase; KEGG:00600|Sphingolipid metabolism; KEGG:03040|Spliceosome; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:00510|N-Glycan biosynthesis; KEGG:00760|Nicotinate and nicotinamide metabolism; KEGG:04330|Notch signaling pathway; KEGG:04340|Hedgehog signaling pathway; KEGG:00533|Glycosaminoglycan biosynthesis - keratan sulfate; KEGG:04614|Renin-angiotensin system; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism; KEGG:00790|Folate biosynthesis; KEGG:04140|Regulation of autophagy; KEGG:03060|Protein export; KEGG:00450|Selenocompound metabolism; KEGG:04974|Protein digestion and absorption; KEGG:00565|Ether lipid metabolism; KEGG:00532|Glycosaminoglycan biosynthesis - chondroitin sulfate; KEGG:00511|Other glycan degradation; KEGG:00400|Phenylalanine, tyrosine and tryptophan biosynthesis; KEGG:05340|Primary immunodeficiency; KEGG:04130|SNARE interactions in vesicular transport; KEGG:04122|Sulfur relay system; KEGG:00430|Taurine and hypotaurine metabolism
59-66-5	KEGG:04010|MAPK signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00910|Nitrogen metabolism
64-19-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04612|Antigen processing and presentation; KEGG:00270|Cysteine and methionine metabolism; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04120|Ubiquitin mediated proteolysis
34256-82-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
546-88-3	KEGG:05323|Rheumatoid arthritis
67-64-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:05140|Leishmaniasis; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:04146|Peroxisome; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00590|Arachidonic acid metabolism; KEGG:05310|Asthma
103-02-6	KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
75-05-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00590|Arachidonic acid metabolism; KEGG:00920|Sulfur metabolism
98-86-2	KEGG:05219|Bladder cancer; KEGG:05213|Endometrial cancer; KEGG:05223|Non-small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04930|Type II diabetes mellitus; KEGG:04724|Glutamatergic synapse; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation; KEGG:04730|Long-term depression; KEGG:00790|Folate biosynthesis
81110-73-8	KEGG:04614|Renin-angiotensin system
33665-90-6	KEGG:04973|Carbohydrate digestion and absorption; KEGG:04742|Taste transduction
498-02-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00590|Arachidonic acid metabolism
14992-62-2	KEGG:05010|Alzheimer's disease; KEGG:05016|Huntington's disease; KEGG:05012|Parkinson's disease; KEGG:04350|TGF-beta signaling pathway; KEGG:03010|Ribosome; KEGG:00190|Oxidative phosphorylation
51-84-3	KEGG:05010|Alzheimer's disease; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04270|Vascular smooth muscle contraction; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04640|Hematopoietic cell lineage; KEGG:04810|Regulation of actin cytoskeleton
72-89-9	KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
616-91-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:02010|ABC transporters; KEGG:04360|Axon guidance; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:04140|Regulation of autophagy
7512-17-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05323|Rheumatoid arthritis; KEGG:05144|Malaria; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:00480|Glutathione metabolism; KEGG:04514|Cell adhesion molecules (CAMs)
1068-57-1	KEGG:05210|Colorectal cancer; KEGG:04012|ErbB signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04670|Leukocyte transendothelial migration; KEGG:04660|T cell receptor signaling pathway
110044-82-1	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04310|Wnt signaling pathway
21145-77-7	KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease
53678-77-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
37933-78-1	KEGG:04020|Calcium signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05310|Asthma
4468-05-7	KEGG:04080|Neuroactive ligand-receptor interaction
134044-97-6	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
72420-38-3	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis
55079-83-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway
57576-44-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05016|Huntington's disease; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04120|Ubiquitin mediated proteolysis
302-27-2	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00590|Arachidonic acid metabolism
65-61-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04722|Neurotrophin signaling pathway
107-02-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:00040|Pentose and glucuronate interconversions; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:05340|Primary immunodeficiency
79-06-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:00330|Arginine and proline metabolism
86636-92-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
107-13-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04722|Neurotrophin signaling pathway
18642-44-9	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05162|Measles
61276-17-3	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
16960-16-0	KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway
59277-89-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05215|Prostate cancer; KEGG:00380|Tryptophan metabolism; KEGG:05143|African trypanosomiasis
170157-13-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:04940|Type I diabetes mellitus
281-23-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04260|Cardiac muscle contraction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:03050|Proteasome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:03018|RNA degradation; KEGG:05217|Basal cell carcinoma; KEGG:00190|Oxidative phosphorylation; KEGG:04340|Hedgehog signaling pathway
106685-40-9	KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04672|Intestinal immune network for IgA production
106941-25-7	KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
142340-99-6	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05140|Leishmaniasis; KEGG:05146|Amoebiasis
149091-92-9	KEGG:05010|Alzheimer's disease; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04972|Pancreatic secretion; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04070|Phosphatidylinositol signaling system
58-61-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04977|Vitamin digestion and absorption; KEGG:03410|Base excision repair; KEGG:00310|Lysine degradation; KEGG:00910|Nitrogen metabolism; KEGG:04614|Renin-angiotensin system; KEGG:03450|Non-homologous end-joining; KEGG:04974|Protein digestion and absorption; KEGG:00471|D-Glutamine and D-glutamate metabolism
23645-17-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
3768-14-7	KEGG:04080|Neuroactive ligand-receptor interaction
35094-46-3	KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
60-92-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:04672|Intestinal immune network for IgA production; KEGG:04742|Taste transduction; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05414|Dilated cardiomyopathy; KEGG:05217|Basal cell carcinoma; KEGG:04330|Notch signaling pathway; KEGG:04614|Renin-angiotensin system; KEGG:04974|Protein digestion and absorption
58-64-0	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC)
61-19-8	KEGG:03022|Basal transcription factors
56-65-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04810|Regulation of actin cytoskeleton; KEGG:02010|ABC transporters; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
979-92-0	KEGG:05010|Alzheimer's disease; KEGG:00270|Cysteine and methionine metabolism
29908-03-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00270|Cysteine and methionine metabolism
37115-32-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction
9002-60-2	KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway
53468-06-7	KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway
141434-67-5	KEGG:01100|Metabolic pathways
1162-65-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00120|Primary bile acid biosynthesis; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:03440|Homologous recombination; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:03015|mRNA surveillance pathway; KEGG:00670|One carbon pool by folate; KEGG:00770|Pantothenate and CoA biosynthesis; KEGG:00640|Propanoate metabolism; KEGG:03040|Spliceosome; KEGG:00052|Galactose metabolism; KEGG:00650|Butanoate metabolism; KEGG:00760|Nicotinate and nicotinamide metabolism; KEGG:00910|Nitrogen metabolism; KEGG:00072|Synthesis and degradation of ketone bodies; KEGG:04340|Hedgehog signaling pathway; KEGG:00350|Tyrosine metabolism; KEGG:04974|Protein digestion and absorption; KEGG:00565|Ether lipid metabolism; KEGG:00532|Glycosaminoglycan biosynthesis - chondroitin sulfate; KEGG:04130|SNARE interactions in vesicular transport
42583-46-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00480|Glutathione metabolism
22040-96-6	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production
1165-39-5	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04612|Antigen processing and presentation; KEGG:04145|Phagosome; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease
6795-23-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism
56287-74-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
118409-62-4	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
81443-73-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:05217|Basal cell carcinoma
3031-94-5	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00640|Propanoate metabolism; KEGG:00061|Fatty acid biosynthesis; KEGG:04013|MAPK signaling pathway - fly
15972-60-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04974|Protein digestion and absorption
63631-40-3	KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
100929-53-1	KEGG:05010|Alzheimer's disease; KEGG:05020|Prion diseases; KEGG:04930|Type II diabetes mellitus; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04270|Vascular smooth muscle contraction; KEGG:05216|Thyroid cancer; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton
54965-21-8	KEGG:05219|Bladder cancer; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04060|Cytokine-cytokine receptor interaction
18559-94-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production
66734-13-2	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
23214-96-2	KEGG:04080|Neuroactive ligand-receptor interaction
116-06-3	KEGG:00564|Glycerophospholipid metabolism
35144-64-0	KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism
52-39-1	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04614|Renin-angiotensin system
3604-86-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
309-00-2	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00830|Retinol metabolism; KEGG:04020|Calcium signaling pathway; KEGG:04510|Focal adhesion; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton
66376-36-1	KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05211|Renal cell carcinoma; KEGG:04010|MAPK signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:04510|Focal adhesion; KEGG:04670|Leukocyte transendothelial migration; KEGG:04974|Protein digestion and absorption
22573-93-9	KEGG:05219|Bladder cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04623|Cytosolic DNA-sensing pathway
71195-58-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00983|Drug metabolism - other enzymes
81403-80-7	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction
9005-32-7	KEGG:05323|Rheumatoid arthritis; KEGG:05144|Malaria; KEGG:05143|African trypanosomiasis; KEGG:04650|Natural killer cell mediated cytotoxicity
5300-03-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04512|ECM-receptor interaction; KEGG:04950|Maturity onset diabetes of the young; KEGG:04810|Regulation of actin cytoskeleton; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00983|Drug metabolism - other enzymes; KEGG:00500|Starch and sucrose metabolism; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05414|Dilated cardiomyopathy; KEGG:04974|Protein digestion and absorption
72-48-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
6170-06-5	KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04380|Osteoclast differentiation
97-59-6	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00232|Caffeine metabolism; KEGG:00230|Purine metabolism
584-79-2	KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction
539-86-6	KEGG:05323|Rheumatoid arthritis; KEGG:05144|Malaria; KEGG:05143|African trypanosomiasis; KEGG:04650|Natural killer cell mediated cytotoxicity
17795-27-6	KEGG:05219|Bladder cancer; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer
485-91-6	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
8015-61-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
315-30-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
6038-51-3	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05216|Thyroid cancer; KEGG:05162|Measles
50-71-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:04722|Neurotrophin signaling pathway
107-18-6	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
107-05-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
1069-48-3	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
57-06-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00480|Glutathione metabolism
10152-76-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450
592-88-1	KEGG:04110|Cell cycle; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
154323-57-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:00590|Arachidonic acid metabolism
56293-29-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04010|MAPK signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity
122852-42-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism
105565-56-8	KEGG:04080|Neuroactive ligand-receptor interaction
77521-29-0	KEGG:05016|Huntington's disease
7292-42-4	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction
566-65-4	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
145-14-2	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
521-18-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04672|Intestinal immune network for IgA production; KEGG:00061|Fatty acid biosynthesis
69672-40-8	KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05340|Primary immunodeficiency
27013-91-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism
319-84-6	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04010|MAPK signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:05216|Thyroid cancer; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:00071|Fatty acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:00640|Propanoate metabolism
328-50-7	KEGG:05211|Renal cell carcinoma
816-66-0	KEGG:04910|Insulin signaling pathway; KEGG:04930|Type II diabetes mellitus
463-40-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04976|Bile secretion; KEGG:00590|Arachidonic acid metabolism; KEGG:00061|Fatty acid biosynthesis
146669-29-6	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
15398-87-5	KEGG:00480|Glutathione metabolism
6986-90-9	KEGG:04080|Neuroactive ligand-receptor interaction
604-59-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00590|Arachidonic acid metabolism
86-84-0	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
86-88-4	KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04010|MAPK signaling pathway; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton
487-19-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
101910-24-1	KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:00590|Arachidonic acid metabolism
59-02-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00620|Pyruvate metabolism
23930-19-0	KEGG:04080|Neuroactive ligand-receptor interaction
28981-97-7	KEGG:05010|Alzheimer's disease; KEGG:00591|Linoleic acid metabolism; KEGG:04080|Neuroactive ligand-receptor interaction
13655-52-2	KEGG:05219|Bladder cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04520|Adherens junction; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04144|Endocytosis; KEGG:04744|Phototransduction
641-38-3	KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis
23452-05-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis
7429-90-5	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:00480|Glutathione metabolism; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00564|Glycerophospholipid metabolism
7446-70-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00330|Arginine and proline metabolism; KEGG:04974|Protein digestion and absorption
21645-51-2	KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
99874-23-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04146|Peroxisome; KEGG:05216|Thyroid cancer
23058-19-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00360|Phenylalanine metabolism
1344-28-1	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04974|Protein digestion and absorption
20859-73-8	KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:00500|Starch and sucrose metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:00052|Galactose metabolism
10043-01-3	KEGG:04010|MAPK signaling pathway
102121-60-8	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:01100|Metabolic pathways; KEGG:05140|Leishmaniasis; KEGG:05146|Amoebiasis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04640|Hematopoietic cell lineage; KEGG:04512|ECM-receptor interaction
94497-51-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:04360|Axon guidance; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:04142|Lysosome; KEGG:03015|mRNA surveillance pathway; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:05340|Primary immunodeficiency; KEGG:04966|Collecting duct acid secretion
768-94-5	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity
21018-84-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS)
177036-94-1	KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04623|Cytosolic DNA-sensing pathway
1617-53-4	KEGG:05222|Small cell lung cancer; KEGG:01100|Metabolic pathways; KEGG:05140|Leishmaniasis; KEGG:04916|Melanogenesis; KEGG:00350|Tyrosine metabolism
20537-88-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
2609-46-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04971|Gastric acid secretion; KEGG:04742|Taste transduction
298-08-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04146|Peroxisome
540-61-4	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton
90-45-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:04722|Neurotrophin signaling pathway
542-32-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus
60-09-3	KEGG:00910|Nitrogen metabolism
97-56-3	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism; KEGG:02010|ABC transporters
150-13-0	KEGG:04210|Apoptosis; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00232|Caffeine metabolism; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:00983|Drug metabolism - other enzymes
56-12-2	KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04972|Pancreatic secretion; KEGG:04976|Bile secretion; KEGG:00071|Fatty acid metabolism; KEGG:03010|Ribosome; KEGG:02010|ABC transporters; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00770|Pantothenate and CoA biosynthesis; KEGG:00350|Tyrosine metabolism
39984-17-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis
141-43-5	KEGG:05218|Melanoma; KEGG:04810|Regulation of actin cytoskeleton
125-84-8	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04912|GnRH signaling pathway
60-32-2	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis
61-78-9	KEGG:04976|Bile secretion
360-97-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:00640|Propanoate metabolism; KEGG:00061|Fatty acid biosynthesis; KEGG:04013|MAPK signaling pathway - fly
106-60-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
454-28-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00270|Cysteine and methionine metabolism; KEGG:04360|Axon guidance
134-32-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00590|Arachidonic acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions
91-59-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00232|Caffeine metabolism; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:05150|Staphylococcus aureus infection; KEGG:00920|Sulfur metabolism; KEGG:04614|Renin-angiotensin system
329-89-5	KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04672|Intestinal immune network for IgA production; KEGG:05414|Dilated cardiomyopathy
645-88-5	KEGG:01100|Metabolic pathways; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00410|beta-Alanine metabolism; KEGG:00650|Butanoate metabolism
317-34-0	KEGG:04080|Neuroactive ligand-receptor interaction
107-11-9	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04012|ErbB signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05131|Shigellosis; KEGG:04510|Focal adhesion; KEGG:04512|ECM-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC)
54-62-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00983|Drug metabolism - other enzymes; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:04977|Vitamin digestion and absorption; KEGG:00410|beta-Alanine metabolism; KEGG:04142|Lysosome; KEGG:00670|One carbon pool by folate; KEGG:00640|Propanoate metabolism; KEGG:00600|Sphingolipid metabolism; KEGG:00790|Folate biosynthesis; KEGG:04974|Protein digestion and absorption; KEGG:05340|Primary immunodeficiency; KEGG:00062|Fatty acid elongation in mitochondria
452-06-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04621|NOD-like receptor signaling pathway
504-24-5	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05213|Endometrial cancer; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04930|Type II diabetes mellitus; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04270|Vascular smooth muscle contraction; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation
58-15-1	KEGG:04210|Apoptosis; KEGG:05214|Glioma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04623|Cytosolic DNA-sensing pathway
89-57-6	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04940|Type I diabetes mellitus; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00232|Caffeine metabolism; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles
65-49-6	KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
1951-25-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:05144|Malaria; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:03050|Proteasome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:03010|Ribosome; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00410|beta-Alanine metabolism; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00510|N-Glycan biosynthesis; KEGG:00910|Nitrogen metabolism; KEGG:04974|Protein digestion and absorption
33089-61-1	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00380|Tryptophan metabolism
50-48-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:04976|Bile secretion; KEGG:00270|Cysteine and methionine metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00330|Arginine and proline metabolism; KEGG:00340|Histidine metabolism; KEGG:00910|Nitrogen metabolism
61-82-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05016|Huntington's disease; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04146|Peroxisome
88150-42-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04930|Type II diabetes mellitus; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis; KEGG:05414|Dilated cardiomyopathy; KEGG:04614|Renin-angiotensin system
7664-41-7	KEGG:05152|Tuberculosis; KEGG:01100|Metabolic pathways; KEGG:04724|Glutamatergic synapse; KEGG:04270|Vascular smooth muscle contraction; KEGG:04978|Mineral absorption; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:04976|Bile secretion; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00330|Arginine and proline metabolism; KEGG:00910|Nitrogen metabolism
631-61-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:01100|Metabolic pathways; KEGG:04720|Long-term potentiation; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:00230|Purine metabolism; KEGG:00330|Arginine and proline metabolism
12125-02-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:00100|Steroid biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00120|Primary bile acid biosynthesis; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00562|Inositol phosphate metabolism; KEGG:04742|Taste transduction; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04977|Vitamin digestion and absorption; KEGG:00564|Glycerophospholipid metabolism; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:04710|Circadian rhythm - mammal; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:00640|Propanoate metabolism; KEGG:00600|Sphingolipid metabolism; KEGG:03040|Spliceosome; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:04330|Notch signaling pathway; KEGG:04340|Hedgehog signaling pathway; KEGG:04614|Renin-angiotensin system; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism; KEGG:00790|Folate biosynthesis; KEGG:04974|Protein digestion and absorption; KEGG:00565|Ether lipid metabolism; KEGG:05340|Primary immunodeficiency; KEGG:04130|SNARE interactions in vesicular transport; KEGG:04744|Phototransduction; KEGG:04966|Collecting duct acid secretion; KEGG:00062|Fatty acid elongation in mitochondria; KEGG:00592|alpha-Linolenic acid metabolism
16919-58-7	KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05162|Measles; KEGG:04612|Antigen processing and presentation
7790-98-9	KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04640|Hematopoietic cell lineage; KEGG:04512|ECM-receptor interaction; KEGG:05320|Autoimmune thyroid disease; KEGG:05414|Dilated cardiomyopathy; KEGG:04974|Protein digestion and absorption
7783-20-2	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation
57-43-2	KEGG:05145|Toxoplasmosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:05140|Leishmaniasis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:05146|Amoebiasis; KEGG:04976|Bile secretion; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
86-42-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:00590|Arachidonic acid metabolism
70958-86-0	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04360|Axon guidance
14028-44-5	KEGG:04080|Neuroactive ligand-receptor interaction
26787-78-0	KEGG:00140|Steroid hormone biosynthesis
27200-12-0	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton
51-64-9	KEGG:05010|Alzheimer's disease; KEGG:05210|Colorectal cancer; KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance; KEGG:05130|Pathogenic Escherichia coli infection
300-62-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:04360|Axon guidance; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC)
1397-89-3	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04630|Jak-STAT signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway
69-53-4	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04962|Vasopressin-regulated water reabsorption
161814-49-9	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04062|Chemokine signaling pathway; KEGG:04976|Bile secretion
60719-84-8	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis
51264-14-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04010|MAPK signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis
142437-67-0	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles
494-52-0	KEGG:04080|Neuroactive ligand-receptor interaction
18654-18-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
94421-68-8	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton
120511-73-1	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04912|GnRH signaling pathway
5508-58-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:00380|Tryptophan metabolism; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:00480|Glutathione metabolism; KEGG:00983|Drug metabolism - other enzymes
27195-25-1	KEGG:00140|Steroid hormone biosynthesis
25126-76-5	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04976|Bile secretion; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00120|Primary bile acid biosynthesis; KEGG:00514|Other types of O-glycan biosynthesis
521-17-5	KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis
63-05-8	KEGG:05215|Prostate cancer; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04930|Type II diabetes mellitus
53-41-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
104-46-1	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis
532-11-6	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:04660|T cell receptor signaling pathway
1333-38-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
523-50-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04976|Bile secretion
11128-99-7	KEGG:05219|Bladder cancer; KEGG:05146|Amoebiasis; KEGG:04614|Renin-angiotensin system
62-53-3	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00330|Arginine and proline metabolism; KEGG:03410|Base excision repair
72432-10-1	KEGG:01100|Metabolic pathways; KEGG:00983|Drug metabolism - other enzymes
22862-76-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
584-85-0	KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism
120-12-7	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis
118-92-3	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles
577-33-3	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
49863-47-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
39349-74-1	KEGG:05200|Pathways in cancer; KEGG:04310|Wnt signaling pathway
7440-36-0	KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05162|Measles; KEGG:00100|Steroid biosynthesis
28300-74-5	KEGG:01100|Metabolic pathways; KEGG:04610|Complement and coagulation cascades; KEGG:00100|Steroid biosynthesis; KEGG:03030|DNA replication
10025-91-9	KEGG:03420|Nucleotide excision repair
1309-64-4	KEGG:05200|Pathways in cancer; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:05221|Acute myeloid leukemia; KEGG:04664|Fc epsilon RI signaling pathway
11118-72-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04380|Osteoclast differentiation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
642-15-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
60-80-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs)
77238-17-6	KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:04010|MAPK signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04310|Wnt signaling pathway
38966-21-1	KEGG:04110|Cell cycle; KEGG:04115|p53 signaling pathway; KEGG:00230|Purine metabolism; KEGG:03030|DNA replication; KEGG:03420|Nucleotide excision repair; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:03450|Non-homologous end-joining
520-36-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:00590|Arachidonic acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:03040|Spliceosome
1107-26-2	KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:00071|Fatty acid metabolism; KEGG:05320|Autoimmune thyroid disease; KEGG:00410|beta-Alanine metabolism; KEGG:00350|Tyrosine metabolism; KEGG:04140|Regulation of autophagy
58-00-4	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction
506-32-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:00590|Arachidonic acid metabolism; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:00592|alpha-Linolenic acid metabolism
149301-79-1	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis
37226-48-5	KEGG:05140|Leishmaniasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
130783-37-8	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04144|Endocytosis
497-76-7	KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04310|Wnt signaling pathway
7770-78-7	KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway
20362-31-6	KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage
63-75-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:05162|Measles; KEGG:04114|Oocyte meiosis; KEGG:00340|Histidine metabolism; KEGG:03420|Nucleotide excision repair; KEGG:03022|Basal transcription factors
113-79-1	KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04270|Vascular smooth muscle contraction; KEGG:04510|Focal adhesion; KEGG:04962|Vasopressin-regulated water reabsorption
99896-85-2	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC)
129722-12-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04540|Gap junction; KEGG:00983|Drug metabolism - other enzymes
313-67-7	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04360|Axon guidance; KEGG:00983|Drug metabolism - other enzymes
465-00-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
11104-28-2	KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05414|Dilated cardiomyopathy
53469-21-9	KEGG:05012|Parkinson's disease; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04940|Type I diabetes mellitus; KEGG:00410|beta-Alanine metabolism; KEGG:00650|Butanoate metabolism; KEGG:00430|Taurine and hypotaurine metabolism
12672-29-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:01100|Metabolic pathways; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04940|Type I diabetes mellitus; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:00410|beta-Alanine metabolism; KEGG:00650|Butanoate metabolism; KEGG:00430|Taurine and hypotaurine metabolism
11096-82-5	KEGG:05012|Parkinson's disease; KEGG:01100|Metabolic pathways; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04940|Type I diabetes mellitus; KEGG:00410|beta-Alanine metabolism; KEGG:00650|Butanoate metabolism; KEGG:00430|Taurine and hypotaurine metabolism
7440-38-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:00270|Cysteine and methionine metabolism; KEGG:04144|Endocytosis; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03420|Nucleotide excision repair; KEGG:03410|Base excision repair; KEGG:00190|Oxidative phosphorylation
7778-39-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05323|Rheumatoid arthritis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:00480|Glutathione metabolism; KEGG:00450|Selenocompound metabolism
56320-22-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction
1303-28-2	KEGG:04978|Mineral absorption
7784-34-1	KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04010|MAPK signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04670|Leukocyte transendothelial migration
1327-53-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:03050|Proteasome; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:03410|Base excision repair; KEGG:03440|Homologous recombination; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:00640|Propanoate metabolism; KEGG:00600|Sphingolipid metabolism; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00360|Phenylalanine metabolism
1303-33-9	KEGG:05200|Pathways in cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04144|Endocytosis
15502-74-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:03410|Base excision repair; KEGG:04330|Notch signaling pathway
63968-64-9	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:00590|Arachidonic acid metabolism
83507-69-1	KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:00480|Glutathione metabolism; KEGG:03010|Ribosome
532-65-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05216|Thyroid cancer; KEGG:04722|Neurotrophin signaling pathway
1332-21-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04742|Taste transduction; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05414|Dilated cardiomyopathy; KEGG:04330|Notch signaling pathway; KEGG:04740|Olfactory transduction
12172-73-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04722|Neurotrophin signaling pathway; KEGG:04810|Regulation of actin cytoskeleton
12001-28-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:04742|Taste transduction; KEGG:04740|Olfactory transduction
512-85-6	KEGG:03420|Nucleotide excision repair
23313-12-4	KEGG:05219|Bladder cancer; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04510|Focal adhesion; KEGG:04512|ECM-receptor interaction; KEGG:04974|Protein digestion and absorption
50-81-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04114|Oocyte meiosis; KEGG:04530|Tight junction; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:00970|Aminoacyl-tRNA biosynthesis; KEGG:04974|Protein digestion and absorption
16830-15-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism
22839-47-0	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton
50-78-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:05340|Primary immunodeficiency
472-61-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05016|Huntington's disease; KEGG:05012|Parkinson's disease; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04260|Cardiac muscle contraction; KEGG:00190|Oxidative phosphorylation
68844-77-9	KEGG:05010|Alzheimer's disease; KEGG:05152|Tuberculosis; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05414|Dilated cardiomyopathy
480-10-4	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
83207-58-3	KEGG:04020|Calcium signaling pathway; KEGG:05414|Dilated cardiomyopathy
170809-51-5	KEGG:00140|Steroid hormone biosynthesis
198904-31-3	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04062|Chemokine signaling pathway; KEGG:00983|Drug metabolism - other enzymes
29122-68-7	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04916|Melanogenesis; KEGG:05143|African trypanosomiasis; KEGG:04320|Dorso-ventral axis formation; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04977|Vitamin digestion and absorption
110862-48-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04140|Regulation of autophagy
90779-69-4	KEGG:04080|Neuroactive ligand-receptor interaction
119509-24-9	KEGG:05214|Glioma; KEGG:05223|Non-small cell lung cancer; KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
64228-79-1	KEGG:04080|Neuroactive ligand-receptor interaction
479-20-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
1912-24-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:04360|Axon guidance; KEGG:00983|Drug metabolism - other enzymes; KEGG:05217|Basal cell carcinoma; KEGG:00190|Oxidative phosphorylation
51-55-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04810|Regulation of actin cytoskeleton
34031-32-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04145|Phagosome; KEGG:05150|Staphylococcus aureus infection; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production; KEGG:00450|Selenocompound metabolism
495-02-3	KEGG:05200|Pathways in cancer; KEGG:04370|VEGF signaling pathway
12192-57-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04145|Phagosome; KEGG:05150|Staphylococcus aureus infection; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
55303-98-5	KEGG:05160|Hepatitis C; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction
166518-60-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
320-67-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:05217|Basal cell carcinoma; KEGG:03430|Mismatch repair; KEGG:04974|Protein digestion and absorption
11141-17-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
35575-96-3	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04610|Complement and coagulation cascades
123018-47-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
446-86-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:00230|Purine metabolism; KEGG:00983|Drug metabolism - other enzymes
123-99-9	KEGG:05219|Bladder cancer; KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04610|Complement and coagulation cascades; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04320|Dorso-ventral axis formation; KEGG:00350|Tyrosine metabolism
58581-89-8	KEGG:05146|Amoebiasis; KEGG:04510|Focal adhesion; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04974|Protein digestion and absorption
83905-01-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04142|Lysosome
25843-45-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00591|Linoleic acid metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
131860-33-8	KEGG:05219|Bladder cancer; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
104970-08-3	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04144|Endocytosis
149759-96-6	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
1405-87-4	KEGG:05219|Bladder cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04510|Focal adhesion; KEGG:00330|Arginine and proline metabolism
1134-47-0	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04380|Osteoclast differentiation
88899-55-2	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
491-67-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
21967-41-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
10309-37-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
20048-27-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04146|Peroxisome; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:00480|Glutathione metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00040|Pentose and glucuronate interconversions
7440-39-3	KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:04062|Chemokine signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:04260|Cardiac muscle contraction; KEGG:04971|Gastric acid secretion; KEGG:04742|Taste transduction; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC)
10361-37-2	KEGG:04971|Gastric acid secretion
73348-75-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
130370-60-4	KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation
329773-35-5	KEGG:05140|Leishmaniasis; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:00230|Purine metabolism
138356-20-4	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
40077-13-2	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction
4419-39-0	KEGG:05219|Bladder cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:02010|ABC transporters
39552-01-7	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04144|Endocytosis
86541-75-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:04975|Fat digestion and absorption; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04614|Renin-angiotensin system; KEGG:04974|Protein digestion and absorption
16506-27-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:04010|MAPK signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04120|Ubiquitin mediated proteolysis
82560-54-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism
105979-17-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04270|Vascular smooth muscle contraction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04320|Dorso-ventral axis formation
17804-35-2	KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
51234-28-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism
322-35-0	KEGG:05219|Bladder cancer; KEGG:05020|Prion diseases; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04320|Dorso-ventral axis formation; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway
1302-78-9	KEGG:04080|Neuroactive ligand-receptor interaction
56-55-3	KEGG:05219|Bladder cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04810|Regulation of actin cytoskeleton
100-52-7	KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:00380|Tryptophan metabolism; KEGG:00071|Fatty acid metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism
27208-38-4	KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04144|Endocytosis
618-39-3	KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04144|Endocytosis
613-92-3	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
2898-76-2	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04742|Taste transduction
3562-84-3	KEGG:05010|Alzheimer's disease; KEGG:05016|Huntington's disease; KEGG:05012|Parkinson's disease; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:05144|Malaria; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04976|Bile secretion; KEGG:00071|Fatty acid metabolism; KEGG:03050|Proteasome; KEGG:00620|Pyruvate metabolism; KEGG:03010|Ribosome; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:02010|ABC transporters; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:04977|Vitamin digestion and absorption; KEGG:00410|beta-Alanine metabolism; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism; KEGG:00190|Oxidative phosphorylation
63805-80-1	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:04660|T cell receptor signaling pathway
71-43-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04950|Maturity onset diabetes of the young; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production; KEGG:03440|Homologous recombination
98-10-2	KEGG:05213|Endometrial cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04510|Focal adhesion; KEGG:04530|Tight junction; KEGG:05100|Bacterial invasion of epithelial cells
121-54-0	KEGG:05219|Bladder cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04623|Cytosolic DNA-sensing pathway
92-87-5	KEGG:05222|Small cell lung cancer; KEGG:01100|Metabolic pathways; KEGG:00232|Caffeine metabolism; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes
51-17-2	KEGG:04080|Neuroactive ligand-receptor interaction
273-77-8	KEGG:00980|Metabolism of xenobiotics by cytochrome P450
238-84-6	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
3067-13-8	KEGG:05200|Pathways in cancer; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:04012|ErbB signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles
63148-10-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
3067-14-9	KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:04012|ErbB signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05221|Acute myeloid leukemia; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles
73891-82-4	KEGG:00980|Metabolism of xenobiotics by cytochrome P450
13345-25-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism
65199-11-3	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00051|Fructose and mannose metabolism; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:00140|Steroid hormone biosynthesis; KEGG:05216|Thyroid cancer; KEGG:04320|Dorso-ventral axis formation; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:00052|Galactose metabolism
60268-85-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation
205-99-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00051|Fructose and mannose metabolism; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:03320|PPAR signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:00040|Pentose and glucuronate interconversions
243-17-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:00480|Glutathione metabolism
94-09-7	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
195-19-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
12794-10-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
192-97-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
6051-87-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:00620|Pyruvate metabolism; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:00561|Glycerolipid metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:00340|Histidine metabolism; KEGG:04710|Circadian rhythm - mammal; KEGG:00910|Nitrogen metabolism; KEGG:04974|Protein digestion and absorption; KEGG:00603|Glycosphingolipid biosynthesis - globo series
271-89-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways
196-78-1	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00980|Metabolism of xenobiotics by cytochrome P450
132832-27-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
65-85-0	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04370|VEGF signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00480|Glutathione metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00590|Arachidonic acid metabolism
207-08-9	KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
3368-13-6	KEGG:00910|Nitrogen metabolism
50-32-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00120|Primary bile acid biosynthesis; KEGG:00500|Starch and sucrose metabolism; KEGG:00920|Sulfur metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00970|Aminoacyl-tRNA biosynthesis; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03022|Basal transcription factors; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:04710|Circadian rhythm - mammal; KEGG:00563|Glycosylphosphatidylinositol(GPI)-anchor biosynthesis; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:03440|Homologous recombination; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:03015|mRNA surveillance pathway; KEGG:00670|One carbon pool by folate; KEGG:00640|Propanoate metabolism; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:03020|RNA polymerase; KEGG:00600|Sphingolipid metabolism; KEGG:03040|Spliceosome; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:00510|N-Glycan biosynthesis; KEGG:00760|Nicotinate and nicotinamide metabolism; KEGG:00910|Nitrogen metabolism; KEGG:04330|Notch signaling pathway; KEGG:00072|Synthesis and degradation of ketone bodies; KEGG:04340|Hedgehog signaling pathway; KEGG:04614|Renin-angiotensin system; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism; KEGG:03060|Protein export; KEGG:03450|Non-homologous end-joining; KEGG:00450|Selenocompound metabolism; KEGG:04974|Protein digestion and absorption; KEGG:00565|Ether lipid metabolism; KEGG:00532|Glycosaminoglycan biosynthesis - chondroitin sulfate; KEGG:00511|Other glycan degradation; KEGG:05340|Primary immunodeficiency; KEGG:04130|SNARE interactions in vesicular transport; KEGG:00430|Taurine and hypotaurine metabolism; KEGG:04966|Collecting duct acid secretion; KEGG:00603|Glycosphingolipid biosynthesis - globo series; KEGG:00534|Glycosaminoglycan biosynthesis - heparan sulfate; KEGG:00604|Glycosphingolipid biosynthesis - ganglio series; KEGG:00601|Glycosphingolipid biosynthesis - lacto and neolacto series; KEGG:00512|Mucin type O-Glycan biosynthesis; KEGG:00290|Valine, leucine and isoleucine biosynthesis
55097-80-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:04530|Tight junction; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03022|Basal transcription factors; KEGG:03410|Base excision repair; KEGG:04710|Circadian rhythm - mammal; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03015|mRNA surveillance pathway; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:03020|RNA polymerase; KEGG:00600|Sphingolipid metabolism; KEGG:03040|Spliceosome; KEGG:04330|Notch signaling pathway; KEGG:04340|Hedgehog signaling pathway
106-51-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma
95-16-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
27556-51-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
215-58-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
94-36-0	KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:00480|Glutathione metabolism
156-08-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00590|Arachidonic acid metabolism
86-13-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00590|Arachidonic acid metabolism
642-72-8	KEGG:00982|Drug metabolism - cytochrome P450
100-39-0	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04640|Hematopoietic cell lineage
122-57-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
622-78-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00380|Tryptophan metabolism; KEGG:00480|Glutathione metabolism
133407-82-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:03050|Proteasome; KEGG:04120|Ubiquitin mediated proteolysis
87687-02-3	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
4671-93-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
114776-28-2	KEGG:05222|Small cell lung cancer; KEGG:01100|Metabolic pathways; KEGG:04020|Calcium signaling pathway; KEGG:05140|Leishmaniasis
64706-54-3	KEGG:04210|Apoptosis; KEGG:04976|Bile secretion
478-61-5	KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer
2086-83-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
7380-40-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
7440-41-7	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:02010|ABC transporters; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs)
7787-49-7	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04660|T cell receptor signaling pathway; KEGG:02010|ABC transporters
13510-49-1	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04145|Phagosome; KEGG:03010|Ribosome; KEGG:05150|Staphylococcus aureus infection; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs)
9051-97-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
7235-40-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:04145|Phagosome; KEGG:04360|Axon guidance; KEGG:05320|Autoimmune thyroid disease; KEGG:00350|Tyrosine metabolism; KEGG:04140|Regulation of autophagy
466-81-9	KEGG:04080|Neuroactive ligand-receptor interaction
17181-54-3	KEGG:05200|Pathways in cancer; KEGG:05146|Amoebiasis; KEGG:04510|Focal adhesion; KEGG:04512|ECM-receptor interaction
319-85-7	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis
107-43-7	KEGG:01100|Metabolic pathways; KEGG:04310|Wnt signaling pathway; KEGG:00531|Glycosaminoglycan degradation
4707-32-8	KEGG:04140|Regulation of autophagy
378-44-9	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04614|Renin-angiotensin system
2152-44-5	KEGG:05416|Viral myocarditis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
7562-87-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04370|VEGF signaling pathway; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:04360|Axon guidance; KEGG:03030|DNA replication; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:00240|Pyrimidine metabolism; KEGG:03022|Basal transcription factors; KEGG:03410|Base excision repair; KEGG:04142|Lysosome; KEGG:03015|mRNA surveillance pathway; KEGG:00640|Propanoate metabolism; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:03040|Spliceosome; KEGG:00190|Oxidative phosphorylation; KEGG:04966|Collecting duct acid secretion
14937-32-7	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04670|Leukocyte transendothelial migration; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04514|Cell adhesion molecules (CAMs)
3671-38-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04010|MAPK signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway
1125-12-8	KEGG:04080|Neuroactive ligand-receptor interaction
63659-18-7	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction
674-38-4	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04972|Pancreatic secretion; KEGG:04971|Gastric acid secretion; KEGG:04810|Regulation of actin cytoskeleton
473-98-3	KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:04350|TGF-beta signaling pathway
472-15-1	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
41859-67-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:00071|Fatty acid metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00561|Glycerolipid metabolism; KEGG:00020|Citrate cycle (TCA cycle); KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:00640|Propanoate metabolism; KEGG:00650|Butanoate metabolism; KEGG:00061|Fatty acid biosynthesis
90357-06-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton
485-49-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
82657-04-3	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05221|Acute myeloid leukemia; KEGG:04912|GnRH signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04612|Antigen processing and presentation; KEGG:04114|Oocyte meiosis
60628-96-8	KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis
635-65-4	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:00983|Drug metabolism - other enzymes; KEGG:00500|Starch and sucrose metabolism
114-25-0	KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma
33570-04-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
28434-00-6	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05144|Malaria; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection
491-80-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04670|Leukocyte transendothelial migration; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00920|Sulfur metabolism; KEGG:00514|Other types of O-glycan biosynthesis
22150-76-1	KEGG:01100|Metabolic pathways; KEGG:00330|Arginine and proline metabolism; KEGG:04977|Vitamin digestion and absorption
28434-01-7	KEGG:00983|Drug metabolism - other enzymes
58-85-5	KEGG:05143|African trypanosomiasis; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04977|Vitamin digestion and absorption
51317-25-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
366-18-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04370|VEGF signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway
24939-16-0	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
1565-94-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04110|Cell cycle; KEGG:04115|p53 signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis
119139-23-0	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04530|Tight junction
133052-90-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance; KEGG:00562|Inositol phosphate metabolism; KEGG:04013|MAPK signaling pathway - fly
38213-69-3	KEGG:05210|Colorectal cancer; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:05323|Rheumatoid arthritis; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:00500|Starch and sucrose metabolism; KEGG:00052|Galactose metabolism
7440-69-9	KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04612|Antigen processing and presentation
57644-54-9	KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:04660|T cell receptor signaling pathway; KEGG:00620|Pyruvate metabolism
66722-44-9	KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04020|Calcium signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04976|Bile secretion; KEGG:05310|Asthma; KEGG:05414|Dilated cardiomyopathy
80-05-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00970|Aminoacyl-tRNA biosynthesis; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03022|Basal transcription factors; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:04710|Circadian rhythm - mammal; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:03440|Homologous recombination; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:03015|mRNA surveillance pathway; KEGG:00640|Propanoate metabolism; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:03020|RNA polymerase; KEGG:00600|Sphingolipid metabolism; KEGG:03040|Spliceosome; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:00510|N-Glycan biosynthesis; KEGG:04330|Notch signaling pathway; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism; KEGG:00790|Folate biosynthesis; KEGG:03060|Protein export; KEGG:03450|Non-homologous end-joining; KEGG:04974|Protein digestion and absorption; KEGG:00565|Ether lipid metabolism; KEGG:04130|SNARE interactions in vesicular transport; KEGG:00061|Fatty acid biosynthesis; KEGG:00604|Glycosphingolipid biosynthesis - ganglio series; KEGG:00740|Riboflavin metabolism
56-35-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:00590|Arachidonic acid metabolism; KEGG:03030|DNA replication; KEGG:05320|Autoimmune thyroid disease; KEGG:00240|Pyrimidine metabolism; KEGG:03040|Spliceosome; KEGG:00190|Oxidative phosphorylation
97-18-7	KEGG:04080|Neuroactive ligand-receptor interaction
128270-60-0	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04610|Complement and coagulation cascades; KEGG:04810|Regulation of actin cytoskeleton
11116-32-8	KEGG:01100|Metabolic pathways; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04512|ECM-receptor interaction; KEGG:05414|Dilated cardiomyopathy
11056-06-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:04145|Phagosome; KEGG:05310|Asthma
21102-94-3	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:04914|Progesterone-mediated oocyte maturation
128672-07-1	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:04660|T cell receptor signaling pathway
31362-50-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
11113-50-1	KEGG:05146|Amoebiasis
147536-97-8	KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05146|Amoebiasis
380443-75-4	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04530|Tight junction; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05130|Pathogenic Escherichia coli infection
141594-26-5	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04270|Vascular smooth muscle contraction
141595-53-1	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04270|Vascular smooth muscle contraction
58-82-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton
15958-92-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04010|MAPK signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation
72962-43-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05216|Thyroid cancer; KEGG:05162|Measles; KEGG:04114|Oocyte meiosis
50924-49-7	KEGG:05213|Endometrial cancer; KEGG:04510|Focal adhesion
20350-15-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway
84379-13-5	KEGG:04080|Neuroactive ligand-receptor interaction
23402-09-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:04630|Jak-STAT signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04144|Endocytosis; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production
59803-98-4	KEGG:04270|Vascular smooth muscle contraction; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04912|GnRH signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04971|Gastric acid secretion; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:05130|Pathogenic Escherichia coli infection
138890-62-7	KEGG:00910|Nitrogen metabolism
114333-71-0	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:03320|PPAR signaling pathway; KEGG:04144|Endocytosis
118343-19-4	KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation
7726-95-6	KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
103373-69-9	KEGG:01100|Metabolic pathways; KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
108-86-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:00270|Cysteine and methionine metabolism; KEGG:00071|Fatty acid metabolism; KEGG:03050|Proteasome; KEGG:00620|Pyruvate metabolism; KEGG:03010|Ribosome; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00410|beta-Alanine metabolism; KEGG:00640|Propanoate metabolism; KEGG:00072|Synthesis and degradation of ketone bodies; KEGG:00360|Phenylalanine metabolism
23583-48-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04310|Wnt signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04971|Gastric acid secretion; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:04360|Axon guidance; KEGG:00983|Drug metabolism - other enzymes; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05414|Dilated cardiomyopathy; KEGG:05217|Basal cell carcinoma; KEGG:04614|Renin-angiotensin system; KEGG:04974|Protein digestion and absorption
5589-96-8	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04670|Leukocyte transendothelial migration; KEGG:04722|Neurotrophin signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04950|Maturity onset diabetes of the young; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:05217|Basal cell carcinoma
75-27-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
25614-03-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation
75-25-2	KEGG:04110|Cell cycle; KEGG:04080|Neuroactive ligand-receptor interaction
1113-59-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05016|Huntington's disease; KEGG:00524|Butirosin and neomycin biosynthesis; KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04973|Carbohydrate digestion and absorption; KEGG:00500|Starch and sucrose metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:00052|Galactose metabolism
1689-99-2	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
56741-95-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
99217-68-2	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
76596-57-1	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04144|Endocytosis
357-57-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00591|Linoleic acid metabolism; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
17301-81-4	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
83314-01-6	KEGG:04210|Apoptosis; KEGG:05214|Glioma; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:05146|Amoebiasis; KEGG:04916|Melanogenesis; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04972|Pancreatic secretion; KEGG:04310|Wnt signaling pathway; KEGG:04971|Gastric acid secretion; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection
70369-47-0	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04144|Endocytosis
51333-22-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:00590|Arachidonic acid metabolism; KEGG:05310|Asthma
465-21-4	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
54340-62-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
28395-03-1	KEGG:04976|Bile secretion; KEGG:05110|Vibrio cholerae infection; KEGG:02010|ABC transporters
2180-92-9	KEGG:05152|Tuberculosis; KEGG:00590|Arachidonic acid metabolism
138726-08-6	KEGG:04110|Cell cycle; KEGG:04115|p53 signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation
23284-25-5	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04144|Endocytosis
52485-79-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00983|Drug metabolism - other enzymes
34841-39-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity
34970-69-9	KEGG:04080|Neuroactive ligand-receptor interaction
57982-77-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:04912|GnRH signaling pathway
36505-84-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction
55-98-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04510|Focal adhesion; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04114|Oocyte meiosis
23184-66-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:04976|Bile secretion
431-03-8	KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:05146|Amoebiasis
96-48-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway
71-36-3	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction
69648-38-0	KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:04060|Cytokine-cytokine receptor interaction
487-52-5	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
5072-26-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:03010|Ribosome; KEGG:04360|Axon guidance; KEGG:04672|Intestinal immune network for IgA production
42408-82-2	KEGG:04080|Neuroactive ligand-receptor interaction
2922-20-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis
29925-17-5	KEGG:04210|Apoptosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
33629-47-9	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04610|Complement and coagulation cascades
25013-16-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04114|Oocyte meiosis; KEGG:02010|ABC transporters; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00330|Arginine and proline metabolism; KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00640|Propanoate metabolism
128-37-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:04672|Intestinal immune network for IgA production; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC)
85-68-7	KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis
109-65-9	KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction
75-91-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:03420|Nucleotide excision repair; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:03040|Spliceosome; KEGG:00190|Oxidative phosphorylation; KEGG:00760|Nicotinate and nicotinamide metabolism; KEGG:03060|Protein export; KEGG:00450|Selenocompound metabolism; KEGG:04974|Protein digestion and absorption
3817-11-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:04940|Type I diabetes mellitus; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
551-08-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05216|Thyroid cancer; KEGG:05162|Measles
66556-73-8	KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage
98-54-4	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00514|Other types of O-glycan biosynthesis
123-72-8	KEGG:00620|Pyruvate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism
107-92-6	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04510|Focal adhesion; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway
81409-90-7	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04540|Gap junction
75-60-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04978|Mineral absorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03030|DNA replication; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03410|Base excision repair; KEGG:03430|Mismatch repair
462-94-2	KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:05221|Acute myeloid leukemia; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway
7440-43-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00590|Arachidonic acid metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03410|Base excision repair; KEGG:00190|Oxidative phosphorylation
543-90-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04260|Cardiac muscle contraction; KEGG:04114|Oocyte meiosis; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:00190|Oxidative phosphorylation
10108-64-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:03050|Proteasome; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00983|Drug metabolism - other enzymes; KEGG:00500|Starch and sucrose metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04977|Vitamin digestion and absorption; KEGG:00564|Glycerophospholipid metabolism; KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03022|Basal transcription factors; KEGG:03410|Base excision repair; KEGG:04710|Circadian rhythm - mammal; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03015|mRNA surveillance pathway; KEGG:03040|Spliceosome; KEGG:00190|Oxidative phosphorylation; KEGG:04330|Notch signaling pathway; KEGG:04340|Hedgehog signaling pathway; KEGG:00350|Tyrosine metabolism; KEGG:04974|Protein digestion and absorption; KEGG:05340|Primary immunodeficiency; KEGG:00740|Riboflavin metabolism
10325-94-7	KEGG:04510|Focal adhesion
1306-24-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04672|Intestinal immune network for IgA production
10124-36-4	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04144|Endocytosis; KEGG:00240|Pyrimidine metabolism
1306-23-6	KEGG:03010|Ribosome
1306-25-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:03010|Ribosome
17650-98-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04623|Cytosolic DNA-sensing pathway
469-83-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
331-39-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:00480|Glutathione metabolism; KEGG:00270|Cysteine and methionine metabolism; KEGG:00590|Arachidonic acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00920|Sulfur metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:04142|Lysosome
104594-70-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:05414|Dilated cardiomyopathy
58-08-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:00620|Pyruvate metabolism; KEGG:03013|RNA transport; KEGG:00100|Steroid biosynthesis; KEGG:04360|Axon guidance; KEGG:00330|Arginine and proline metabolism; KEGG:00190|Oxidative phosphorylation
61020-70-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
148504-34-1	KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
52665-69-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
83652-28-2	KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease
119911-68-1	KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease
7440-70-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:04360|Axon guidance; KEGG:04672|Intestinal immune network for IgA production; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04974|Protein digestion and absorption
471-34-1	KEGG:00480|Glutathione metabolism
10043-52-4	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04310|Wnt signaling pathway; KEGG:04260|Cardiac muscle contraction; KEGG:04144|Endocytosis; KEGG:04145|Phagosome; KEGG:00052|Galactose metabolism
1305-62-0	KEGG:05140|Leishmaniasis; KEGG:05146|Amoebiasis
10103-46-5	KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction
1344-95-2	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton
57265-65-3	KEGG:05144|Malaria; KEGG:05143|African trypanosomiasis
88191-84-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:05146|Amoebiasis; KEGG:04612|Antigen processing and presentation
117591-20-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05162|Measles
121263-19-2	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04810|Regulation of actin cytoskeleton
101932-71-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
76-22-2	KEGG:04080|Neuroactive ligand-receptor interaction
7689-03-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03420|Nucleotide excision repair; KEGG:03410|Base excision repair; KEGG:00310|Lysine degradation; KEGG:03430|Mismatch repair; KEGG:04330|Notch signaling pathway
139481-59-7	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04670|Leukocyte transendothelial migration; KEGG:04722|Neurotrophin signaling pathway; KEGG:04145|Phagosome; KEGG:05414|Dilated cardiomyopathy; KEGG:04614|Renin-angiotensin system
145040-37-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:04020|Calcium signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05414|Dilated cardiomyopathy; KEGG:04614|Renin-angiotensin system
13956-29-1	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
137252-25-6	KEGG:05200|Pathways in cancer; KEGG:04621|NOD-like receptor signaling pathway
521-35-7	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04672|Intestinal immune network for IgA production
56-25-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
143108-26-3	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04623|Cytosolic DNA-sensing pathway
154361-50-9	KEGG:05219|Bladder cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:01100|Metabolic pathways; KEGG:05211|Renal cell carcinoma; KEGG:00983|Drug metabolism - other enzymes
404-86-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:05414|Dilated cardiomyopathy; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism
133-06-2	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04012|ErbB signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04310|Wnt signaling pathway
149-30-4	KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04672|Intestinal immune network for IgA production
466-85-3	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
51-83-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04971|Gastric acid secretion; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
298-46-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05330|Allograft rejection; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:00230|Purine metabolism; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy
36507-30-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:04976|Bile secretion
63-25-2	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
5697-56-3	KEGG:04960|Aldosterone-regulated sodium reabsorption
38821-49-7	KEGG:00350|Tyrosine metabolism
1563-66-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:04010|MAPK signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05162|Measles; KEGG:00590|Arachidonic acid metabolism
7440-44-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:05217|Basal cell carcinoma; KEGG:04710|Circadian rhythm - mammal; KEGG:00310|Lysine degradation; KEGG:03015|mRNA surveillance pathway; KEGG:04340|Hedgehog signaling pathway
124-38-9	KEGG:04080|Neuroactive ligand-receptor interaction
75-15-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04510|Focal adhesion
463-79-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:04010|MAPK signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04978|Mineral absorption; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:04730|Long-term depression; KEGG:04972|Pancreatic secretion; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04145|Phagosome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00030|Pentose phosphate pathway; KEGG:00052|Galactose metabolism; KEGG:00910|Nitrogen metabolism; KEGG:04974|Protein digestion and absorption
630-08-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs)
56-23-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00120|Primary bile acid biosynthesis; KEGG:04672|Intestinal immune network for IgA production; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04977|Vitamin digestion and absorption; KEGG:03420|Nucleotide excision repair; KEGG:00240|Pyrimidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:04710|Circadian rhythm - mammal; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:00640|Propanoate metabolism; KEGG:00600|Sphingolipid metabolism; KEGG:04974|Protein digestion and absorption
555-60-2	KEGG:05220|Chronic myeloid leukemia; KEGG:05212|Pancreatic cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:04623|Cytosolic DNA-sensing pathway
370-86-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:04010|MAPK signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04978|Mineral absorption; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04144|Endocytosis; KEGG:03040|Spliceosome; KEGG:00130|Ubiquinone and other terpenoid-quinone biosynthesis
463-58-1	KEGG:05200|Pathways in cancer; KEGG:04010|MAPK signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton
69552-46-1	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma
39995-74-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00983|Drug metabolism - other enzymes
99519-84-3	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
154-93-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05414|Dilated cardiomyopathy; KEGG:03410|Base excision repair
541-15-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05012|Parkinson's disease; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:00190|Oxidative phosphorylation
305-84-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:05310|Asthma
5957-80-2	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
36-88-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00020|Citrate cycle (TCA cycle); KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03022|Basal transcription factors; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:04710|Circadian rhythm - mammal; KEGG:03440|Homologous recombination; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:03015|mRNA surveillance pathway; KEGG:00640|Propanoate metabolism; KEGG:00600|Sphingolipid metabolism; KEGG:03040|Spliceosome; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:00910|Nitrogen metabolism; KEGG:04330|Notch signaling pathway; KEGG:04340|Hedgehog signaling pathway; KEGG:00533|Glycosaminoglycan biosynthesis - keratan sulfate; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism; KEGG:04974|Protein digestion and absorption; KEGG:00565|Ether lipid metabolism; KEGG:05340|Primary immunodeficiency; KEGG:00601|Glycosphingolipid biosynthesis - lacto and neolacto series; KEGG:00740|Riboflavin metabolism
9000-07-1	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05150|Staphylococcus aureus infection; KEGG:00590|Arachidonic acid metabolism; KEGG:04672|Intestinal immune network for IgA production
51781-06-7	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04144|Endocytosis
499-75-2	KEGG:04978|Mineral absorption
72956-09-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04614|Renin-angiotensin system
99-49-0	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04350|TGF-beta signaling pathway
8047-27-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production; KEGG:05130|Pathogenic Escherichia coli infection
8001-79-4	KEGG:04080|Neuroactive ligand-receptor interaction
154-23-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:04530|Tight junction; KEGG:02010|ABC transporters; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:04672|Intestinal immune network for IgA production; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05414|Dilated cardiomyopathy; KEGG:03018|RNA degradation; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:04710|Circadian rhythm - mammal; KEGG:03015|mRNA surveillance pathway; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:00565|Ether lipid metabolism
120-80-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00920|Sulfur metabolism; KEGG:05310|Asthma
76849-19-9	KEGG:05218|Melanoma; KEGG:01100|Metabolic pathways; KEGG:05211|Renal cell carcinoma; KEGG:05144|Malaria; KEGG:04510|Focal adhesion; KEGG:00330|Arginine and proline metabolism
25126-32-3	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04976|Bile secretion
88040-23-7	KEGG:01100|Metabolic pathways
63527-52-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS)
73384-59-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS)
169590-42-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:05100|Bacterial invasion of epithelial cells
56980-93-9	KEGG:04270|Vascular smooth muscle contraction
10206-21-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05152|Tuberculosis
483-17-0	KEGG:05219|Bladder cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04623|Cytosolic DNA-sensing pathway
50-59-9	KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:00230|Purine metabolism; KEGG:05150|Staphylococcus aureus infection; KEGG:03030|DNA replication; KEGG:00030|Pentose phosphate pathway; KEGG:03420|Nucleotide excision repair; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:03430|Mismatch repair
153-61-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:04010|MAPK signaling pathway; KEGG:04722|Neurotrophin signaling pathway
1306-38-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04623|Cytosolic DNA-sensing pathway
7440-45-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
7790-86-5	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
17397-89-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05416|Viral myocarditis; KEGG:04920|Adipocytokine signaling pathway
7440-46-2	KEGG:03320|PPAR signaling pathway; KEGG:04971|Gastric acid secretion; KEGG:00100|Steroid biosynthesis
83881-51-0	KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04976|Bile secretion; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
120287-85-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04672|Intestinal immune network for IgA production
7773-52-6	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
81047-99-6	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05213|Endometrial cancer; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04370|VEGF signaling pathway; KEGG:04970|Salivary secretion; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04144|Endocytosis
81015-67-0	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04144|Endocytosis
148056-42-2	KEGG:04080|Neuroactive ligand-receptor interaction
107320-86-5	KEGG:04080|Neuroactive ligand-receptor interaction
94-41-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
34316-15-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:05332|Graft-versus-host disease; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:05414|Dilated cardiomyopathy
474-25-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:04950|Maturity onset diabetes of the young; KEGG:02010|ABC transporters; KEGG:00120|Primary bile acid biosynthesis; KEGG:00330|Arginine and proline metabolism
1403-36-7	KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:05410|Hypertrophic cardiomyopathy (HCM)
1398-61-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04145|Phagosome; KEGG:05310|Asthma
9012-76-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04145|Phagosome; KEGG:05310|Asthma
53342-16-8	KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia
302-17-0	KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles
15879-93-3	KEGG:04080|Neuroactive ligand-receptor interaction
305-03-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:00480|Glutathione metabolism; KEGG:02010|ABC transporters
127-65-1	KEGG:04514|Cell adhesion molecules (CAMs)
56-75-7	KEGG:04110|Cell cycle; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:01100|Metabolic pathways
82-93-9	KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
12789-03-6	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:04010|MAPK signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04540|Gap junction; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:00480|Glutathione metabolism; KEGG:04114|Oocyte meiosis
143-50-0	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05140|Leishmaniasis; KEGG:04062|Chemokine signaling pathway; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04650|Natural killer cell mediated cytotoxicity
58-25-3	KEGG:04080|Neuroactive ligand-receptor interaction
115-28-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway
98086-36-3	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction
71422-67-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00983|Drug metabolism - other enzymes
7790-93-4	KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00910|Nitrogen metabolism
7782-50-5	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:03050|Proteasome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:04360|Axon guidance; KEGG:04742|Taste transduction; KEGG:05414|Dilated cardiomyopathy
7701-62-4	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00350|Tyrosine metabolism
533-45-9	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism
107-20-0	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:04115|p53 signaling pathway; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis
146-77-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis
108-90-7	KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:04062|Chemokine signaling pathway; KEGG:00590|Arachidonic acid metabolism
57-15-8	KEGG:04080|Neuroactive ligand-receptor interaction
4291-63-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05310|Asthma
124-48-1	KEGG:04110|Cell cycle
11097-69-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:00140|Steroid hormone biosynthesis; KEGG:04010|MAPK signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:00590|Arachidonic acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:00330|Arginine and proline metabolism; KEGG:00020|Citrate cycle (TCA cycle); KEGG:04977|Vitamin digestion and absorption; KEGG:00410|beta-Alanine metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00430|Taurine and hypotaurine metabolism
67-66-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:00071|Fatty acid metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:02010|ABC transporters; KEGG:05310|Asthma; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00640|Propanoate metabolism
327-97-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
554-77-8	KEGG:04976|Bile secretion
10199-89-0	KEGG:03320|PPAR signaling pathway; KEGG:01040|Biosynthesis of unsaturated fatty acids
55-45-8	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
1406-65-1	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:03050|Proteasome
15611-43-5	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
76-06-2	KEGG:04141|Protein processing in endoplasmic reticulum
54-05-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04612|Antigen processing and presentation; KEGG:04142|Lysosome
50-63-5	KEGG:05010|Alzheimer's disease
58-94-6	KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:04145|Phagosome; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:04614|Renin-angiotensin system
132-22-9	KEGG:02010|ABC transporters
50-53-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:03030|DNA replication
94-20-2	KEGG:04930|Type II diabetes mellitus
113-59-7	KEGG:04080|Neuroactive ligand-receptor interaction
2921-88-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00983|Drug metabolism - other enzymes; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05414|Dilated cardiomyopathy; KEGG:05217|Basal cell carcinoma; KEGG:04142|Lysosome; KEGG:00190|Oxidative phosphorylation; KEGG:04340|Hedgehog signaling pathway
77-36-1	KEGG:05219|Bladder cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05211|Renal cell carcinoma
15545-48-9	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways
95-25-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
9011-97-6	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04976|Bile secretion
18917-24-3	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction
9012-63-9	KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04971|Gastric acid secretion; KEGG:05414|Dilated cardiomyopathy; KEGG:04962|Vasopressin-regulated water reabsorption
566-26-7	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04320|Dorso-ventral axis formation; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:00120|Primary bile acid biosynthesis
115510-05-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis
80-97-7	KEGG:00120|Primary bile acid biosynthesis
57-88-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:04145|Phagosome; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00120|Primary bile acid biosynthesis; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04977|Vitamin digestion and absorption
1250-95-9	KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04810|Regulation of actin cytoskeleton
81-25-4	KEGG:05200|Pathways in cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:03320|PPAR signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00920|Sulfur metabolism
62-49-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:00500|Starch and sucrose metabolism; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03022|Basal transcription factors; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:00563|Glycosylphosphatidylinositol(GPI)-anchor biosynthesis; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03015|mRNA surveillance pathway; KEGG:00670|One carbon pool by folate; KEGG:00640|Propanoate metabolism; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:03020|RNA polymerase; KEGG:00600|Sphingolipid metabolism; KEGG:03040|Spliceosome; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00510|N-Glycan biosynthesis; KEGG:04330|Notch signaling pathway; KEGG:04340|Hedgehog signaling pathway; KEGG:00450|Selenocompound metabolism; KEGG:04974|Protein digestion and absorption; KEGG:00565|Ether lipid metabolism; KEGG:04966|Collecting duct acid secretion; KEGG:00534|Glycosaminoglycan biosynthesis - heparan sulfate; KEGG:00604|Glycosphingolipid biosynthesis - ganglio series; KEGG:00512|Mucin type O-Glycan biosynthesis
9007-27-6	KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:04810|Regulation of actin cytoskeleton
9007-28-7	KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:04810|Regulation of actin cytoskeleton
7440-47-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04672|Intestinal immune network for IgA production; KEGG:00780|Biotin metabolism
18540-29-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:00590|Arachidonic acid metabolism; KEGG:00780|Biotin metabolism
10103-47-6	KEGG:04978|Mineral absorption
1308-38-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05200|Pathways in cancer; KEGG:04350|TGF-beta signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:00480|Glutathione metabolism; KEGG:04144|Endocytosis; KEGG:05217|Basal cell carcinoma; KEGG:04340|Hedgehog signaling pathway
14639-25-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis
804-10-4	KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:00330|Arginine and proline metabolism
10049-05-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:04144|Endocytosis; KEGG:05217|Basal cell carcinoma; KEGG:04340|Hedgehog signaling pathway
218-01-9	KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:04380|Osteoclast differentiation
67252-82-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
480-40-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production
491-71-4	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
139340-56-0	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis
289499-45-2	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04810|Regulation of actin cytoskeleton
12236-82-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
95722-07-9	KEGG:04110|Cell cycle; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04270|Vascular smooth muscle contraction; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:05146|Amoebiasis; KEGG:04916|Melanogenesis; KEGG:05143|African trypanosomiasis; KEGG:04962|Vasopressin-regulated water reabsorption
113852-37-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
53267-01-9	KEGG:04210|Apoptosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:04010|MAPK signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity
74772-77-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:00071|Fatty acid metabolism; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00561|Glycerolipid metabolism; KEGG:00650|Butanoate metabolism; KEGG:04974|Protein digestion and absorption
11050-21-8	KEGG:05219|Bladder cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:00480|Glutathione metabolism; KEGG:00270|Cysteine and methionine metabolism; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00562|Inositol phosphate metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00240|Pyrimidine metabolism; KEGG:03040|Spliceosome
82009-34-5	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04650|Natural killer cell mediated cytotoxicity
92077-78-6	KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:04614|Renin-angiotensin system
132203-70-4	KEGG:05200|Pathways in cancer; KEGG:04010|MAPK signaling pathway
73963-72-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production
51481-61-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04514|Cell adhesion molecules (CAMs)
470-82-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00983|Drug metabolism - other enzymes
66564-14-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism
621-82-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:00590|Arachidonic acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
104-55-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05414|Dilated cardiomyopathy
104-54-1	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04146|Peroxisome; KEGG:00480|Glutathione metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00450|Selenocompound metabolism
298-57-7	KEGG:04080|Neuroactive ligand-receptor interaction
470-37-1	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04012|ErbB signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation
52214-84-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:00071|Fatty acid metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism; KEGG:00650|Butanoate metabolism
85721-33-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:04114|Oocyte meiosis; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production
59939-16-1	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis
34334-69-5	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
81098-60-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism
59729-33-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:00982|Drug metabolism - cytochrome P450; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction
5392-40-5	KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05144|Malaria; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05332|Graft-versus-host disease; KEGG:04672|Intestinal immune network for IgA production
77-92-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05020|Prion diseases; KEGG:04630|Jak-STAT signaling pathway
518-75-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway
66548-69-4	KEGG:04080|Neuroactive ligand-receptor interaction
138908-40-4	KEGG:04910|Insulin signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04920|Adipocytokine signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:00561|Glycerolipid metabolism; KEGG:00061|Fatty acid biosynthesis
35818-31-6	KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
81103-11-9	KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion
37148-27-9	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04973|Carbohydrate digestion and absorption
30299-08-2	KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway
130-26-7	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells
33979-15-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis
22316-47-8	KEGG:04610|Complement and coagulation cascades
145231-45-4	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles
25122-41-2	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs)
10596-23-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs)
123318-82-1	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04010|MAPK signaling pathway
21340-68-1	KEGG:01100|Metabolic pathways; KEGG:04978|Mineral absorption; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:00071|Fatty acid metabolism
637-07-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:03050|Proteasome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00120|Primary bile acid biosynthesis; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04977|Vitamin digestion and absorption; KEGG:00564|Glycerophospholipid metabolism; KEGG:00240|Pyrimidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:04710|Circadian rhythm - mammal; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:00640|Propanoate metabolism; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:00072|Synthesis and degradation of ketone bodies; KEGG:00350|Tyrosine metabolism; KEGG:03060|Protein export; KEGG:04974|Protein digestion and absorption; KEGG:00565|Ether lipid metabolism; KEGG:00062|Fatty acid elongation in mitochondria; KEGG:00740|Riboflavin metabolism
882-09-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:03050|Proteasome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00120|Primary bile acid biosynthesis; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04977|Vitamin digestion and absorption; KEGG:00564|Glycerophospholipid metabolism; KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03022|Basal transcription factors; KEGG:00410|beta-Alanine metabolism; KEGG:04710|Circadian rhythm - mammal; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:00770|Pantothenate and CoA biosynthesis; KEGG:00640|Propanoate metabolism; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:00072|Synthesis and degradation of ketone bodies; KEGG:04614|Renin-angiotensin system; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism; KEGG:03060|Protein export; KEGG:04974|Protein digestion and absorption; KEGG:00565|Ether lipid metabolism; KEGG:00511|Other glycan degradation; KEGG:00062|Fatty acid elongation in mitochondria; KEGG:00740|Riboflavin metabolism
369-77-7	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
911-45-5	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04912|GnRH signaling pathway
303-49-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:05332|Graft-versus-host disease; KEGG:04976|Bile secretion; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00910|Nitrogen metabolism
1622-61-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
4205-90-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
90055-48-4	KEGG:05219|Bladder cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00590|Arachidonic acid metabolism; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05414|Dilated cardiomyopathy
40665-92-7	KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:04010|MAPK signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04510|Focal adhesion; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton
17780-72-2	KEGG:04144|Endocytosis
57808-65-8	KEGG:04080|Neuroactive ligand-receptor interaction
23593-75-1	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04976|Bile secretion; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00030|Pentose phosphate pathway
61-72-3	KEGG:05416|Viral myocarditis; KEGG:05323|Rheumatoid arthritis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04976|Bile secretion; KEGG:05320|Autoimmune thyroid disease
24166-13-0	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
5786-21-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04976|Bile secretion; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:04360|Axon guidance; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:04130|SNARE interactions in vesicular transport
8007-45-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:00480|Glutathione metabolism; KEGG:00590|Arachidonic acid metabolism
7440-48-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:05320|Autoimmune thyroid disease; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:00563|Glycosylphosphatidylinositol(GPI)-anchor biosynthesis; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:00670|One carbon pool by folate; KEGG:00770|Pantothenate and CoA biosynthesis; KEGG:00640|Propanoate metabolism; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:03020|RNA polymerase; KEGG:03040|Spliceosome; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00510|N-Glycan biosynthesis; KEGG:00350|Tyrosine metabolism; KEGG:00450|Selenocompound metabolism; KEGG:00565|Ether lipid metabolism; KEGG:04130|SNARE interactions in vesicular transport; KEGG:00290|Valine, leucine and isoleucine biosynthesis
14325-03-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
7646-79-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:05320|Autoimmune thyroid disease; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:00563|Glycosylphosphatidylinositol(GPI)-anchor biosynthesis; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:00670|One carbon pool by folate; KEGG:00770|Pantothenate and CoA biosynthesis; KEGG:00640|Propanoate metabolism; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:03020|RNA polymerase; KEGG:03040|Spliceosome; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00510|N-Glycan biosynthesis; KEGG:04330|Notch signaling pathway; KEGG:00350|Tyrosine metabolism; KEGG:00450|Selenocompound metabolism; KEGG:00565|Ether lipid metabolism; KEGG:04130|SNARE interactions in vesicular transport; KEGG:00290|Valine, leucine and isoleucine biosynthesis
10124-43-3	KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04640|Hematopoietic cell lineage
50-36-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04710|Circadian rhythm - mammal; KEGG:00190|Oxidative phosphorylation
76-57-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway
53-84-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05222|Small cell lung cancer; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:00071|Fatty acid metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism
53-59-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:00480|Glutathione metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:00030|Pentose phosphate pathway
85-61-0	KEGG:01100|Metabolic pathways; KEGG:00232|Caffeine metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:00071|Fatty acid metabolism; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00983|Drug metabolism - other enzymes; KEGG:00410|beta-Alanine metabolism; KEGG:00640|Propanoate metabolism
303-98-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05146|Amoebiasis; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
64-86-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04145|Phagosome; KEGG:02010|ABC transporters; KEGG:05130|Pathogenic Escherichia coli infection
182815-44-7	KEGG:04976|Bile secretion
73573-88-3	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:05310|Asthma
69344-77-0	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
93438-65-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus
7440-50-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:03050|Proteasome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:00120|Primary bile acid biosynthesis; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:03440|Homologous recombination; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:03015|mRNA surveillance pathway; KEGG:00670|One carbon pool by folate; KEGG:00640|Propanoate metabolism; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:03040|Spliceosome; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:00910|Nitrogen metabolism; KEGG:04330|Notch signaling pathway; KEGG:04340|Hedgehog signaling pathway; KEGG:00450|Selenocompound metabolism; KEGG:04974|Protein digestion and absorption; KEGG:04966|Collecting duct acid secretion; KEGG:00062|Fatty acid elongation in mitochondria
77280-83-2	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
13985-65-4	KEGG:04080|Neuroactive ligand-receptor interaction
7758-98-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00120|Primary bile acid biosynthesis; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00970|Aminoacyl-tRNA biosynthesis; KEGG:00020|Citrate cycle (TCA cycle); KEGG:04977|Vitamin digestion and absorption; KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:00563|Glycosylphosphatidylinositol(GPI)-anchor biosynthesis; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:03440|Homologous recombination; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:03015|mRNA surveillance pathway; KEGG:00670|One carbon pool by folate; KEGG:00770|Pantothenate and CoA biosynthesis; KEGG:00640|Propanoate metabolism; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:03020|RNA polymerase; KEGG:00600|Sphingolipid metabolism; KEGG:03040|Spliceosome; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:00510|N-Glycan biosynthesis; KEGG:00760|Nicotinate and nicotinamide metabolism; KEGG:00910|Nitrogen metabolism; KEGG:00533|Glycosaminoglycan biosynthesis - keratan sulfate; KEGG:00350|Tyrosine metabolism; KEGG:00790|Folate biosynthesis; KEGG:03060|Protein export; KEGG:04974|Protein digestion and absorption; KEGG:04130|SNARE interactions in vesicular transport; KEGG:04122|Sulfur relay system; KEGG:04966|Collecting duct acid secretion
6872-73-7	KEGG:05219|Bladder cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04623|Cytosolic DNA-sensing pathway
73-03-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway
8001-30-7	KEGG:05218|Melanoma; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:03320|PPAR signaling pathway; KEGG:04976|Bile secretion; KEGG:00270|Cysteine and methionine metabolism; KEGG:04975|Fat digestion and absorption; KEGG:00400|Phenylalanine, tyrosine and tryptophan biosynthesis; KEGG:00061|Fatty acid biosynthesis
50-22-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:00480|Glutathione metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04530|Tight junction; KEGG:03030|DNA replication; KEGG:03430|Mismatch repair
10215-77-7	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04360|Axon guidance
9015-71-8	KEGG:00140|Steroid hormone biosynthesis; KEGG:04080|Neuroactive ligand-receptor interaction
96118-75-1	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04730|Long-term depression
2203-97-6	KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway
53-06-5	KEGG:00140|Steroid hormone biosynthesis; KEGG:04960|Aldosterone-regulated sodium reabsorption
486-56-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00232|Caffeine metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
56-72-4	KEGG:00564|Glycerophospholipid metabolism
91-64-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04110|Cell cycle; KEGG:04115|p53 signaling pathway; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:00270|Cysteine and methionine metabolism; KEGG:00071|Fatty acid metabolism; KEGG:00590|Arachidonic acid metabolism; KEGG:03030|DNA replication; KEGG:03410|Base excision repair; KEGG:00910|Nitrogen metabolism
479-13-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
132746-60-2	KEGG:04080|Neuroactive ligand-receptor interaction
64795-35-3	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04540|Gap junction
93822-42-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00983|Drug metabolism - other enzymes
57-00-1	KEGG:00260|Glycine, serine and threonine metabolism; KEGG:00330|Arginine and proline metabolism
8021-39-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:00480|Glutathione metabolism; KEGG:00071|Fatty acid metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism; KEGG:00360|Phenylalanine metabolism
596-27-0	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
27876-94-4	KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04623|Cytosolic DNA-sensing pathway
15826-37-6	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04920|Adipocytokine signaling pathway
8001-28-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04672|Intestinal immune network for IgA production
6117-91-5	KEGG:04080|Neuroactive ligand-receptor interaction
35825-57-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
2222-07-3	KEGG:05145|Toxoplasmosis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles
98-82-8	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05211|Renal cell carcinoma; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion
80-15-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05200|Pathways in cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:00480|Glutathione metabolism; KEGG:00590|Arachidonic acid metabolism
142-71-2	KEGG:05210|Colorectal cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04660|T cell receptor signaling pathway
7447-39-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:03320|PPAR signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:03050|Proteasome
1317-38-0	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05323|Rheumatoid arthritis; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04978|Mineral absorption; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:05110|Vibrio cholerae infection; KEGG:03015|mRNA surveillance pathway; KEGG:03040|Spliceosome; KEGG:04966|Collecting duct acid secretion
370-81-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04110|Cell cycle; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:04612|Antigen processing and presentation
8063-06-7	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
458-37-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05217|Basal cell carcinoma; KEGG:03410|Base excision repair; KEGG:04330|Notch signaling pathway; KEGG:03450|Non-homologous end-joining; KEGG:04974|Protein digestion and absorption
54724-00-4	KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production
117574-40-0	KEGG:03050|Proteasome
420-04-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04722|Neurotrophin signaling pathway
21725-46-2	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00350|Tyrosine metabolism
13306-05-3	KEGG:05200|Pathways in cancer; KEGG:04370|VEGF signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:00590|Arachidonic acid metabolism
7084-24-4	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04360|Axon guidance
101043-37-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00500|Starch and sucrose metabolism; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00052|Galactose metabolism
115066-14-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
81608-27-7	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04144|Endocytosis
108-77-0	KEGG:05323|Rheumatoid arthritis; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction
3572-80-3	KEGG:04080|Neuroactive ligand-receptor interaction
469-38-5	KEGG:01100|Metabolic pathways; KEGG:04146|Peroxisome; KEGG:00480|Glutathione metabolism
66-81-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04810|Regulation of actin cytoskeleton; KEGG:02010|ABC transporters; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy
121-82-4	KEGG:03010|Ribosome
4449-51-8	KEGG:05200|Pathways in cancer; KEGG:04510|Focal adhesion; KEGG:05217|Basal cell carcinoma; KEGG:04340|Hedgehog signaling pathway
219-08-9	KEGG:04080|Neuroactive ligand-receptor interaction
930-30-3	KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer
50-18-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:00590|Arachidonic acid metabolism; KEGG:04360|Axon guidance; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03420|Nucleotide excision repair; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:03440|Homologous recombination; KEGG:03430|Mismatch repair; KEGG:05340|Primary immunodeficiency
18172-33-3	KEGG:04115|p53 signaling pathway
71615-27-5	KEGG:04610|Complement and coagulation cascades
4163-15-9	KEGG:04080|Neuroactive ligand-receptor interaction
68-41-7	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis
59865-13-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00120|Primary bile acid biosynthesis; KEGG:00500|Starch and sucrose metabolism; KEGG:00920|Sulfur metabolism; KEGG:04672|Intestinal immune network for IgA production; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00970|Aminoacyl-tRNA biosynthesis; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04977|Vitamin digestion and absorption; KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:00240|Pyrimidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:03440|Homologous recombination; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:03015|mRNA surveillance pathway; KEGG:00670|One carbon pool by folate; KEGG:00770|Pantothenate and CoA biosynthesis; KEGG:00640|Propanoate metabolism; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:00600|Sphingolipid metabolism; KEGG:03040|Spliceosome; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:00510|N-Glycan biosynthesis; KEGG:00760|Nicotinate and nicotinamide metabolism; KEGG:00910|Nitrogen metabolism; KEGG:00072|Synthesis and degradation of ketone bodies; KEGG:04614|Renin-angiotensin system; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism; KEGG:00790|Folate biosynthesis; KEGG:03060|Protein export; KEGG:00450|Selenocompound metabolism; KEGG:04974|Protein digestion and absorption; KEGG:00565|Ether lipid metabolism; KEGG:00532|Glycosaminoglycan biosynthesis - chondroitin sulfate; KEGG:04130|SNARE interactions in vesicular transport; KEGG:00062|Fatty acid elongation in mitochondria; KEGG:00290|Valine, leucine and isoleucine biosynthesis; KEGG:00750|Vitamin B6 metabolism
74436-00-3	KEGG:05323|Rheumatoid arthritis; KEGG:04380|Osteoclast differentiation
83602-39-5	KEGG:05323|Rheumatoid arthritis; KEGG:04380|Osteoclast differentiation
136553-81-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05323|Rheumatoid arthritis; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05146|Amoebiasis; KEGG:04510|Focal adhesion; KEGG:04670|Leukocyte transendothelial migration
68359-37-5	KEGG:05220|Chronic myeloid leukemia; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04320|Dorso-ventral axis formation; KEGG:04722|Neurotrophin signaling pathway; KEGG:04114|Oocyte meiosis
68085-85-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
13121-70-5	KEGG:00140|Steroid hormone biosynthesis
143545-90-8	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05215|Prostate cancer; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
52315-07-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:00380|Tryptophan metabolism; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:04013|MAPK signaling pathway - fly
94361-06-5	KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:04010|MAPK signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04975|Fat digestion and absorption; KEGG:03060|Protein export
129-03-3	KEGG:04210|Apoptosis; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04976|Bile secretion; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
2098-66-0	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04060|Cytokine-cytokine receptor interaction
427-51-0	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04060|Cytokine-cytokine receptor interaction
144602-02-8	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04916|Melanogenesis
60-23-1	KEGG:00982|Drug metabolism - cytochrome P450
52-90-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04360|Axon guidance; KEGG:00983|Drug metabolism - other enzymes; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03410|Base excision repair; KEGG:04710|Circadian rhythm - mammal; KEGG:04140|Regulation of autophagy; KEGG:04974|Protein digestion and absorption
19641-92-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
56-89-3	KEGG:05010|Alzheimer's disease; KEGG:05160|Hepatitis C; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04640|Hematopoietic cell lineage; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00450|Selenocompound metabolism; KEGG:04974|Protein digestion and absorption
147-94-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04310|Wnt signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04145|Phagosome; KEGG:04360|Axon guidance; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04974|Protein digestion and absorption
65-46-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00562|Inositol phosphate metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:00600|Sphingolipid metabolism; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:04340|Hedgehog signaling pathway; KEGG:04974|Protein digestion and absorption; KEGG:00062|Fatty acid elongation in mitochondria
63-38-7	KEGG:05416|Viral myocarditis; KEGG:04650|Natural killer cell mediated cytotoxicity
987-78-0	KEGG:05416|Viral myocarditis; KEGG:04650|Natural killer cell mediated cytotoxicity
485-35-8	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04612|Antigen processing and presentation
14930-96-2	KEGG:04146|Peroxisome
22144-77-0	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway
71-30-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04722|Neurotrophin signaling pathway; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:03410|Base excision repair
94-75-7	KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04630|Jak-STAT signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production
3056-17-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:00480|Glutathione metabolism
4342-03-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:03410|Base excision repair; KEGG:04140|Regulation of autophagy
50-76-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:02010|ABC transporters
486-66-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:02010|ABC transporters; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
17230-88-5	KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04630|Jak-STAT signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:05150|Staphylococcus aureus infection; KEGG:05310|Asthma
117-10-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04010|MAPK signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04120|Ubiquitin mediated proteolysis
7261-97-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:04010|MAPK signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway; KEGG:05414|Dilated cardiomyopathy
80-08-0	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:04114|Oocyte meiosis; KEGG:04360|Axon guidance
133099-04-4	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
302962-49-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04114|Oocyte meiosis; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:04360|Axon guidance; KEGG:03030|DNA replication; KEGG:05414|Dilated cardiomyopathy; KEGG:03420|Nucleotide excision repair; KEGG:00240|Pyrimidine metabolism; KEGG:03430|Mismatch repair; KEGG:00760|Nicotinate and nicotinamide metabolism
20830-81-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:03050|Proteasome; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:05320|Autoimmune thyroid disease; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00020|Citrate cycle (TCA cycle); KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00240|Pyrimidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:04614|Renin-angiotensin system; KEGG:04974|Protein digestion and absorption
28008-55-1	KEGG:01100|Metabolic pathways; KEGG:00561|Glycerolipid metabolism
533-74-4	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04610|Complement and coagulation cascades
7481-89-2	KEGG:05010|Alzheimer's disease; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:01100|Metabolic pathways; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:00071|Fatty acid metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00970|Aminoacyl-tRNA biosynthesis; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:00062|Fatty acid elongation in mitochondria
53-19-0	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04020|Calcium signaling pathway; KEGG:04144|Endocytosis
50-29-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04114|Oocyte meiosis; KEGG:03050|Proteasome; KEGG:03010|Ribosome; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
4906-84-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05145|Toxoplasmosis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04912|GnRH signaling pathway
16679-58-6	KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04510|Focal adhesion; KEGG:04742|Taste transduction; KEGG:04962|Vasopressin-regulated water reabsorption
69-33-0	KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway
1163-19-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00380|Tryptophan metabolism
156-74-1	KEGG:04080|Neuroactive ligand-receptor interaction
52820-00-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:00230|Purine metabolism; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes
706-14-9	KEGG:01100|Metabolic pathways
112-31-2	KEGG:00620|Pyruvate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism
124-18-5	KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction
334-48-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
36761-83-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00983|Drug metabolism - other enzymes
2353-33-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:05217|Basal cell carcinoma; KEGG:04974|Protein digestion and absorption
891-60-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis
5928-25-6	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer
134-62-3	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00232|Caffeine metabolism; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes
30652-11-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
70-51-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:00020|Citrate cycle (TCA cycle)
522-17-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
490-83-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis
313-04-2	KEGG:04976|Bile secretion
477-43-0	KEGG:05323|Rheumatoid arthritis; KEGG:04060|Cytokine-cytokine receptor interaction
53-43-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:00071|Fatty acid metabolism; KEGG:04114|Oocyte meiosis; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:04975|Fat digestion and absorption; KEGG:00983|Drug metabolism - other enzymes; KEGG:00920|Sulfur metabolism
651-48-9	KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:03320|PPAR signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:04976|Bile secretion
41598-07-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:00590|Arachidonic acid metabolism; KEGG:04120|Ubiquitin mediated proteolysis
472-87-7	KEGG:00051|Fructose and mannose metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:00052|Galactose metabolism
136817-59-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
13270-61-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:04722|Neurotrophin signaling pathway
5957-75-5	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation
319-86-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04080|Neuroactive ligand-receptor interaction
65907-30-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism
1972-08-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:00100|Steroid biosynthesis; KEGG:04530|Tight junction; KEGG:04360|Axon guidance; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00970|Aminoacyl-tRNA biosynthesis; KEGG:00240|Pyrimidine metabolism; KEGG:03040|Spliceosome; KEGG:04962|Vasopressin-regulated water reabsorption
119-13-1	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway
122752-16-3	KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04144|Endocytosis
127-33-3	KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles
24939-17-1	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
58957-92-9	KEGG:04210|Apoptosis
83-44-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:04950|Maturity onset diabetes of the young; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:04530|Tight junction; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00983|Drug metabolism - other enzymes; KEGG:00120|Primary bile acid biosynthesis; KEGG:00500|Starch and sucrose metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:04977|Vitamin digestion and absorption; KEGG:00061|Fatty acid biosynthesis
951-77-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:04360|Axon guidance; KEGG:00983|Drug metabolism - other enzymes; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00020|Citrate cycle (TCA cycle); KEGG:00240|Pyrimidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00190|Oxidative phosphorylation
501-15-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00480|Glutathione metabolism
154-17-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00330|Arginine and proline metabolism; KEGG:04013|MAPK signaling pathway - fly
961-07-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:00450|Selenocompound metabolism
19130-96-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage
51481-10-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs)
951-78-0	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:01100|Metabolic pathways; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:00983|Drug metabolism - other enzymes; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:03430|Mismatch repair
6707-58-0	KEGG:05219|Bladder cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04623|Cytosolic DNA-sensing pathway
24967-94-0	KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:04010|MAPK signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04810|Regulation of actin cytoskeleton
83409-32-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04976|Bile secretion
79352-78-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:00590|Arachidonic acid metabolism
1476-52-4	KEGG:00982|Drug metabolism - cytochrome P450
57041-67-5	KEGG:05323|Rheumatoid arthritis; KEGG:05144|Malaria; KEGG:05143|African trypanosomiasis; KEGG:04514|Cell adhesion molecules (CAMs)
50-47-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00232|Caffeine metabolism; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00983|Drug metabolism - other enzymes
54024-22-5	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04610|Complement and coagulation cascades
152-58-9	KEGG:00140|Steroid hormone biosynthesis
2503-26-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
50-02-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:00100|Steroid biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04742|Taste transduction; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05217|Basal cell carcinoma; KEGG:04710|Circadian rhythm - mammal; KEGG:04340|Hedgehog signaling pathway; KEGG:00350|Tyrosine metabolism; KEGG:04974|Protein digestion and absorption; KEGG:05340|Primary immunodeficiency
312-93-6	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
78901-95-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism
119817-90-2	KEGG:04080|Neuroactive ligand-receptor interaction
113775-47-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
5822-43-5	KEGG:04080|Neuroactive ligand-receptor interaction
9004-54-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04810|Regulation of actin cytoskeleton
9042-14-2	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04810|Regulation of actin cytoskeleton
125-73-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00983|Drug metabolism - other enzymes
2044-85-1	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
57-71-6	KEGG:05220|Chronic myeloid leukemia; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway
13739-02-1	KEGG:05146|Amoebiasis; KEGG:04510|Focal adhesion; KEGG:04512|ECM-receptor interaction; KEGG:04974|Protein digestion and absorption
5542-28-9	KEGG:05012|Parkinson's disease
2179-57-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04310|Wnt signaling pathway; KEGG:04530|Tight junction; KEGG:04514|Cell adhesion molecules (CAMs)
131-17-9	KEGG:01100|Metabolic pathways; KEGG:04146|Peroxisome
2444-49-7	KEGG:00480|Glutathione metabolism
2050-87-5	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis
10465-78-8	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:00480|Glutathione metabolism
41575-94-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation
117-96-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway
131-49-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05020|Prion diseases
3618-05-1	KEGG:05200|Pathways in cancer
439-14-5	KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
333-41-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:05330|Allograft rejection; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00590|Arachidonic acid metabolism; KEGG:05217|Basal cell carcinoma; KEGG:04340|Hedgehog signaling pathway; KEGG:00350|Tyrosine metabolism
364-98-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04950|Maturity onset diabetes of the young
192-65-4	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
191-30-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
1421-83-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
132-64-9	KEGG:04110|Cell cycle; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:04012|ErbB signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:00590|Arachidonic acid metabolism
120-78-5	KEGG:05140|Leishmaniasis; KEGG:05330|Allograft rejection; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway
120-46-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:04910|Insulin signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:00480|Glutathione metabolism
631-64-1	KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:04010|MAPK signaling pathway; KEGG:05143|African trypanosomiasis
106-93-4	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:00480|Glutathione metabolism; KEGG:00983|Drug metabolism - other enzymes
683-18-1	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
924-16-3	KEGG:00980|Metabolism of xenobiotics by cytochrome P450
84-74-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03022|Basal transcription factors; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:03440|Homologous recombination; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:03015|mRNA surveillance pathway; KEGG:00670|One carbon pool by folate; KEGG:00770|Pantothenate and CoA biosynthesis; KEGG:00640|Propanoate metabolism; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:03020|RNA polymerase; KEGG:00600|Sphingolipid metabolism; KEGG:03040|Spliceosome; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:00510|N-Glycan biosynthesis; KEGG:04330|Notch signaling pathway; KEGG:04340|Hedgehog signaling pathway; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism; KEGG:04130|SNARE interactions in vesicular transport; KEGG:00062|Fatty acid elongation in mitochondria; KEGG:00531|Glycosaminoglycan degradation
362-74-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production; KEGG:04330|Notch signaling pathway
632-93-9	KEGG:00270|Cysteine and methionine metabolism
17411-19-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis
79-43-6	KEGG:04010|MAPK signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction
15663-27-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:02010|ABC transporters; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00562|Inositol phosphate metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:03420|Nucleotide excision repair; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:03440|Homologous recombination; KEGG:03430|Mismatch repair; KEGG:03040|Spliceosome; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:04330|Notch signaling pathway; KEGG:03450|Non-homologous end-joining; KEGG:00565|Ether lipid metabolism
72-54-8	KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:04020|Calcium signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04144|Endocytosis
72-55-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05320|Autoimmune thyroid disease
67198-13-4	KEGG:04062|Chemokine signaling pathway
53-85-0	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
120-97-8	KEGG:00910|Nitrogen metabolism
62-73-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:01100|Metabolic pathways; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04940|Type I diabetes mellitus; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04612|Antigen processing and presentation; KEGG:05320|Autoimmune thyroid disease
15307-86-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04145|Phagosome; KEGG:05150|Staphylococcus aureus infection; KEGG:00590|Arachidonic acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs)
3116-76-5	KEGG:05323|Rheumatoid arthritis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction
115-32-2	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways
66-76-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
84-61-7	KEGG:04080|Neuroactive ligand-receptor interaction
69655-05-6	KEGG:05016|Huntington's disease; KEGG:04260|Cardiac muscle contraction
134678-17-4	KEGG:05010|Alzheimer's disease; KEGG:04110|Cell cycle; KEGG:05016|Huntington's disease; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:01100|Metabolic pathways; KEGG:04920|Adipocytokine signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05162|Measles; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:00071|Fatty acid metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00970|Aminoacyl-tRNA biosynthesis; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:00062|Fatty acid elongation in mitochondria
60-57-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00590|Arachidonic acid metabolism; KEGG:05217|Basal cell carcinoma; KEGG:04340|Hedgehog signaling pathway
84-17-3	KEGG:00140|Steroid hormone biosynthesis
2227-17-0	KEGG:04141|Protein processing in endoplasmic reticulum
65928-58-7	KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway
111-42-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05152|Tuberculosis; KEGG:05020|Prion diseases; KEGG:04012|ErbB signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:00480|Glutathione metabolism
109-89-7	KEGG:05152|Tuberculosis; KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway
92818-79-6	KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:00230|Purine metabolism
90-89-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
117-81-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:03050|Proteasome; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00920|Sulfur metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00410|beta-Alanine metabolism; KEGG:04142|Lysosome; KEGG:00640|Propanoate metabolism; KEGG:00650|Butanoate metabolism; KEGG:00072|Synthesis and degradation of ketone bodies; KEGG:04974|Protein digestion and absorption
141-05-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:05162|Measles; KEGG:00480|Glutathione metabolism; KEGG:00071|Fatty acid metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00340|Histidine metabolism; KEGG:04710|Circadian rhythm - mammal
55-18-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00120|Primary bile acid biosynthesis; KEGG:00500|Starch and sucrose metabolism; KEGG:00920|Sulfur metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:04710|Circadian rhythm - mammal; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:00640|Propanoate metabolism; KEGG:00600|Sphingolipid metabolism; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:00910|Nitrogen metabolism; KEGG:00072|Synthesis and degradation of ketone bodies; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism; KEGG:00790|Folate biosynthesis; KEGG:04974|Protein digestion and absorption; KEGG:00603|Glycosphingolipid biosynthesis - globo series
84-66-2	KEGG:00250|Alanine, aspartate and glutamate metabolism
1609-47-8	KEGG:05218|Melanoma; KEGG:05211|Renal cell carcinoma; KEGG:05144|Malaria
56-53-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:03050|Proteasome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:05217|Basal cell carcinoma; KEGG:04142|Lysosome; KEGG:04340|Hedgehog signaling pathway; KEGG:05340|Primary immunodeficiency
64-67-5	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
26914-14-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450
119446-68-3	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer
49866-87-7	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04610|Complement and coagulation cascades
33564-31-7	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04672|Intestinal immune network for IgA production
35367-38-5	KEGG:00380|Tryptophan metabolism
22494-42-4	KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
143-62-4	KEGG:05219|Bladder cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04623|Cytosolic DNA-sensing pathway
71-63-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04540|Gap junction; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis
1672-46-4	KEGG:05219|Bladder cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction
20830-75-5	KEGG:05219|Bladder cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04370|VEGF signaling pathway; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04510|Focal adhesion; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:02010|ABC transporters
97067-70-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05310|Asthma
3648-21-3	KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis
123039-93-0	KEGG:04540|Gap junction
60106-89-0	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04144|Endocytosis
23255-54-1	KEGG:05223|Non-small cell lung cancer; KEGG:04080|Neuroactive ligand-receptor interaction
19408-84-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05216|Thyroid cancer; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis; KEGG:00590|Arachidonic acid metabolism
4033-27-6	KEGG:01100|Metabolic pathways; KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
462-20-4	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton
71939-50-9	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
66000-40-6	KEGG:00590|Arachidonic acid metabolism
57-04-5	KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis
480-22-8	KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
40013-87-4	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction
1528-72-9	KEGG:04010|MAPK signaling pathway
102-32-9	KEGG:05010|Alzheimer's disease; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00350|Tyrosine metabolism
63-84-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00380|Tryptophan metabolism; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:00350|Tyrosine metabolism
3343-19-9	KEGG:05016|Huntington's disease; KEGG:01100|Metabolic pathways; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04540|Gap junction; KEGG:04730|Long-term depression
32222-06-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:04530|Tight junction; KEGG:02010|ABC transporters; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:03440|Homologous recombination; KEGG:03430|Mismatch repair; KEGG:00910|Nitrogen metabolism; KEGG:04974|Protein digestion and absorption
84-69-5	KEGG:00140|Steroid hormone biosynthesis
26761-40-0	KEGG:00230|Purine metabolism; KEGG:00920|Sulfur metabolism; KEGG:00450|Selenocompound metabolism
28553-12-0	KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04940|Type I diabetes mellitus; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
53609-64-6	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04940|Type I diabetes mellitus; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway
53005-05-3	KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:04966|Collecting duct acid secretion
42399-41-7	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion
65119-89-3	KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
115-26-4	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer
59-52-9	KEGG:04060|Cytokine-cytokine receptor interaction
60-51-5	KEGG:01100|Metabolic pathways; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00380|Tryptophan metabolism; KEGG:04810|Regulation of actin cytoskeleton
110488-70-5	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04610|Complement and coagulation cascades
19982-08-2	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05146|Amoebiasis
593-57-7	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
57-97-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:04974|Protein digestion and absorption
68-12-2	KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00920|Sulfur metabolism
624-49-7	KEGG:04350|TGF-beta signaling pathway
540-73-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:05216|Thyroid cancer; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:05217|Basal cell carcinoma
593-74-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450
60355-79-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway; KEGG:00480|Glutathione metabolism
62-75-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04114|Oocyte meiosis; KEGG:03050|Proteasome; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:00100|Steroid biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:02010|ABC transporters; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00410|beta-Alanine metabolism; KEGG:04142|Lysosome; KEGG:00770|Pantothenate and CoA biosynthesis; KEGG:00350|Tyrosine metabolism; KEGG:00565|Ether lipid metabolism
34184-77-5	KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04978|Mineral absorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis
54-77-3	KEGG:04080|Neuroactive ligand-receptor interaction
39746-25-3	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway
67-68-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:04530|Tight junction; KEGG:00983|Drug metabolism - other enzymes; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04974|Protein digestion and absorption
61-50-7	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction
1002-53-5	KEGG:05010|Alzheimer's disease; KEGG:04020|Calcium signaling pathway; KEGG:04970|Salivary secretion
84-75-3	KEGG:05200|Pathways in cancer; KEGG:00140|Steroid hormone biosynthesis
76714-88-0	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04610|Complement and coagulation cascades; KEGG:04060|Cytokine-cytokine receptor interaction
12379-41-8	KEGG:05144|Malaria; KEGG:05143|African trypanosomiasis; KEGG:04670|Leukocyte transendothelial migration; KEGG:05150|Staphylococcus aureus infection; KEGG:04514|Cell adhesion molecules (CAMs)
97-00-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:04114|Oocyte meiosis; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
70-34-8	KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs)
81720-10-7	KEGG:05160|Hepatitis C; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04350|TGF-beta signaling pathway; KEGG:04730|Long-term depression; KEGG:04310|Wnt signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04530|Tight junction; KEGG:03015|mRNA surveillance pathway
139933-46-3	KEGG:04110|Cell cycle; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04350|TGF-beta signaling pathway; KEGG:04730|Long-term depression; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04310|Wnt signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:03015|mRNA surveillance pathway
131-18-0	KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04976|Bile secretion; KEGG:00100|Steroid biosynthesis
512-04-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
520-34-3	KEGG:04210|Apoptosis; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00140|Steroid hormone biosynthesis; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism
520-27-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05146|Amoebiasis; KEGG:04722|Neurotrophin signaling pathway
2644-64-6	KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction
58-73-1	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:05322|Systemic lupus erythematosus; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04730|Long-term depression; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04971|Gastric acid secretion; KEGG:05150|Staphylococcus aureus infection
92-52-4	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00380|Tryptophan metabolism
117-34-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
122-39-4	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03420|Nucleotide excision repair
93-99-2	KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
886-38-4	KEGG:04978|Mineral absorption
1666-13-3	KEGG:05219|Bladder cancer; KEGG:05213|Endometrial cancer; KEGG:05223|Non-small cell lung cancer; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04930|Type II diabetes mellitus; KEGG:04724|Glutamatergic synapse; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation
244-54-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
10182-84-0	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton
102-08-9	KEGG:00980|Metabolism of xenobiotics by cytochrome P450
138-81-8	KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04144|Endocytosis
58-32-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:00230|Purine metabolism; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05414|Dilated cardiomyopathy
68-89-3	KEGG:04210|Apoptosis; KEGG:05214|Glioma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04623|Cytosolic DNA-sensing pathway
2764-72-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04146|Peroxisome; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation
37686-84-3	KEGG:04080|Neuroactive ligand-receptor interaction
16923-58-3	KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
3737-09-5	KEGG:04976|Bile secretion
97-77-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04144|Endocytosis; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00590|Arachidonic acid metabolism; KEGG:04360|Axon guidance; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:04340|Hedgehog signaling pathway
69-78-3	KEGG:00240|Pyrimidine metabolism; KEGG:00450|Selenocompound metabolism
496-74-2	KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
3483-12-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00310|Lysine degradation
147-84-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04144|Endocytosis; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00590|Arachidonic acid metabolism; KEGG:04360|Axon guidance; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:00564|Glycerophospholipid metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:04340|Hedgehog signaling pathway
330-54-1	KEGG:05010|Alzheimer's disease; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:04142|Lysosome; KEGG:00640|Propanoate metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism; KEGG:04974|Protein digestion and absorption
77086-22-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
51-28-5	KEGG:05010|Alzheimer's disease; KEGG:05016|Huntington's disease; KEGG:00380|Tryptophan metabolism
34368-04-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04530|Tight junction; KEGG:04742|Taste transduction; KEGG:05414|Dilated cardiomyopathy
114977-28-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:02010|ABC transporters; KEGG:00983|Drug metabolism - other enzymes; KEGG:03450|Non-homologous end-joining
25167-62-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00590|Arachidonic acid metabolism; KEGG:04975|Fat digestion and absorption
112-53-8	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
14277-97-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis
57808-66-9	KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction
120011-70-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway; KEGG:04310|Wnt signaling pathway
51-61-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00650|Butanoate metabolism; KEGG:00350|Tyrosine metabolism
86197-47-9	KEGG:04621|NOD-like receptor signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction
117704-25-3	KEGG:04145|Phagosome; KEGG:05130|Pathogenic Escherichia coli infection
130693-82-2	KEGG:00910|Nitrogen metabolism
309-29-5	KEGG:04080|Neuroactive ligand-receptor interaction
74191-85-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
3094-09-5	KEGG:05219|Bladder cancer; KEGG:05160|Hepatitis C; KEGG:01100|Metabolic pathways; KEGG:05144|Malaria; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:00983|Drug metabolism - other enzymes; KEGG:00240|Pyrimidine metabolism
23214-92-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:03050|Proteasome; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:05320|Autoimmune thyroid disease; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00020|Citrate cycle (TCA cycle); KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:03420|Nucleotide excision repair; KEGG:00240|Pyrimidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:04614|Renin-angiotensin system; KEGG:04974|Protein digestion and absorption
564-25-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:04630|Jak-STAT signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
643-56-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway
67392-87-4	KEGG:04114|Oocyte meiosis
116539-58-3	KEGG:00982|Drug metabolism - cytochrome P450
88149-94-4	KEGG:04210|Apoptosis; KEGG:04370|VEGF signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:00590|Arachidonic acid metabolism
1306-06-5	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway
152-62-5	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
74913-18-1	KEGG:04080|Neuroactive ligand-receptor interaction
145096-30-6	KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
60940-34-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:00590|Arachidonic acid metabolism
474-00-0	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
510-30-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:04621|NOD-like receptor signaling pathway
512-64-1	KEGG:05200|Pathways in cancer; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma
88798-74-7	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton
65492-82-2	KEGG:05222|Small cell lung cancer; KEGG:05143|African trypanosomiasis
60-00-4	KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:04640|Hematopoietic cell lineage; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00450|Selenocompound metabolism
154635-17-3	KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:00590|Arachidonic acid metabolism; KEGG:05320|Autoimmune thyroid disease
111011-53-1	KEGG:02010|ABC transporters
99590-86-0	KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:05323|Rheumatoid arthritis; KEGG:04370|VEGF signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:00590|Arachidonic acid metabolism
67-42-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection
1553-41-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00590|Arachidonic acid metabolism; KEGG:04975|Fat digestion and absorption; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04977|Vitamin digestion and absorption
1191-85-1	KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04912|GnRH signaling pathway; KEGG:04660|T cell receptor signaling pathway
13296-76-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05216|Thyroid cancer; KEGG:04722|Neurotrophin signaling pathway
476-66-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04144|Endocytosis
519-23-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis
137512-74-4	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04610|Complement and coagulation cascades
483-18-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
518-82-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production; KEGG:05130|Pathogenic Escherichia coli infection
75847-73-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:05414|Dilated cardiomyopathy; KEGG:04614|Renin-angiotensin system; KEGG:04974|Protein digestion and absorption
84680-54-6	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05146|Amoebiasis; KEGG:04144|Endocytosis; KEGG:05414|Dilated cardiomyopathy; KEGG:04614|Renin-angiotensin system
115-29-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance; KEGG:00630|Glyoxylate and dicarboxylate metabolism
67924-63-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway
72-20-8	KEGG:05200|Pathways in cancer; KEGG:00830|Retinol metabolism
13838-16-9	KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease
88457-22-1	KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
58822-25-6	KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
4245-77-6	KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04612|Antigen processing and presentation
116314-67-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04146|Peroxisome; KEGG:00071|Fatty acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
37337-57-8	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation
39424-53-8	KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
38102-62-4	KEGG:04114|Oocyte meiosis
18472-87-2	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05146|Amoebiasis; KEGG:04650|Natural killer cell mediated cytotoxicity
299-42-3	KEGG:05210|Colorectal cancer; KEGG:03320|PPAR signaling pathway; KEGG:04975|Fat digestion and absorption; KEGG:04977|Vitamin digestion and absorption
140111-52-0	KEGG:04080|Neuroactive ligand-receptor interaction
863-03-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:04360|Axon guidance
106-89-8	KEGG:04210|Apoptosis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity
56420-45-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:02010|ABC transporters; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
989-51-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:04530|Tight junction; KEGG:02010|ABC transporters; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:03018|RNA degradation; KEGG:00564|Glycerophospholipid metabolism; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:03015|mRNA surveillance pathway; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:00565|Ether lipid metabolism
80012-43-7	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
51-43-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00562|Inositol phosphate metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:00020|Citrate cycle (TCA cycle); KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04614|Renin-angiotensin system; KEGG:00350|Tyrosine metabolism
56084-15-2	KEGG:01100|Metabolic pathways; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion
133855-98-8	KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:00480|Glutathione metabolism; KEGG:00564|Glycerophospholipid metabolism; KEGG:00510|N-Glycan biosynthesis; KEGG:03060|Protein export
134381-21-8	KEGG:04210|Apoptosis
62218-08-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes
759-94-4	KEGG:04080|Neuroactive ligand-receptor interaction
517-09-9	KEGG:05214|Glioma; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:04012|ErbB signaling pathway; KEGG:03010|Ribosome
531-95-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
84611-23-4	KEGG:01100|Metabolic pathways; KEGG:04146|Peroxisome; KEGG:00230|Purine metabolism
57-87-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04010|MAPK signaling pathway; KEGG:04722|Neurotrophin signaling pathway
113-15-5	KEGG:05210|Colorectal cancer
552-58-9	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway
4430-36-8	KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04062|Chemokine signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:00053|Ascorbate and aldarate metabolism
1464-53-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450
114-07-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism
3521-62-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04010|MAPK signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:00071|Fatty acid metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:02010|ABC transporters; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism
16423-68-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
305-01-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway
29975-16-4	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
1090-04-6	KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway
1035-77-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism
983-30-2	KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04010|MAPK signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04510|Focal adhesion; KEGG:00270|Cysteine and methionine metabolism; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton
313-06-4	KEGG:04912|GnRH signaling pathway; KEGG:04145|Phagosome
1806-98-0	KEGG:04976|Bile secretion; KEGG:04530|Tight junction; KEGG:02010|ABC transporters
50-50-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04013|MAPK signaling pathway - fly
50-28-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00120|Primary bile acid biosynthesis; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:00650|Butanoate metabolism; KEGG:04340|Hedgehog signaling pathway; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism; KEGG:00790|Folate biosynthesis; KEGG:04974|Protein digestion and absorption; KEGG:05340|Primary immunodeficiency
979-32-8	KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis
140-67-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00232|Caffeine metabolism
50-27-1	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs)
53-16-7	KEGG:05219|Bladder cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:00140|Steroid hormone biosynthesis; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04920|Adipocytokine signaling pathway; KEGG:04970|Salivary secretion; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04976|Bile secretion; KEGG:04810|Regulation of actin cytoskeleton; KEGG:02010|ABC transporters; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:00561|Glycerolipid metabolism
2393-53-5	KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04010|MAPK signaling pathway; KEGG:04810|Regulation of actin cytoskeleton
481-97-0	KEGG:05020|Prion diseases; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05332|Graft-versus-host disease; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
58-54-8	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism
74-55-5	KEGG:05152|Tuberculosis; KEGG:04142|Lysosome
74-84-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00140|Steroid hormone biosynthesis
64-17-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00120|Primary bile acid biosynthesis; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00564|Glycerophospholipid metabolism; KEGG:00240|Pyrimidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00640|Propanoate metabolism; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:00650|Butanoate metabolism; KEGG:00910|Nitrogen metabolism; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism; KEGG:04974|Protein digestion and absorption; KEGG:04130|SNARE interactions in vesicular transport
60-29-7	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04730|Long-term depression
3546-21-2	KEGG:05010|Alzheimer's disease; KEGG:04110|Cell cycle; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:01100|Metabolic pathways; KEGG:05162|Measles; KEGG:04260|Cardiac muscle contraction; KEGG:00190|Oxidative phosphorylation
57-63-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:03050|Proteasome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00120|Primary bile acid biosynthesis; KEGG:00500|Starch and sucrose metabolism; KEGG:04672|Intestinal immune network for IgA production; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00970|Aminoacyl-tRNA biosynthesis; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03022|Basal transcription factors; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:04710|Circadian rhythm - mammal; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:03440|Homologous recombination; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:03015|mRNA surveillance pathway; KEGG:00670|One carbon pool by folate; KEGG:00640|Propanoate metabolism; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:03020|RNA polymerase; KEGG:00600|Sphingolipid metabolism; KEGG:03040|Spliceosome; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:00510|N-Glycan biosynthesis; KEGG:00760|Nicotinate and nicotinamide metabolism; KEGG:04330|Notch signaling pathway; KEGG:00072|Synthesis and degradation of ketone bodies; KEGG:04340|Hedgehog signaling pathway; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism; KEGG:03060|Protein export; KEGG:00450|Selenocompound metabolism; KEGG:04974|Protein digestion and absorption; KEGG:00565|Ether lipid metabolism; KEGG:00400|Phenylalanine, tyrosine and tryptophan biosynthesis; KEGG:04130|SNARE interactions in vesicular transport; KEGG:04966|Collecting duct acid secretion; KEGG:00062|Fatty acid elongation in mitochondria; KEGG:00750|Vitamin B6 metabolism
152-43-2	KEGG:05323|Rheumatoid arthritis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation
72-33-3	KEGG:05219|Bladder cancer; KEGG:05213|Endometrial cancer; KEGG:04012|ErbB signaling pathway; KEGG:04610|Complement and coagulation cascades
8056-51-7	KEGG:05144|Malaria; KEGG:05143|African trypanosomiasis; KEGG:04670|Leukocyte transendothelial migration; KEGG:04514|Cell adhesion molecules (CAMs)
13073-35-3	KEGG:05010|Alzheimer's disease; KEGG:05016|Huntington's disease; KEGG:05012|Parkinson's disease; KEGG:00830|Retinol metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:00071|Fatty acid metabolism; KEGG:03050|Proteasome; KEGG:00620|Pyruvate metabolism; KEGG:03010|Ribosome; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism; KEGG:00190|Oxidative phosphorylation
80844-07-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
627-03-2	KEGG:03430|Mismatch repair
91-53-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:00620|Pyruvate metabolism; KEGG:02010|ABC transporters; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism
452-35-7	KEGG:00910|Nitrogen metabolism
88352-44-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
141-78-6	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
100-41-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04144|Endocytosis; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05340|Primary immunodeficiency
35920-39-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05310|Asthma
75-00-3	KEGG:00980|Metabolism of xenobiotics by cytochrome P450
63918-37-6	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
74-85-1	KEGG:03410|Base excision repair
4672-49-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:05162|Measles; KEGG:00480|Glutathione metabolism; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:00072|Synthesis and degradation of ketone bodies
107-21-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00071|Fatty acid metabolism; KEGG:00350|Tyrosine metabolism
75-21-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:03410|Base excision repair
96-45-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04110|Cell cycle; KEGG:05200|Pathways in cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:03030|DNA replication
1154-25-2	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
128-53-0	KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04940|Type I diabetes mellitus; KEGG:02010|ABC transporters; KEGG:00410|beta-Alanine metabolism; KEGG:00650|Butanoate metabolism; KEGG:00430|Taurine and hypotaurine metabolism
107-27-7	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease
62-50-0	KEGG:03410|Base excision repair
759-73-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:05217|Basal cell carcinoma; KEGG:03430|Mismatch repair; KEGG:04340|Hedgehog signaling pathway; KEGG:00350|Tyrosine metabolism
617-35-6	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway
84226-12-0	KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04660|T cell receptor signaling pathway
2809-21-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04660|T cell receptor signaling pathway; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells
709-55-7	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04144|Endocytosis
33996-58-6	KEGG:00140|Steroid hormone biosynthesis; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters; KEGG:05414|Dilated cardiomyopathy
2986-20-1	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:05146|Amoebiasis
40054-69-1	KEGG:04080|Neuroactive ligand-receptor interaction
41340-25-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:05140|Leishmaniasis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04510|Focal adhesion; KEGG:04670|Leukocyte transendothelial migration; KEGG:04512|ECM-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:04514|Cell adhesion molecules (CAMs)
33125-97-2	KEGG:04080|Neuroactive ligand-receptor interaction
82258-36-4	KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:00071|Fatty acid metabolism
33419-42-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00100|Steroid biosynthesis; KEGG:02010|ABC transporters; KEGG:04360|Axon guidance
202409-33-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:04976|Bile secretion
97-53-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:03410|Base excision repair
22368-21-4	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
855-96-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
159351-69-6	KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05221|Acute myeloid leukemia; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04310|Wnt signaling pathway; KEGG:03013|RNA transport
5956-87-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
141732-76-5	KEGG:05323|Rheumatoid arthritis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation
163222-33-1	KEGG:05160|Hepatitis C; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04976|Bile secretion; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:04977|Vitamin digestion and absorption
17924-92-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04976|Bile secretion; KEGG:04114|Oocyte meiosis; KEGG:02010|ABC transporters; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
102676-47-1	KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04614|Renin-angiotensin system
21852-80-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
76824-35-6	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
19317-11-4	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
4602-84-0	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
13058-04-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
103745-39-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04530|Tight junction
107052-56-2	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04540|Gap junction
25451-15-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism
72509-76-3	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
91-40-7	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
60168-88-9	KEGG:05215|Prostate cancer; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
43210-67-9	KEGG:05219|Bladder cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction
13042-18-7	KEGG:04080|Neuroactive ligand-receptor interaction
458-24-2	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04540|Gap junction
122-14-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00561|Glycerolipid metabolism
49562-28-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00120|Primary bile acid biosynthesis; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00640|Propanoate metabolism; KEGG:00650|Butanoate metabolism; KEGG:00072|Synthesis and degradation of ketone bodies; KEGG:04140|Regulation of autophagy; KEGG:00062|Fatty acid elongation in mitochondria
26129-32-8	KEGG:05200|Pathways in cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:04920|Adipocytokine signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04976|Bile secretion; KEGG:00071|Fatty acid metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00650|Butanoate metabolism; KEGG:00062|Fatty acid elongation in mitochondria
67227-56-9	KEGG:05416|Viral myocarditis; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04610|Complement and coagulation cascades; KEGG:05146|Amoebiasis; KEGG:04510|Focal adhesion; KEGG:04512|ECM-receptor interaction; KEGG:04145|Phagosome; KEGG:05130|Pathogenic Escherichia coli infection
31879-05-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04920|Adipocytokine signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:03320|PPAR signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:00071|Fatty acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
93-72-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
13392-18-2	KEGG:05219|Bladder cancer; KEGG:05160|Hepatitis C; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04320|Dorso-ventral axis formation; KEGG:04540|Gap junction; KEGG:04144|Endocytosis
72490-01-8	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04610|Complement and coagulation cascades
16397-28-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways
134098-61-6	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04610|Complement and coagulation cascades
437-38-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00983|Drug metabolism - other enzymes
55-38-9	KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00983|Drug metabolism - other enzymes
51630-58-1	KEGG:05010|Alzheimer's disease; KEGG:05214|Glioma; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:00140|Steroid hormone biosynthesis; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04270|Vascular smooth muscle contraction; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04976|Bile secretion; KEGG:04114|Oocyte meiosis; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes
1185-57-5	KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:04978|Mineral absorption; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00630|Glyoxylate and dicarboxylate metabolism
7705-08-0	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
3522-50-7	KEGG:05200|Pathways in cancer; KEGG:04610|Complement and coagulation cascades
16448-54-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:02010|ABC transporters
1309-37-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:03040|Spliceosome
8047-67-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04722|Neurotrophin signaling pathway
10028-22-5	KEGG:01100|Metabolic pathways; KEGG:00250|Alanine, aspartate and glutamate metabolism
7758-94-3	KEGG:04110|Cell cycle; KEGG:05200|Pathways in cancer; KEGG:05211|Renal cell carcinoma; KEGG:04380|Osteoclast differentiation
1345-25-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05323|Rheumatoid arthritis; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04650|Natural killer cell mediated cytotoxicity
7720-78-7	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
28048-33-1	KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism
1135-24-6	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
119683-68-0	KEGG:05200|Pathways in cancer; KEGG:04670|Leukocyte transendothelial migration
1317-61-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:03018|RNA degradation; KEGG:03040|Spliceosome; KEGG:05340|Primary immunodeficiency
138452-21-8	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
2379-57-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS)
66-97-7	KEGG:04976|Bile secretion
136087-85-9	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma
480-49-9	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
98319-26-7	KEGG:00140|Steroid hormone biosynthesis
162359-55-9	KEGG:04975|Fat digestion and absorption
120068-37-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
528-48-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
79335-75-4	KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs)
138449-07-7	KEGG:04080|Neuroactive ligand-receptor interaction
487-26-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00140|Steroid hormone biosynthesis; KEGG:04010|MAPK signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:05216|Thyroid cancer; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway
525-82-6	KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis
146426-40-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis
50-91-9	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:01100|Metabolic pathways; KEGG:04010|MAPK signaling pathway; KEGG:05144|Malaria; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:00983|Drug metabolism - other enzymes; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:03430|Mismatch repair
79622-59-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
86386-73-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions
21679-14-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03030|DNA replication; KEGG:03410|Base excision repair; KEGG:03440|Homologous recombination; KEGG:03430|Mismatch repair; KEGG:03450|Non-homologous end-joining
530-78-9	KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04971|Gastric acid secretion
78755-81-4	KEGG:04080|Neuroactive ligand-receptor interaction
52468-60-7	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04540|Gap junction; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:04142|Lysosome; KEGG:00511|Other glycan degradation; KEGG:00603|Glycosphingolipid biosynthesis - globo series; KEGG:00604|Glycosphingolipid biosynthesis - ganglio series; KEGG:00531|Glycosaminoglycan degradation
3385-03-3	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:00120|Primary bile acid biosynthesis
1622-62-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
121714-13-4	KEGG:02010|ABC transporters
67-73-2	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:00120|Primary bile acid biosynthesis
206-44-0	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:00190|Oxidative phosphorylation
86-73-7	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism
2321-07-5	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
3326-32-7	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
1461-15-0	KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
7782-41-4	KEGG:04062|Chemokine signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05100|Bacterial invasion of epithelial cells
21330-18-7	KEGG:04062|Chemokine signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05100|Bacterial invasion of epithelial cells
154540-49-5	KEGG:04080|Neuroactive ligand-receptor interaction
127-31-1	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction
2022-85-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04722|Neurotrophin signaling pathway
51-21-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:02010|ABC transporters; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:05320|Autoimmune thyroid disease; KEGG:00562|Inositol phosphate metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:03440|Homologous recombination; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:00670|One carbon pool by folate; KEGG:03040|Spliceosome; KEGG:03450|Non-homologous end-joining; KEGG:04974|Protein digestion and absorption
54910-89-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:00590|Arachidonic acid metabolism; KEGG:04360|Axon guidance; KEGG:04710|Circadian rhythm - mammal; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:04330|Notch signaling pathway
2709-56-0	KEGG:00590|Arachidonic acid metabolism
69-23-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04540|Gap junction; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes
40666-16-8	KEGG:05200|Pathways in cancer; KEGG:03320|PPAR signaling pathway
17617-23-1	KEGG:04080|Neuroactive ligand-receptor interaction
5104-49-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00590|Arachidonic acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
333-36-8	KEGG:04080|Neuroactive ligand-receptor interaction
85509-19-9	KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:01100|Metabolic pathways; KEGG:04010|MAPK signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion; KEGG:04310|Wnt signaling pathway; KEGG:04950|Maturity onset diabetes of the young; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:05217|Basal cell carcinoma
13311-84-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:00071|Fatty acid metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00561|Glycerolipid metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00410|beta-Alanine metabolism; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:00072|Synthesis and degradation of ketone bodies; KEGG:00062|Fatty acid elongation in mitochondria
90566-53-3	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00591|Linoleic acid metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma
93957-54-1	KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04510|Focal adhesion; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis
54739-18-3	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:04020|Calcium signaling pathway; KEGG:00983|Drug metabolism - other enzymes
59-30-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04977|Vitamin digestion and absorption; KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:04142|Lysosome; KEGG:00670|One carbon pool by folate; KEGG:00640|Propanoate metabolism; KEGG:00600|Sphingolipid metabolism; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00510|N-Glycan biosynthesis; KEGG:04330|Notch signaling pathway; KEGG:04340|Hedgehog signaling pathway; KEGG:00360|Phenylalanine metabolism; KEGG:00450|Selenocompound metabolism; KEGG:04974|Protein digestion and absorption; KEGG:00604|Glycosphingolipid biosynthesis - ganglio series; KEGG:00512|Mucin type O-Glycan biosynthesis
7554-65-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:00071|Fatty acid metabolism; KEGG:00350|Tyrosine metabolism
72178-02-0	KEGG:01100|Metabolic pathways; KEGG:00860|Porphyrin and chlorophyll metabolism
944-22-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism
50-00-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:03018|RNA degradation; KEGG:03015|mRNA surveillance pathway
566-48-3	KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis
22259-30-9	KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05020|Prion diseases; KEGG:05162|Measles; KEGG:04612|Antigen processing and presentation; KEGG:04144|Endocytosis; KEGG:03040|Spliceosome
64-18-6	KEGG:04920|Adipocytokine signaling pathway
485-72-3	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:02010|ABC transporters; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
50773-42-7	KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:05323|Rheumatoid arthritis; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration
73573-87-2	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
4289-98-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:00590|Arachidonic acid metabolism; KEGG:04360|Axon guidance; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00565|Ether lipid metabolism
59880-97-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:00590|Arachidonic acid metabolism; KEGG:04360|Axon guidance; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00565|Ether lipid metabolism
58-05-9	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis; KEGG:00670|One carbon pool by folate
66428-89-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:02010|ABC transporters; KEGG:05414|Dilated cardiomyopathy; KEGG:00350|Tyrosine metabolism
98048-97-6	KEGG:04020|Calcium signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04614|Renin-angiotensin system
87810-56-8	KEGG:04350|TGF-beta signaling pathway
59721-28-7	KEGG:04020|Calcium signaling pathway
142375-60-8	KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04270|Vascular smooth muscle contraction; KEGG:05146|Amoebiasis; KEGG:04510|Focal adhesion; KEGG:04512|ECM-receptor interaction
574-84-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:04146|Peroxisome
9007-81-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04144|Endocytosis; KEGG:00590|Arachidonic acid metabolism; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:05414|Dilated cardiomyopathy
559-74-0	KEGG:05200|Pathways in cancer
30237-26-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:00071|Fatty acid metabolism; KEGG:04950|Maturity onset diabetes of the young; KEGG:00620|Pyruvate metabolism; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04975|Fat digestion and absorption; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:04977|Vitamin digestion and absorption; KEGG:00564|Glycerophospholipid metabolism; KEGG:00052|Galactose metabolism; KEGG:00910|Nitrogen metabolism; KEGG:00061|Fatty acid biosynthesis
488-69-7	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04360|Axon guidance
9072-19-9	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
3713-31-3	KEGG:01100|Metabolic pathways
3351-86-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:03320|PPAR signaling pathway
99685-96-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00591|Linoleic acid metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:04530|Tight junction; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:00564|Glycerophospholipid metabolism; KEGG:05217|Basal cell carcinoma; KEGG:04710|Circadian rhythm - mammal; KEGG:00310|Lysine degradation; KEGG:03015|mRNA surveillance pathway; KEGG:00533|Glycosaminoglycan biosynthesis - keratan sulfate
129453-61-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05217|Basal cell carcinoma; KEGG:04340|Hedgehog signaling pathway
23110-15-8	KEGG:04722|Neurotrophin signaling pathway
116355-83-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion; KEGG:04670|Leukocyte transendothelial migration; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:00100|Steroid biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome
80288-49-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:00590|Arachidonic acid metabolism
110-00-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:00270|Cysteine and methionine metabolism; KEGG:00071|Fatty acid metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:03030|DNA replication; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:03420|Nucleotide excision repair; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:03440|Homologous recombination; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:00640|Propanoate metabolism; KEGG:00650|Butanoate metabolism; KEGG:03060|Protein export
67-45-8	KEGG:01100|Metabolic pathways
98-00-0	KEGG:05140|Leishmaniasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
54-31-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:04672|Intestinal immune network for IgA production; KEGG:05414|Dilated cardiomyopathy
7618-86-2	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
23255-69-8	KEGG:04141|Protein processing in endoplasmic reticulum
6990-06-3	KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
60142-96-3	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:00380|Tryptophan metabolism; KEGG:04260|Cardiac muscle contraction; KEGG:03010|Ribosome; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC)
39492-01-8	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage
122795-43-1	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04672|Intestinal immune network for IgA production
7440-54-2	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05310|Asthma
10138-52-0	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production
80529-93-7	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04672|Intestinal immune network for IgA production
7535-00-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
26566-61-0	KEGG:01100|Metabolic pathways; KEGG:04973|Carbohydrate digestion and absorption; KEGG:00052|Galactose metabolism
548-83-4	KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
357-70-0	KEGG:04080|Neuroactive ligand-receptor interaction
1222-05-5	KEGG:04114|Oocyte meiosis
65-29-2	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
149-91-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:00330|Arginine and proline metabolism
7440-55-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05016|Huntington's disease; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway
1303-00-0	KEGG:05010|Alzheimer's disease; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway
13494-90-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05020|Prion diseases; KEGG:04978|Mineral absorption; KEGG:04146|Peroxisome; KEGG:04612|Antigen processing and presentation
1617-55-6	KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
2752-65-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04910|Insulin signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway
636-58-8	KEGG:01100|Metabolic pathways; KEGG:00480|Glutathione metabolism
105644-04-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
506-26-3	KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04540|Gap junction; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis; KEGG:04530|Tight junction
31271-07-5	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04540|Gap junction
82410-32-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04722|Neurotrophin signaling pathway
12707-58-3	KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04145|Phagosome; KEGG:05130|Pathogenic Escherichia coli infection
62010-37-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04010|MAPK signaling pathway; KEGG:05146|Amoebiasis; KEGG:04650|Natural killer cell mediated cytotoxicity
78824-30-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells
60748-06-3	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
2753-30-2	KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05020|Prion diseases; KEGG:04010|MAPK signaling pathway; KEGG:05162|Measles; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04612|Antigen processing and presentation
184475-35-2	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
30562-34-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:04013|MAPK signaling pathway - fly
103882-84-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis
25812-30-0	KEGG:05010|Alzheimer's disease; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04976|Bile secretion; KEGG:00071|Fatty acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00983|Drug metabolism - other enzymes
6902-77-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
24512-63-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:04722|Neurotrophin signaling pathway; KEGG:00480|Glutathione metabolism
446-72-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00100|Steroid biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:04142|Lysosome; KEGG:00350|Tyrosine metabolism; KEGG:00790|Folate biosynthesis; KEGG:04974|Protein digestion and absorption
529-59-9	KEGG:04978|Mineral absorption
437-64-9	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
11097-82-8	KEGG:04976|Bile secretion
20831-76-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
624-15-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis
7614-21-3	KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05211|Renal cell carcinoma; KEGG:04010|MAPK signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04670|Leukocyte transendothelial migration; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04660|T cell receptor signaling pathway; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells
6809-52-5	KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:04010|MAPK signaling pathway; KEGG:05162|Measles; KEGG:04612|Antigen processing and presentation; KEGG:04144|Endocytosis; KEGG:03040|Spliceosome
6699-20-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:04360|Axon guidance; KEGG:04672|Intestinal immune network for IgA production
60282-87-3	KEGG:04610|Complement and coagulation cascades
143664-11-3	KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
67884-30-4	KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
1391-73-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05217|Basal cell carcinoma
99796-69-7	KEGG:05010|Alzheimer's disease; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion
52286-58-5	KEGG:03320|PPAR signaling pathway
22427-39-0	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis
52286-74-5	KEGG:04910|Insulin signaling pathway; KEGG:04920|Adipocytokine signaling pathway
14197-60-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
63223-86-9	KEGG:05416|Viral myocarditis; KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:05143|African trypanosomiasis; KEGG:04670|Leukocyte transendothelial migration; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04512|ECM-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC)
79498-31-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
21187-98-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04623|Cytosolic DNA-sensing pathway
93479-97-1	KEGG:04930|Type II diabetes mellitus; KEGG:02010|ABC transporters
67-99-2	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
71965-57-6	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage
21973-56-8	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
526-95-4	KEGG:05200|Pathways in cancer
3416-24-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00524|Butirosin and neomycin biosynthesis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04512|ECM-receptor interaction; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00590|Arachidonic acid metabolism; KEGG:04975|Fat digestion and absorption; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism
91674-26-9	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00590|Arachidonic acid metabolism
3616-42-0	KEGG:05010|Alzheimer's disease; KEGG:05200|Pathways in cancer; KEGG:04940|Type I diabetes mellitus; KEGG:03320|PPAR signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease
50-99-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04950|Maturity onset diabetes of the young; KEGG:04145|Phagosome; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00500|Starch and sucrose metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:05217|Basal cell carcinoma; KEGG:00052|Galactose metabolism; KEGG:04614|Renin-angiotensin system
56-73-5	KEGG:05010|Alzheimer's disease; KEGG:04910|Insulin signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:03320|PPAR signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease
576-37-4	KEGG:05323|Rheumatoid arthritis; KEGG:05144|Malaria; KEGG:05143|African trypanosomiasis; KEGG:04650|Natural killer cell mediated cytotoxicity
76082-65-0	KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs)
125387-12-4	KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05146|Amoebiasis
111-30-8	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04672|Intestinal immune network for IgA production
70-18-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:00071|Fatty acid metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
27025-41-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04010|MAPK signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:02010|ABC transporters
77-21-4	KEGG:05219|Bladder cancer; KEGG:05213|Endometrial cancer; KEGG:04012|ErbB signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04912|GnRH signaling pathway
10238-21-8	KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
367-47-5	KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:00620|Pyruvate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:00052|Galactose metabolism
56-81-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04145|Phagosome; KEGG:00230|Purine metabolism; KEGG:00590|Arachidonic acid metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00340|Histidine metabolism
5694-00-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:00480|Glutathione metabolism; KEGG:00590|Arachidonic acid metabolism; KEGG:00920|Sulfur metabolism; KEGG:03430|Mismatch repair
556-52-5	KEGG:05210|Colorectal cancer; KEGG:04310|Wnt signaling pathway
40957-83-3	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04350|TGF-beta signaling pathway; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
640-79-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04650|Natural killer cell mediated cytotoxicity
475-31-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04976|Bile secretion
360-65-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04976|Bile secretion
9005-79-2	KEGG:04910|Insulin signaling pathway; KEGG:04540|Gap junction
141-46-8	KEGG:00380|Tryptophan metabolism; KEGG:04612|Antigen processing and presentation; KEGG:00620|Pyruvate metabolism; KEGG:04975|Fat digestion and absorption; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism
64480-66-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04976|Bile secretion
471-53-4	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00590|Arachidonic acid metabolism
1405-86-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
107-22-2	KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:00620|Pyruvate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism
19600-01-2	KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04012|ErbB signaling pathway
136194-77-9	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00565|Ether lipid metabolism; KEGG:04013|MAPK signaling pathway - fly
13190-34-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
7440-57-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway
11118-27-7	KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway
12244-57-4	KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00450|Selenocompound metabolism
33515-09-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:00230|Purine metabolism; KEGG:04672|Intestinal immune network for IgA production; KEGG:05414|Dilated cardiomyopathy
17303-67-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis
65807-02-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04722|Neurotrophin signaling pathway
303-45-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04010|MAPK signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction
148672-13-3	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04270|Vascular smooth muscle contraction
133156-06-6	KEGG:04080|Neuroactive ligand-receptor interaction
109889-09-0	KEGG:04970|Salivary secretion
83869-56-1	KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway
7782-42-5	KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways
119914-60-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
6379-55-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
126-07-8	KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:05216|Thyroid cancer; KEGG:04510|Focal adhesion; KEGG:04512|ECM-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04974|Protein digestion and absorption
9002-72-6	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04630|Jak-STAT signaling pathway
90-05-1	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00910|Nitrogen metabolism
489-84-9	KEGG:05146|Amoebiasis
5051-62-7	KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04724|Glutamatergic synapse; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:04540|Gap junction; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04971|Gastric acid secretion; KEGG:04530|Tight junction; KEGG:04360|Axon guidance
55-65-2	KEGG:05323|Rheumatoid arthritis; KEGG:04142|Lysosome
29110-47-2	KEGG:04080|Neuroactive ligand-receptor interaction
73-40-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:04010|MAPK signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:05143|African trypanosomiasis; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:00480|Glutathione metabolism; KEGG:02010|ABC transporters; KEGG:03430|Mismatch repair; KEGG:00670|One carbon pool by folate; KEGG:00790|Folate biosynthesis
118-00-3	KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:00983|Drug metabolism - other enzymes
7665-99-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00230|Purine metabolism; KEGG:04742|Taste transduction
37589-80-3	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04270|Vascular smooth muscle contraction; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04062|Chemokine signaling pathway; KEGG:04510|Focal adhesion; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:04972|Pancreatic secretion; KEGG:04310|Wnt signaling pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
86-01-1	KEGG:05211|Renal cell carcinoma; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04310|Wnt signaling pathway; KEGG:04971|Gastric acid secretion; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05130|Pathogenic Escherichia coli infection
25525-21-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis
61789-92-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
102771-26-6	KEGG:04612|Antigen processing and presentation
548-89-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
84477-87-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction
17395-31-2	KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04510|Focal adhesion; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00330|Arginine and proline metabolism
52-86-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:04974|Protein digestion and absorption; KEGG:04130|SNARE interactions in vesicular transport
151-67-7	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04971|Gastric acid secretion; KEGG:00590|Arachidonic acid metabolism
304-21-2	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway
442-51-3	KEGG:05200|Pathways in cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:00920|Sulfur metabolism
487-03-6	KEGG:00920|Sulfur metabolism
6754-13-8	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs)
68335-15-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05310|Asthma
14875-96-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04114|Oocyte meiosis
16009-13-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00630|Glyoxylate and dicarboxylate metabolism
54473-24-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway
9005-49-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:04360|Axon guidance; KEGG:04672|Intestinal immune network for IgA production
9050-30-0	KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00531|Glycosaminoglycan degradation
76-44-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction
70563-58-5	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway
561-27-3	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
520-33-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:01100|Metabolic pathways; KEGG:05140|Leishmaniasis; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:05162|Measles; KEGG:02010|ABC transporters
520-26-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:02010|ABC transporters
71160-24-2	KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:00590|Arachidonic acid metabolism; KEGG:05310|Asthma
59985-28-3	KEGG:05200|Pathways in cancer; KEGG:00591|Linoleic acid metabolism; KEGG:01100|Metabolic pathways; KEGG:03320|PPAR signaling pathway; KEGG:00590|Arachidonic acid metabolism
25637-99-4	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00514|Other types of O-glycan biosynthesis
118-74-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04144|Endocytosis; KEGG:05150|Staphylococcus aureus infection; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs)
87-68-3	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:00480|Glutathione metabolism; KEGG:00983|Drug metabolism - other enzymes
70-30-4	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04630|Jak-STAT signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:05217|Basal cell carcinoma
79983-71-4	KEGG:05200|Pathways in cancer; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:00100|Steroid biosynthesis
76-21-1	KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:03320|PPAR signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04976|Bile secretion
86479-06-3	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00983|Drug metabolism - other enzymes
60-26-4	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04660|T cell receptor signaling pathway
3073-59-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04012|ErbB signaling pathway; KEGG:05221|Acute myeloid leukemia; KEGG:04640|Hematopoietic cell lineage; KEGG:04722|Neurotrophin signaling pathway
5635-50-7	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
101-86-0	KEGG:04110|Cell cycle; KEGG:04115|p53 signaling pathway; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04114|Oocyte meiosis; KEGG:00620|Pyruvate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
24425-56-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
34433-31-3	KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00360|Phenylalanine metabolism
6879-74-9	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
555-55-5	KEGG:05200|Pathways in cancer; KEGG:04310|Wnt signaling pathway
51-45-6	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04971|Gastric acid secretion; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00590|Arachidonic acid metabolism; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00340|Histidine metabolism
3650-73-5	KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism
83509-42-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05162|Measles
10593-85-8	KEGG:05200|Pathways in cancer; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05146|Amoebiasis
7324-41-6	KEGG:05213|Endometrial cancer; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:04150|mTOR signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05221|Acute myeloid leukemia; KEGG:00590|Arachidonic acid metabolism
4261-42-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04672|Intestinal immune network for IgA production; KEGG:05414|Dilated cardiomyopathy
118-56-9	KEGG:04114|Oocyte meiosis
306-08-1	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00330|Arginine and proline metabolism; KEGG:00350|Tyrosine metabolism
35354-74-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
65646-68-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04114|Oocyte meiosis; KEGG:00190|Oxidative phosphorylation
112924-45-5	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04360|Axon guidance
12629-01-5	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04630|Jak-STAT signaling pathway
102518-79-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
172705-89-4	KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:04920|Adipocytokine signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04672|Intestinal immune network for IgA production
9004-61-9	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton
86-54-4	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:04670|Leukocyte transendothelial migration; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04260|Cardiac muscle contraction; KEGG:04144|Endocytosis; KEGG:04145|Phagosome; KEGG:03050|Proteasome; KEGG:03010|Ribosome; KEGG:05110|Vibrio cholerae infection; KEGG:00330|Arginine and proline metabolism; KEGG:00564|Glycerophospholipid metabolism; KEGG:03040|Spliceosome; KEGG:00190|Oxidative phosphorylation; KEGG:04614|Renin-angiotensin system
492-37-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
93-53-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
302-01-2	KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:04660|T cell receptor signaling pathway; KEGG:04975|Fat digestion and absorption; KEGG:00120|Primary bile acid biosynthesis
10035-10-6	KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04742|Taste transduction
7647-01-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:00100|Steroid biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00120|Primary bile acid biosynthesis; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00562|Inositol phosphate metabolism; KEGG:04742|Taste transduction; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04977|Vitamin digestion and absorption; KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03022|Basal transcription factors; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:04710|Circadian rhythm - mammal; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:03015|mRNA surveillance pathway; KEGG:00670|One carbon pool by folate; KEGG:00770|Pantothenate and CoA biosynthesis; KEGG:00640|Propanoate metabolism; KEGG:00600|Sphingolipid metabolism; KEGG:03040|Spliceosome; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:00910|Nitrogen metabolism; KEGG:04330|Notch signaling pathway; KEGG:04340|Hedgehog signaling pathway; KEGG:04614|Renin-angiotensin system; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism; KEGG:00790|Folate biosynthesis; KEGG:03450|Non-homologous end-joining; KEGG:04974|Protein digestion and absorption; KEGG:00565|Ether lipid metabolism; KEGG:05340|Primary immunodeficiency; KEGG:04130|SNARE interactions in vesicular transport; KEGG:04744|Phototransduction; KEGG:04966|Collecting duct acid secretion; KEGG:00062|Fatty acid elongation in mitochondria; KEGG:00592|alpha-Linolenic acid metabolism; KEGG:00603|Glycosphingolipid biosynthesis - globo series; KEGG:00290|Valine, leucine and isoleucine biosynthesis; KEGG:00740|Riboflavin metabolism
58-93-5	KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:04145|Phagosome; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:04614|Renin-angiotensin system
125-29-1	KEGG:04080|Neuroactive ligand-receptor interaction
50-23-7	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04710|Circadian rhythm - mammal
7664-39-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:05414|Dilated cardiomyopathy
1333-74-0	KEGG:04976|Bile secretion; KEGG:04971|Gastric acid secretion
74-90-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00330|Arginine and proline metabolism
7722-84-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:00562|Inositol phosphate metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03015|mRNA surveillance pathway; KEGG:00640|Propanoate metabolism; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:03040|Spliceosome; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:04330|Notch signaling pathway; KEGG:00350|Tyrosine metabolism; KEGG:00790|Folate biosynthesis; KEGG:00565|Ether lipid metabolism
7783-06-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05130|Pathogenic Escherichia coli infection; KEGG:04974|Protein digestion and absorption
39800-28-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis
123-31-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production
53-95-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
300-85-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
502-85-2	KEGG:04080|Neuroactive ligand-receptor interaction
118-42-3	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease
107-75-5	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease
27323-64-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
1199-18-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation
5289-74-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04150|mTOR signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05221|Acute myeloid leukemia
76898-47-0	KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04640|Hematopoietic cell lineage; KEGG:04962|Vasopressin-regulated water reabsorption
868-77-9	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
52806-53-8	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer
533-73-3	KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04612|Antigen processing and presentation; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
3352-57-6	KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04146|Peroxisome
56433-44-4	KEGG:04080|Neuroactive ligand-receptor interaction
2784-27-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
68-96-2	KEGG:04114|Oocyte meiosis
64-85-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:05332|Graft-versus-host disease; KEGG:04670|Leukocyte transendothelial migration; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton
1321-48-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04972|Pancreatic secretion; KEGG:04976|Bile secretion; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
1113-60-6	KEGG:00380|Tryptophan metabolism
146087-19-6	KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04514|Cell adhesion molecules (CAMs)
50-67-9	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05310|Asthma
154-02-9	KEGG:00920|Sulfur metabolism
127-07-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:05310|Asthma; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:03420|Nucleotide excision repair; KEGG:03450|Non-homologous end-joining
19356-17-3	KEGG:05152|Tuberculosis
68-88-2	KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04976|Bile secretion; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
90-33-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
6900-87-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes
11079-53-1	KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
548-04-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion
482-36-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis
7790-92-3	KEGG:05010|Alzheimer's disease; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:03050|Proteasome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:04360|Axon guidance
68-94-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:01100|Metabolic pathways
114084-78-5	KEGG:05200|Pathways in cancer; KEGG:05211|Renal cell carcinoma; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04370|VEGF signaling pathway; KEGG:00900|Terpenoid backbone biosynthesis
505-44-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism; KEGG:00480|Glutathione metabolism
129203-60-7	KEGG:04210|Apoptosis; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation
50847-11-5	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles
15687-27-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:00590|Arachidonic acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
489-32-7	KEGG:05010|Alzheimer's disease; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy
130308-48-4	KEGG:05210|Colorectal cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04610|Complement and coagulation cascades; KEGG:04380|Osteoclast differentiation
72795-19-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04144|Endocytosis
98007-99-9	KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton
117621-64-4	KEGG:05150|Staphylococcus aureus infection; KEGG:04514|Cell adhesion molecules (CAMs)
79944-58-4	KEGG:04080|Neuroactive ligand-receptor interaction
23210-56-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04730|Long-term depression; KEGG:04660|T cell receptor signaling pathway
3778-73-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes
78919-13-8	KEGG:05010|Alzheimer's disease; KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04320|Dorso-ventral axis formation
152459-95-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:02010|ABC transporters
35554-44-0	KEGG:00140|Steroid hormone biosynthesis; KEGG:04060|Cytokine-cytokine receptor interaction
102203-18-9	KEGG:04080|Neuroactive ligand-receptor interaction
105827-78-9	KEGG:04141|Protein processing in endoplasmic reticulum
89396-94-1	KEGG:01100|Metabolic pathways
120294-09-9	KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:04614|Renin-angiotensin system
288-32-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
39236-46-9	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04672|Intestinal immune network for IgA production
50-49-7	KEGG:05210|Colorectal cancer; KEGG:05145|Toxoplasmosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:00910|Nitrogen metabolism
99011-02-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:03420|Nucleotide excision repair; KEGG:03022|Basal transcription factors; KEGG:03410|Base excision repair; KEGG:03440|Homologous recombination; KEGG:03430|Mismatch repair
482-44-0	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04320|Dorso-ventral axis formation
55273-05-7	KEGG:04971|Gastric acid secretion
26807-65-8	KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton
95-13-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
193-39-5	KEGG:05200|Pathways in cancer; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:04012|ErbB signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04660|T cell receptor signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
487-94-5	KEGG:05323|Rheumatoid arthritis; KEGG:05144|Malaria; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:04670|Leukocyte transendothelial migration; KEGG:04514|Cell adhesion molecules (CAMs)
482-89-3	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
150378-17-9	KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction
479-41-4	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles
7440-74-6	KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:04612|Antigen processing and presentation
10025-82-8	KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:04612|Antigen processing and presentation
3599-32-4	KEGG:04976|Bile secretion
120-72-9	KEGG:04080|Neuroactive ligand-receptor interaction
700-06-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:02010|ABC transporters; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:04672|Intestinal immune network for IgA production; KEGG:00340|Histidine metabolism; KEGG:04710|Circadian rhythm - mammal; KEGG:03008|Ribosome biogenesis in eukaryotes
87-51-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05016|Huntington's disease; KEGG:04146|Peroxisome; KEGG:00480|Glutathione metabolism
241-55-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
53-86-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:05217|Basal cell carcinoma; KEGG:00910|Nitrogen metabolism
500-85-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04612|Antigen processing and presentation; KEGG:03040|Spliceosome
31842-01-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
26844-12-2	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction
58-63-9	KEGG:05016|Huntington's disease; KEGG:05143|African trypanosomiasis
6917-35-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04950|Maturity onset diabetes of the young; KEGG:04810|Regulation of actin cytoskeleton
9008-11-1	KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
9005-80-5	KEGG:04210|Apoptosis; KEGG:05214|Glioma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04970|Salivary secretion; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04973|Carbohydrate digestion and absorption
114073-91-5	KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04510|Focal adhesion; KEGG:04512|ECM-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC)
7553-56-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04530|Tight junction; KEGG:05320|Autoimmune thyroid disease; KEGG:04514|Cell adhesion molecules (CAMs)
144-48-9	KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05020|Prion diseases
83498-72-0	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04144|Endocytosis
75-47-8	KEGG:05200|Pathways in cancer
100038-54-8	KEGG:04080|Neuroactive ligand-receptor interaction
66108-95-0	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05146|Amoebiasis
78649-41-9	KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
56092-81-0	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
62883-00-5	KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
87771-40-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
59017-64-0	KEGG:04610|Complement and coagulation cascades
1689-83-4	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:04914|Progesterone-mediated oocyte maturation
83291-20-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
138402-11-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:04614|Renin-angiotensin system
100286-90-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:03420|Nucleotide excision repair; KEGG:04330|Notch signaling pathway
142569-99-1	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction
7439-89-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04144|Endocytosis; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:00590|Arachidonic acid metabolism; KEGG:04975|Fat digestion and absorption; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00564|Glycerophospholipid metabolism; KEGG:03410|Base excision repair
9004-66-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:00480|Glutathione metabolism
91-56-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:00340|Histidine metabolism; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism
10385-78-1	KEGG:04080|Neuroactive ligand-receptor interaction
78-83-1	KEGG:04080|Neuroactive ligand-receptor interaction
28822-58-4	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04672|Intestinal immune network for IgA production; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection
542-56-3	KEGG:05219|Bladder cancer; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04060|Cytokine-cytokine receptor interaction
4328-19-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:00480|Glutathione metabolism
97-54-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00620|Pyruvate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:04672|Intestinal immune network for IgA production
26675-46-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs)
55-91-4	KEGG:05210|Colorectal cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway
482-45-1	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:04976|Bile secretion
9034-50-8	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04270|Vascular smooth muscle contraction; KEGG:04962|Vasopressin-regulated water reabsorption
54750-10-6	KEGG:05016|Huntington's disease; KEGG:04146|Peroxisome
961-29-5	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:05146|Amoebiasis; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
93-16-3	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
54-85-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:04978|Mineral absorption; KEGG:00232|Caffeine metabolism; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:00983|Drug metabolism - other enzymes
1453-82-3	KEGG:03320|PPAR signaling pathway; KEGG:04380|Osteoclast differentiation
358-71-4	KEGG:05145|Toxoplasmosis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05162|Measles
123-51-3	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:05146|Amoebiasis
4098-71-9	KEGG:05140|Leishmaniasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
482-27-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:00480|Glutathione metabolism
7683-59-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:00640|Propanoate metabolism; KEGG:00600|Sphingolipid metabolism; KEGG:04974|Protein digestion and absorption; KEGG:00531|Glycosaminoglycan degradation
34123-59-6	KEGG:05010|Alzheimer's disease; KEGG:05016|Huntington's disease; KEGG:05012|Parkinson's disease; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00232|Caffeine metabolism; KEGG:03010|Ribosome; KEGG:00190|Oxidative phosphorylation
21637-25-2	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:00480|Glutathione metabolism; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:00072|Synthesis and degradation of ketone bodies
120-58-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:04976|Bile secretion
652-67-5	KEGG:04270|Vascular smooth muscle contraction
87-33-2	KEGG:04270|Vascular smooth muscle contraction
22584-04-9	KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04660|T cell receptor signaling pathway; KEGG:00350|Tyrosine metabolism
503-74-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
75695-93-1	KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04912|GnRH signaling pathway; KEGG:04260|Cardiac muscle contraction; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC)
84625-61-6	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:05330|Allograft rejection; KEGG:04976|Bile secretion; KEGG:00100|Steroid biosynthesis; KEGG:02010|ABC transporters; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
70288-86-7	KEGG:05130|Pathogenic Escherichia coli infection
102396-24-7	KEGG:05323|Rheumatoid arthritis; KEGG:05144|Malaria; KEGG:05143|African trypanosomiasis; KEGG:04670|Leukocyte transendothelial migration; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04514|Cell adhesion molecules (CAMs)
155148-31-5	KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04370|VEGF signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04672|Intestinal immune network for IgA production
481-39-0	KEGG:00240|Pyrimidine metabolism; KEGG:00450|Selenocompound metabolism
520-18-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04114|Oocyte meiosis; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
19895-95-5	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04145|Phagosome; KEGG:04514|Cell adhesion molecules (CAMs)
6894-43-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
81760-47-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis
81760-45-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
487-79-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
342-10-9	KEGG:04210|Apoptosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage
71800-36-7	KEGG:04210|Apoptosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage
73981-34-7	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:04660|T cell receptor signaling pathway; KEGG:04120|Ubiquitin mediated proteolysis
59-01-8	KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04380|Osteoclast differentiation; KEGG:04510|Focal adhesion; KEGG:04670|Leukocyte transendothelial migration; KEGG:04722|Neurotrophin signaling pathway; KEGG:04310|Wnt signaling pathway
1332-58-7	KEGG:04610|Complement and coagulation cascades
9056-36-4	KEGG:01100|Metabolic pathways; KEGG:00533|Glycosaminoglycan biosynthesis - keratan sulfate; KEGG:00601|Glycosphingolipid biosynthesis - lacto and neolacto series
6740-88-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton
74050-98-9	KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04520|Adherens junction; KEGG:04320|Dorso-ventral axis formation; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway
65277-42-1	KEGG:04115|p53 signaling pathway; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:04976|Bile secretion; KEGG:00100|Steroid biosynthesis; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00983|Drug metabolism - other enzymes; KEGG:00910|Nitrogen metabolism
58962-34-8	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05146|Amoebiasis; KEGG:00590|Arachidonic acid metabolism
22071-15-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:04976|Bile secretion; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
66635-83-4	KEGG:05143|African trypanosomiasis; KEGG:05310|Asthma
34580-13-7	KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04514|Cell adhesion molecules (CAMs)
131875-08-6	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04012|ErbB signaling pathway; KEGG:05162|Measles; KEGG:04114|Oocyte meiosis
525-79-1	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04914|Progesterone-mediated oocyte maturation
127191-97-3	KEGG:05010|Alzheimer's disease; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis
139298-40-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
501-30-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:03420|Nucleotide excision repair; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism
97560-11-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05020|Prion diseases; KEGG:04146|Peroxisome; KEGG:04722|Neurotrophin signaling pathway
66455-27-4	KEGG:05016|Huntington's disease
158021-47-7	KEGG:04620|Toll-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction
108068-98-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04971|Gastric acid secretion; KEGG:04810|Regulation of actin cytoskeleton
126643-37-6	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance; KEGG:05414|Dilated cardiomyopathy
126643-38-7	KEGG:05144|Malaria; KEGG:05143|African trypanosomiasis
12708-05-3	KEGG:01100|Metabolic pathways
75629-19-5	KEGG:04080|Neuroactive ligand-receptor interaction
76472-87-2	KEGG:04080|Neuroactive ligand-receptor interaction
492-27-3	KEGG:05152|Tuberculosis; KEGG:05020|Prion diseases; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04623|Cytosolic DNA-sensing pathway
111466-41-2	KEGG:04080|Neuroactive ligand-receptor interaction
118414-82-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:05216|Thyroid cancer; KEGG:05143|African trypanosomiasis; KEGG:05162|Measles; KEGG:00590|Arachidonic acid metabolism
122384-14-9	KEGG:04080|Neuroactive ligand-receptor interaction
137403-12-4	KEGG:04080|Neuroactive ligand-receptor interaction
144425-84-3	KEGG:04080|Neuroactive ligand-receptor interaction
36894-69-6	KEGG:05219|Bladder cancer; KEGG:05020|Prion diseases; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04270|Vascular smooth muscle contraction; KEGG:05216|Thyroid cancer; KEGG:04320|Dorso-ventral axis formation; KEGG:04540|Gap junction; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:04614|Renin-angiotensin system
133343-34-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway
50-21-5	KEGG:01100|Metabolic pathways; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00480|Glutathione metabolism; KEGG:00620|Pyruvate metabolism
77501-63-4	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04610|Complement and coagulation cascades
118288-08-7	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05146|Amoebiasis; KEGG:04971|Gastric acid secretion
9008-22-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04146|Peroxisome
84057-84-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00983|Drug metabolism - other enzymes
17575-22-3	KEGG:05219|Bladder cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04623|Cytosolic DNA-sensing pathway
79-63-0	KEGG:01100|Metabolic pathways; KEGG:04976|Bile secretion
118992-92-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction
103577-45-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04320|Dorso-ventral axis formation; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00590|Arachidonic acid metabolism
7439-91-0	KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04380|Osteoclast differentiation
10099-58-8	KEGG:05210|Colorectal cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
76343-93-6	KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05131|Shigellosis; KEGG:04520|Adherens junction; KEGG:04670|Leukocyte transendothelial migration; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC)
76343-94-7	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04360|Axon guidance
143-07-7	KEGG:05160|Hepatitis C; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:05131|Shigellosis; KEGG:00071|Fatty acid metabolism; KEGG:00590|Arachidonic acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
1166-52-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
7439-92-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04114|Oocyte meiosis; KEGG:03050|Proteasome; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism; KEGG:03040|Spliceosome; KEGG:00650|Butanoate metabolism; KEGG:04974|Protein digestion and absorption
301-04-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:00970|Aminoacyl-tRNA biosynthesis; KEGG:00564|Glycerophospholipid metabolism; KEGG:04142|Lysosome; KEGG:00190|Oxidative phosphorylation; KEGG:04974|Protein digestion and absorption
7758-95-4	KEGG:05010|Alzheimer's disease; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04612|Antigen processing and presentation
18256-98-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04660|T cell receptor signaling pathway; KEGG:04950|Maturity onset diabetes of the young; KEGG:04810|Regulation of actin cytoskeleton
546-67-8	KEGG:05010|Alzheimer's disease
75706-12-6	KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:03010|Ribosome; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC)
191732-72-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04144|Endocytosis
37339-90-5	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
87081-35-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04010|MAPK signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04120|Ubiquitin mediated proteolysis
100427-26-7	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
112809-51-5	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton
75715-89-8	KEGG:04020|Calcium signaling pathway
24365-47-7	KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05216|Thyroid cancer; KEGG:05162|Measles
53714-56-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04380|Osteoclast differentiation; KEGG:04510|Focal adhesion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04145|Phagosome; KEGG:04530|Tight junction; KEGG:05414|Dilated cardiomyopathy
152-02-3	KEGG:04080|Neuroactive ligand-receptor interaction
79516-68-0	KEGG:04080|Neuroactive ligand-receptor interaction
7101-51-1	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04540|Gap junction
78994-23-7	KEGG:04270|Vascular smooth muscle contraction; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04510|Focal adhesion; KEGG:04670|Leukocyte transendothelial migration; KEGG:04310|Wnt signaling pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance; KEGG:05130|Pathogenic Escherichia coli infection
77-07-6	KEGG:04080|Neuroactive ligand-receptor interaction
86855-16-5	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04912|GnRH signaling pathway
79561-22-1	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04912|GnRH signaling pathway
83539-08-6	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04912|GnRH signaling pathway
137-58-6	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00591|Linoleic acid metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:05310|Asthma
138-86-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04260|Cardiac muscle contraction
78-70-6	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04310|Wnt signaling pathway
58-89-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:00270|Cysteine and methionine metabolism; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:03050|Proteasome; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00640|Propanoate metabolism; KEGG:00910|Nitrogen metabolism
165800-03-3	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00340|Histidine metabolism; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism
25657-09-4	KEGG:00480|Glutathione metabolism; KEGG:00590|Arachidonic acid metabolism
40757-80-0	KEGG:03320|PPAR signaling pathway
19878-10-5	KEGG:00564|Glycerophospholipid metabolism
8001-26-1	KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion; KEGG:04914|Progesterone-mediated oocyte maturation
330-55-2	KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00140|Steroid hormone biosynthesis; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04114|Oocyte meiosis
940-69-2	KEGG:00240|Pyrimidine metabolism; KEGG:00450|Selenocompound metabolism
11096-66-5	KEGG:05144|Malaria
11096-62-1	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
56411-57-5	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05310|Asthma
83915-83-7	KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:04270|Vascular smooth muscle contraction; KEGG:04614|Renin-angiotensin system
18016-80-3	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04540|Gap junction; KEGG:04630|Jak-STAT signaling pathway
7439-93-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:03050|Proteasome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:04530|Tight junction; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection
7447-41-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04360|Axon guidance; KEGG:03030|DNA replication; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:05217|Basal cell carcinoma
434-13-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:04976|Bile secretion; KEGG:04950|Maturity onset diabetes of the young; KEGG:02010|ABC transporters
122021-74-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
90-69-7	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis
18524-94-2	KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway
95693-76-8	KEGG:04144|Endocytosis
13010-47-4	KEGG:05145|Toxoplasmosis; KEGG:04120|Ubiquitin mediated proteolysis
193275-84-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
50264-69-2	KEGG:04976|Bile secretion
79794-75-5	KEGG:04210|Apoptosis; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04976|Bile secretion; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
846-49-1	KEGG:04080|Neuroactive ligand-receptor interaction
117857-45-1	KEGG:04080|Neuroactive ligand-receptor interaction
70374-39-9	KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05140|Leishmaniasis; KEGG:05146|Amoebiasis; KEGG:00590|Arachidonic acid metabolism
114798-26-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04971|Gastric acid secretion; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05414|Dilated cardiomyopathy; KEGG:04614|Renin-angiotensin system; KEGG:04974|Protein digestion and absorption
75330-75-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:00100|Steroid biosynthesis; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:05217|Basal cell carcinoma; KEGG:04974|Protein digestion and absorption
1977-10-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04540|Gap junction
68767-14-6	KEGG:05146|Amoebiasis
121288-39-9	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles
72025-60-6	KEGG:05219|Bladder cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:05310|Asthma
73836-78-9	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production
479-50-5	KEGG:04110|Cell cycle; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05323|Rheumatoid arthritis; KEGG:05322|Systemic lupus erythematosus; KEGG:05144|Malaria; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis; KEGG:03440|Homologous recombination
464-99-3	KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
545-47-1	KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04146|Peroxisome; KEGG:04510|Focal adhesion; KEGG:05217|Basal cell carcinoma
127-40-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05020|Prion diseases; KEGG:04146|Peroxisome; KEGG:05221|Acute myeloid leukemia; KEGG:04722|Neurotrophin signaling pathway; KEGG:00590|Arachidonic acid metabolism
491-70-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs)
5373-11-5	KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage
63676-25-5	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
88107-10-2	KEGG:05160|Hepatitis C; KEGG:04920|Adipocytokine signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:05216|Thyroid cancer
106138-88-9	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction
502-65-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03430|Mismatch repair
476-28-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles
82-58-6	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04540|Gap junction
55898-33-4	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer
22002-87-5	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells
34540-22-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism
88859-04-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:03410|Base excision repair
7439-95-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:04972|Pancreatic secretion; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04145|Phagosome; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00640|Propanoate metabolism; KEGG:00052|Galactose metabolism; KEGG:04974|Protein digestion and absorption
7786-30-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05144|Malaria; KEGG:04650|Natural killer cell mediated cytotoxicity
1309-42-8	KEGG:04080|Neuroactive ligand-receptor interaction
63335-24-0	KEGG:05200|Pathways in cancer; KEGG:00590|Arachidonic acid metabolism
63335-25-1	KEGG:05200|Pathways in cancer; KEGG:00590|Arachidonic acid metabolism
10309-95-2	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04114|Oocyte meiosis
1634-78-2	KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection
121-75-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04530|Tight junction; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes
542-78-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:00330|Arginine and proline metabolism; KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism
141-82-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis
118-71-8	KEGG:05323|Rheumatoid arthritis; KEGG:04080|Neuroactive ligand-receptor interaction
69-79-4	KEGG:04973|Carbohydrate digestion and absorption
10463-84-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
8018-01-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00330|Arginine and proline metabolism
12427-38-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04360|Axon guidance
7439-96-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03030|DNA replication; KEGG:04672|Intestinal immune network for IgA production; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:00020|Citrate cycle (TCA cycle); KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:04974|Protein digestion and absorption
7773-01-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04142|Lysosome
7785-87-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04724|Glutamatergic synapse; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00330|Arginine and proline metabolism
4773-96-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:05150|Staphylococcus aureus infection; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:04672|Intestinal immune network for IgA production
6147-11-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05222|Small cell lung cancer; KEGG:05140|Leishmaniasis
89226-50-6	KEGG:05144|Malaria
69-65-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00232|Caffeine metabolism; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes
31103-86-3	KEGG:01100|Metabolic pathways; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04950|Maturity onset diabetes of the young
75088-80-1	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage
52665-74-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton
10262-69-8	KEGG:04020|Calcium signaling pathway
154039-60-8	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation
72093-21-1	KEGG:05010|Alzheimer's disease; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04970|Salivary secretion; KEGG:05143|African trypanosomiasis; KEGG:04730|Long-term depression; KEGG:04971|Gastric acid secretion; KEGG:04975|Fat digestion and absorption
519-02-8	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04722|Neurotrophin signaling pathway; KEGG:04310|Wnt signaling pathway
103909-75-7	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04012|ErbB signaling pathway
35846-53-8	KEGG:05213|Endometrial cancer; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04012|ErbB signaling pathway; KEGG:04510|Focal adhesion
22232-71-9	KEGG:05012|Parkinson's disease
139290-65-6	KEGG:04020|Calcium signaling pathway; KEGG:05140|Leishmaniasis
31431-39-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
60-40-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
10605-21-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes
51-75-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis; KEGG:03050|Proteasome
569-65-3	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism
2013-58-3	KEGG:05219|Bladder cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04623|Cytosolic DNA-sensing pathway
644-62-2	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:00920|Sulfur metabolism
13422-55-4	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis
93-65-2	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation
2898-12-6	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
520-85-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton
71-58-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton
61-68-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00920|Sulfur metabolism; KEGG:00514|Other types of O-glycan biosynthesis
53230-10-7	KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
6284-40-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05020|Prion diseases
9002-79-3	KEGG:04080|Neuroactive ligand-receptor interaction
494-79-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
73-31-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:00590|Arachidonic acid metabolism; KEGG:05320|Autoimmune thyroid disease; KEGG:04710|Circadian rhythm - mammal
20449-79-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway
71125-38-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:02010|ABC transporters
148-82-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04360|Axon guidance
8002-50-4	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles
494-90-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
1490-04-6	KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00232|Caffeine metabolism; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
89-80-5	KEGG:04080|Neuroactive ligand-receptor interaction
57-42-1	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00983|Drug metabolism - other enzymes
50-12-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
104713-75-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:04976|Bile secretion; KEGG:00590|Arachidonic acid metabolism
60-24-2	KEGG:05200|Pathways in cancer; KEGG:04976|Bile secretion
107-96-0	KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04940|Type I diabetes mellitus; KEGG:00410|beta-Alanine metabolism; KEGG:00650|Butanoate metabolism; KEGG:00430|Taurine and hypotaurine metabolism
50-44-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00983|Drug metabolism - other enzymes; KEGG:04672|Intestinal immune network for IgA production
7487-94-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:00270|Cysteine and methionine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:03050|Proteasome; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:02010|ABC transporters; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00020|Citrate cycle (TCA cycle); KEGG:04977|Vitamin digestion and absorption; KEGG:00640|Propanoate metabolism; KEGG:03040|Spliceosome; KEGG:00190|Oxidative phosphorylation; KEGG:00450|Selenocompound metabolism
7439-97-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:05110|Vibrio cholerae infection; KEGG:02010|ABC transporters; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:05414|Dilated cardiomyopathy
24670-15-3	KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:04630|Jak-STAT signaling pathway; KEGG:04672|Intestinal immune network for IgA production
9002-91-9	KEGG:01100|Metabolic pathways
4005-68-9	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05162|Measles; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis
586-06-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04540|Gap junction; KEGG:04722|Neurotrophin signaling pathway
17692-51-2	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction
657-24-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04950|Maturity onset diabetes of the young; KEGG:04140|Regulation of autophagy; KEGG:00061|Fatty acid biosynthesis
62-51-1	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction
76-99-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles
509-74-0	KEGG:04080|Neuroactive ligand-receptor interaction
10265-92-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04080|Neuroactive ligand-receptor interaction
537-46-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04360|Axon guidance; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00190|Oxidative phosphorylation; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism
150314-39-9	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton
74-82-8	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05215|Prostate cancer; KEGG:04910|Insulin signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04370|VEGF signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:04360|Axon guidance
60343-91-1	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05020|Prion diseases; KEGG:04012|ErbB signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation
67-56-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:00071|Fatty acid metabolism; KEGG:00350|Tyrosine metabolism
91-80-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04722|Neurotrophin signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:00071|Fatty acid metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:03050|Proteasome; KEGG:03010|Ribosome; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00983|Drug metabolism - other enzymes; KEGG:00410|beta-Alanine metabolism; KEGG:00650|Butanoate metabolism
554-57-4	KEGG:00910|Nitrogen metabolism
60-56-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04610|Complement and coagulation cascades; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04510|Focal adhesion; KEGG:04640|Hematopoietic cell lineage; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04260|Cardiac muscle contraction; KEGG:03030|DNA replication; KEGG:05414|Dilated cardiomyopathy; KEGG:03420|Nucleotide excision repair
63-68-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:04672|Intestinal immune network for IgA production; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:04142|Lysosome; KEGG:00670|One carbon pool by folate; KEGG:00600|Sphingolipid metabolism; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00510|N-Glycan biosynthesis; KEGG:04330|Notch signaling pathway; KEGG:04340|Hedgehog signaling pathway; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism; KEGG:00450|Selenocompound metabolism; KEGG:04974|Protein digestion and absorption; KEGG:00604|Glycosphingolipid biosynthesis - ganglio series; KEGG:00512|Mucin type O-Glycan biosynthesis
1982-67-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:03010|Ribosome; KEGG:04360|Axon guidance; KEGG:04672|Intestinal immune network for IgA production
20229-30-5	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction
104807-46-7	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00330|Arginine and proline metabolism
18652-93-2	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
16752-77-5	KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04612|Antigen processing and presentation
40596-69-8	KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:04920|Adipocytokine signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:05216|Thyroid cancer
125-71-3	KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00232|Caffeine metabolism; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes
59-05-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00983|Drug metabolism - other enzymes; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:04977|Vitamin digestion and absorption; KEGG:00410|beta-Alanine metabolism; KEGG:04142|Lysosome; KEGG:00670|One carbon pool by folate; KEGG:00640|Propanoate metabolism; KEGG:00600|Sphingolipid metabolism; KEGG:00790|Folate biosynthesis; KEGG:04974|Protein digestion and absorption; KEGG:05340|Primary immunodeficiency; KEGG:00062|Fatty acid elongation in mitochondria
390-28-3	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00590|Arachidonic acid metabolism
625-45-6	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis
67-62-9	KEGG:03410|Base excision repair
72-43-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00590|Arachidonic acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease
76-38-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes
534-82-7	KEGG:05016|Huntington's disease; KEGG:01100|Metabolic pathways; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04540|Gap junction; KEGG:04730|Long-term depression
4091-50-3	KEGG:04080|Neuroactive ligand-receptor interaction
298-81-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00232|Caffeine metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04976|Bile secretion; KEGG:00983|Drug metabolism - other enzymes
82499-00-1	KEGG:04080|Neuroactive ligand-receptor interaction
56856-83-8	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton
593-58-8	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
590-96-5	KEGG:01100|Metabolic pathways
592-62-1	KEGG:01100|Metabolic pathways
25155-18-4	KEGG:05219|Bladder cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04623|Cytosolic DNA-sensing pathway
109-86-4	KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04144|Endocytosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05100|Bacterial invasion of epithelial cells
94-74-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04612|Antigen processing and presentation; KEGG:04966|Collecting duct acid secretion
56-49-5	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:03050|Proteasome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:00590|Arachidonic acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:03018|RNA degradation; KEGG:00240|Pyrimidine metabolism; KEGG:03430|Mismatch repair; KEGG:03040|Spliceosome; KEGG:00190|Oxidative phosphorylation
144-54-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway
555-30-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism; KEGG:00350|Tyrosine metabolism
5124-30-1	KEGG:05140|Leishmaniasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
101-14-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes
6317-18-6	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04610|Complement and coagulation cascades; KEGG:04060|Cytokine-cytokine receptor interaction
61-73-4	KEGG:04920|Adipocytokine signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:00030|Pentose phosphate pathway
75-09-2	KEGG:04210|Apoptosis; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04144|Endocytosis; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05340|Primary immunodeficiency
4747-90-4	KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
4764-17-4	KEGG:04080|Neuroactive ligand-receptor interaction
93-15-2	KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism; KEGG:03410|Base excision repair
123-39-7	KEGG:05219|Bladder cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:01100|Metabolic pathways; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04510|Focal adhesion
83-34-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
624-83-9	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
556-61-6	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles
1211-29-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity
21019-30-7	KEGG:05010|Alzheimer's disease; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
115-09-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04940|Type I diabetes mellitus; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:04672|Intestinal immune network for IgA production; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:04330|Notch signaling pathway
12628-19-2	KEGG:00450|Selenocompound metabolism
1184-57-2	KEGG:04330|Notch signaling pathway
22967-92-6	KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04010|MAPK signaling pathway; KEGG:05146|Amoebiasis; KEGG:04630|Jak-STAT signaling pathway
80-62-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:00480|Glutathione metabolism
66-27-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05152|Tuberculosis; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05143|African trypanosomiasis; KEGG:04722|Neurotrophin signaling pathway; KEGG:03410|Base excision repair
42542-10-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00562|Inositol phosphate metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03040|Spliceosome; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:04330|Notch signaling pathway; KEGG:04340|Hedgehog signaling pathway; KEGG:04974|Protein digestion and absorption; KEGG:04130|SNARE interactions in vesicular transport
70-25-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04510|Focal adhesion; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:04360|Axon guidance; KEGG:03030|DNA replication; KEGG:03410|Base excision repair; KEGG:03430|Mismatch repair
684-93-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:03410|Base excision repair; KEGG:03430|Mismatch repair
112-39-0	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma
950-35-6	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
298-00-0	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00380|Tryptophan metabolism; KEGG:00480|Glutathione metabolism; KEGG:04810|Regulation of actin cytoskeleton
299-11-6	KEGG:01100|Metabolic pathways; KEGG:00480|Glutathione metabolism; KEGG:00030|Pentose phosphate pathway
113-45-1	KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04380|Osteoclast differentiation
48134-75-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway
28289-54-5	KEGG:05010|Alzheimer's disease; KEGG:05016|Huntington's disease; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04144|Endocytosis; KEGG:04145|Phagosome; KEGG:04360|Axon guidance; KEGG:00190|Oxidative phosphorylation
83-43-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production
53-36-1	KEGG:05200|Pathways in cancer; KEGG:05323|Rheumatoid arthritis
600-22-6	KEGG:05215|Prostate cancer; KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04920|Adipocytokine signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation
119-36-8	KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04640|Hematopoietic cell lineage; KEGG:00480|Glutathione metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
13265-10-6	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
28274-57-9	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:04360|Axon guidance; KEGG:03030|DNA replication; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00240|Pyrimidine metabolism; KEGG:03430|Mismatch repair
1634-04-4	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04730|Long-term depression
58-18-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:00140|Steroid hormone biosynthesis
361-37-5	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04270|Vascular smooth muscle contraction
495-85-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
22664-55-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis
364-62-5	KEGG:05215|Prostate cancer; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04060|Cytokine-cytokine receptor interaction
150-75-4	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:04978|Mineral absorption
51218-45-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:04976|Bile secretion
37350-58-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04660|T cell receptor signaling pathway; KEGG:04260|Cardiac muscle contraction; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04614|Renin-angiotensin system
965-93-5	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04370|VEGF signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:03050|Proteasome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:04530|Tight junction; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00360|Phenylalanine metabolism
443-48-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways
54-36-4	KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis
150-97-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs)
7786-34-7	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04020|Calcium signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05131|Shigellosis; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00330|Arginine and proline metabolism
31828-71-4	KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage
34807-41-5	KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:05146|Amoebiasis; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04972|Pancreatic secretion; KEGG:04310|Wnt signaling pathway; KEGG:04971|Gastric acid secretion; KEGG:04070|Phosphatidylinositol signaling system; KEGG:05110|Vibrio cholerae infection
24219-97-4	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04540|Gap junction
116644-53-2	KEGG:00140|Steroid hormone biosynthesis; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04976|Bile secretion; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:04142|Lysosome; KEGG:00511|Other glycan degradation; KEGG:00603|Glycosphingolipid biosynthesis - globo series; KEGG:00604|Glycosphingolipid biosynthesis - ganglio series; KEGG:00531|Glycosaminoglycan degradation
3704-09-4	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer
22916-47-8	KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05140|Leishmaniasis; KEGG:00380|Tryptophan metabolism; KEGG:04380|Osteoclast differentiation; KEGG:04310|Wnt signaling pathway; KEGG:03030|DNA replication; KEGG:03420|Nucleotide excision repair; KEGG:03410|Base excision repair; KEGG:03430|Mismatch repair
77238-39-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04146|Peroxisome; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion
111755-37-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:04722|Neurotrophin signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:03050|Proteasome
59467-70-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04976|Bile secretion
35457-80-8	KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
84371-65-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:02010|ABC transporters; KEGG:04360|Axon guidance; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:05217|Basal cell carcinoma; KEGG:00350|Tyrosine metabolism
72432-03-2	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway
92623-85-3	KEGG:04080|Neuroactive ligand-receptor interaction
78415-72-2	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis
500-44-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:04380|Osteoclast differentiation; KEGG:05162|Measles
10118-90-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
38304-91-5	KEGG:00920|Sulfur metabolism
371-86-8	KEGG:00564|Glycerophospholipid metabolism
2385-85-5	KEGG:01100|Metabolic pathways
61337-67-5	KEGG:04080|Neuroactive ligand-receptor interaction
13551-87-6	KEGG:01100|Metabolic pathways; KEGG:04146|Peroxisome; KEGG:00480|Glutathione metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00531|Glycosaminoglycan degradation
59122-46-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05310|Asthma
97666-60-9	KEGG:05219|Bladder cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:04510|Focal adhesion; KEGG:05162|Measles
50-07-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:03420|Nucleotide excision repair; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:03430|Mismatch repair
54824-17-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04360|Axon guidance
65271-80-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05146|Amoebiasis; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04310|Wnt signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:02010|ABC transporters
4098-40-2	KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
106791-40-6	KEGG:04080|Neuroactive ligand-receptor interaction
54197-05-6	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:05146|Amoebiasis; KEGG:04650|Natural killer cell mediated cytotoxicity
109376-83-2	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC)
105637-50-1	KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04010|MAPK signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04510|Focal adhesion; KEGG:04670|Leukocyte transendothelial migration; KEGG:04810|Regulation of actin cytoskeleton
71320-77-9	KEGG:00982|Drug metabolism - cytochrome P450
7416-34-4	KEGG:04080|Neuroactive ligand-receptor interaction
25717-80-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04920|Adipocytokine signaling pathway; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway
14259-85-9	KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00910|Nitrogen metabolism
7439-98-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04144|Endocytosis; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04672|Intestinal immune network for IgA production; KEGG:05414|Dilated cardiomyopathy; KEGG:00910|Nitrogen metabolism
17090-79-8	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05200|Pathways in cancer; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway
40321-98-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
4376-20-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04976|Bile secretion; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:00100|Steroid biosynthesis; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04360|Axon guidance; KEGG:05414|Dilated cardiomyopathy
131-70-4	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05416|Viral myocarditis; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:04010|MAPK signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04310|Wnt signaling pathway; KEGG:04530|Tight junction; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03008|Ribosome biogenesis in eukaryotes
315-22-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:03050|Proteasome; KEGG:03450|Non-homologous end-joining
6923-22-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:04010|MAPK signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway
10121-91-2	KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:05221|Acute myeloid leukemia; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway
124-58-3	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:04010|MAPK signaling pathway; KEGG:04520|Adherens junction; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters; KEGG:05130|Pathogenic Escherichia coli infection
60-34-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00340|Histidine metabolism; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism
5650-44-2	KEGG:05012|Parkinson's disease; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05322|Systemic lupus erythematosus; KEGG:04610|Complement and coagulation cascades; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04514|Cell adhesion molecules (CAMs)
37115-33-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
12772-57-5	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05020|Prion diseases; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05146|Amoebiasis; KEGG:00330|Arginine and proline metabolism
37758-47-7	KEGG:05012|Parkinson's disease; KEGG:05146|Amoebiasis; KEGG:05130|Pathogenic Escherichia coli infection
158966-92-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:00590|Arachidonic acid metabolism
31883-05-3	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism
480-16-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
57-27-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04962|Vasopressin-regulated water reabsorption
20290-09-9	KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04145|Phagosome
857876-30-3	KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04510|Focal adhesion; KEGG:04144|Endocytosis
34816-55-2	KEGG:05146|Amoebiasis
75438-57-2	KEGG:04080|Neuroactive ligand-receptor interaction
3249-28-3	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
3148-09-2	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
300-54-9	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
2763-96-4	KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04660|T cell receptor signaling pathway
81-14-1	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
81-15-2	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
505-60-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04340|Hedgehog signaling pathway; KEGG:05340|Primary immunodeficiency
8007-40-7	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05152|Tuberculosis; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04360|Axon guidance
128794-94-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease
24280-93-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04360|Axon guidance; KEGG:00983|Drug metabolism - other enzymes; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
85166-31-0	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction
529-44-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis
76706-55-3	KEGG:05010|Alzheimer's disease; KEGG:05160|Hepatitis C; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04360|Axon guidance
121749-39-1	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
127243-85-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04971|Gastric acid secretion; KEGG:05110|Vibrio cholerae infection; KEGG:02010|ABC transporters
120615-25-0	KEGG:04210|Apoptosis; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04120|Ubiquitin mediated proteolysis
123653-11-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00590|Arachidonic acid metabolism
8068-83-5	KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction
171714-74-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
130432-17-6	KEGG:05144|Malaria; KEGG:05143|African trypanosomiasis; KEGG:04514|Cell adhesion molecules (CAMs)
106328-57-8	KEGG:05145|Toxoplasmosis; KEGG:00591|Linoleic acid metabolism; KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
134448-10-5	KEGG:04210|Apoptosis
81705-04-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis
79965-10-9	KEGG:05200|Pathways in cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05323|Rheumatoid arthritis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism
147465-43-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma
152918-18-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
30275-80-0	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis
36396-99-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis
41552-82-3	KEGG:04080|Neuroactive ligand-receptor interaction
938-55-6	KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion; KEGG:04310|Wnt signaling pathway; KEGG:04530|Tight junction; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05130|Pathogenic Escherichia coli infection
42924-53-8	KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05140|Leishmaniasis; KEGG:00590|Arachidonic acid metabolism
3106-85-2	KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction
50700-49-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450
10061-64-0	KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
89784-39-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00983|Drug metabolism - other enzymes
42200-33-9	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04020|Calcium signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04970|Salivary secretion; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04630|Jak-STAT signaling pathway
3771-19-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:00071|Fatty acid metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:01040|Biosynthesis of unsaturated fatty acids
20594-83-6	KEGG:04080|Neuroactive ligand-receptor interaction
300-76-5	KEGG:04060|Cytokine-cytokine receptor interaction
55096-26-9	KEGG:04080|Neuroactive ligand-receptor interaction
465-65-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04614|Renin-angiotensin system
16590-41-3	KEGG:05010|Alzheimer's disease; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04660|T cell receptor signaling pathway
111555-53-4	KEGG:04080|Neuroactive ligand-receptor interaction
26628-22-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05323|Rheumatoid arthritis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04722|Neurotrophin signaling pathway
360-70-3	KEGG:04975|Fat digestion and absorption; KEGG:04977|Vitamin digestion and absorption; KEGG:04614|Renin-angiotensin system
91-20-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04974|Protein digestion and absorption
475-38-7	KEGG:00480|Glutathione metabolism
1338-24-5	KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway
32358-83-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04012|ErbB signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05221|Acute myeloid leukemia; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway
551-06-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:03010|Ribosome; KEGG:02010|ABC transporters; KEGG:00330|Arginine and proline metabolism; KEGG:00970|Aminoacyl-tRNA biosynthesis
22204-53-1	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:00590|Arachidonic acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
121679-13-8	KEGG:04080|Neuroactive ligand-receptor interaction
480-41-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
73692-50-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
10236-47-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:04142|Lysosome; KEGG:00640|Propanoate metabolism; KEGG:00531|Glycosaminoglycan degradation
105816-04-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:04976|Bile secretion
98983-21-2	KEGG:04020|Calcium signaling pathway
86925-97-5	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05211|Renal cell carcinoma; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04722|Neurotrophin signaling pathway; KEGG:03010|Ribosome
52316-57-1	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production
29043-89-8	KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:00071|Fatty acid metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism
111-76-2	KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04070|Phosphatidylinositol signaling system; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:04974|Protein digestion and absorption
51036-13-6	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production
148460-80-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis
31750-48-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00983|Drug metabolism - other enzymes
112-40-3	KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles
99200-09-6	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04670|Leukocyte transendothelial migration; KEGG:04145|Phagosome; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04614|Renin-angiotensin system
11048-13-8	KEGG:04612|Antigen processing and presentation
83366-66-9	KEGG:05152|Tuberculosis; KEGG:00591|Linoleic acid metabolism; KEGG:05323|Rheumatoid arthritis; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:00983|Drug metabolism - other enzymes
2292-16-2	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04730|Long-term depression
159989-64-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
484-11-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04514|Cell adhesion molecules (CAMs)
7440-00-8	KEGG:04010|MAPK signaling pathway
25644-25-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04144|Endocytosis; KEGG:05310|Asthma
20702-77-6	KEGG:04973|Carbohydrate digestion and absorption; KEGG:04742|Taste transduction
1404-04-2	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04360|Axon guidance
59-99-4	KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma
14660-91-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis
161600-01-7	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:03320|PPAR signaling pathway; KEGG:05216|Thyroid cancer
114495-97-5	KEGG:04080|Neuroactive ligand-receptor interaction
39379-15-2	KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
129618-40-2	KEGG:05219|Bladder cancer; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:03320|PPAR signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04510|Focal adhesion; KEGG:05320|Autoimmune thyroid disease
544-76-3	KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles
66-25-1	KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:00071|Fatty acid metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism
110-54-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00480|Glutathione metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00590|Arachidonic acid metabolism; KEGG:00030|Pentose phosphate pathway
4463-22-3	KEGG:01100|Metabolic pathways; KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
6810-26-0	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05215|Prostate cancer; KEGG:05216|Thyroid cancer; KEGG:00920|Sulfur metabolism
19315-64-1	KEGG:00380|Tryptophan metabolism
59-67-6	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04145|Phagosome; KEGG:04975|Fat digestion and absorption
55985-32-5	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:04012|ErbB signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04270|Vascular smooth muscle contraction; KEGG:00232|Caffeine metabolism; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:04114|Oocyte meiosis; KEGG:00590|Arachidonic acid metabolism
7440-02-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:05150|Staphylococcus aureus infection; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00983|Drug metabolism - other enzymes; KEGG:00500|Starch and sucrose metabolism; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00562|Inositol phosphate metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:03018|RNA degradation; KEGG:00020|Citrate cycle (TCA cycle); KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03040|Spliceosome; KEGG:00052|Galactose metabolism; KEGG:00650|Butanoate metabolism; KEGG:04330|Notch signaling pathway; KEGG:04340|Hedgehog signaling pathway; KEGG:00450|Selenocompound metabolism; KEGG:04974|Protein digestion and absorption; KEGG:00565|Ether lipid metabolism; KEGG:00511|Other glycan degradation; KEGG:04966|Collecting duct acid secretion
373-02-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway; KEGG:04310|Wnt signaling pathway
7718-54-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00270|Cysteine and methionine metabolism; KEGG:00071|Fatty acid metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:03010|Ribosome; KEGG:00100|Steroid biosynthesis; KEGG:05110|Vibrio cholerae infection; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:04672|Intestinal immune network for IgA production; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:00240|Pyrimidine metabolism; KEGG:04142|Lysosome; KEGG:03040|Spliceosome; KEGG:00052|Galactose metabolism; KEGG:00450|Selenocompound metabolism
12054-48-7	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage
1313-99-1	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04978|Mineral absorption; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:00190|Oxidative phosphorylation; KEGG:04330|Notch signaling pathway; KEGG:04974|Protein digestion and absorption; KEGG:00565|Ether lipid metabolism; KEGG:04966|Collecting duct acid secretion
13138-45-9	KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway
12035-72-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04380|Osteoclast differentiation; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway; KEGG:00620|Pyruvate metabolism
7786-81-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:04360|Axon guidance; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00240|Pyrimidine metabolism; KEGG:04974|Protein digestion and absorption
16812-54-7	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
50-65-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:05217|Basal cell carcinoma; KEGG:04330|Notch signaling pathway
1986-81-8	KEGG:04060|Cytokine-cytokine receptor interaction
65141-46-0	KEGG:04142|Lysosome; KEGG:00531|Glycosaminoglycan degradation
54-11-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04013|MAPK signaling pathway - fly
21829-25-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:05414|Dilated cardiomyopathy
4394-00-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04971|Gastric acid secretion
63612-50-0	KEGG:05220|Chronic myeloid leukemia; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04012|ErbB signaling pathway; KEGG:05162|Measles
25990-37-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
51803-78-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:05150|Staphylococcus aureus infection; KEGG:00590|Arachidonic acid metabolism
2011-67-8	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis
66085-59-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:01100|Metabolic pathways; KEGG:04270|Vascular smooth muscle contraction; KEGG:04722|Neurotrophin signaling pathway
42471-28-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04115|p53 signaling pathway; KEGG:03420|Nucleotide excision repair
55981-09-4	KEGG:05160|Hepatitis C; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05162|Measles
104206-65-7	KEGG:01100|Metabolic pathways; KEGG:00480|Glutathione metabolism
146-22-5	KEGG:04210|Apoptosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
39562-70-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:04976|Bile secretion; KEGG:04614|Renin-angiotensin system
7697-37-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03420|Nucleotide excision repair; KEGG:03410|Base excision repair; KEGG:00910|Nitrogen metabolism
10102-43-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04260|Cardiac muscle contraction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00330|Arginine and proline metabolism; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:04614|Renin-angiotensin system
139-13-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:02010|ABC transporters
29757-24-2	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
175033-36-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
1836-75-5	KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05416|Viral myocarditis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04010|MAPK signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:04310|Wnt signaling pathway; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05414|Dilated cardiomyopathy; KEGG:05217|Basal cell carcinoma; KEGG:04340|Hedgehog signaling pathway; KEGG:04614|Renin-angiotensin system
158836-71-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04623|Cytosolic DNA-sensing pathway
67-20-9	KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:00030|Pentose phosphate pathway
59-87-0	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05211|Renal cell carcinoma; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04662|B cell receptor signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway
10102-44-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04514|Cell adhesion molecules (CAMs)
55-63-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04145|Phagosome; KEGG:00230|Purine metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00330|Arginine and proline metabolism; KEGG:00340|Histidine metabolism
330-13-2	KEGG:01100|Metabolic pathways; KEGG:00790|Folate biosynthesis
15078-28-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00330|Arginine and proline metabolism
56-57-5	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00071|Fatty acid metabolism; KEGG:04114|Oocyte meiosis
79032-48-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
937-40-6	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:00071|Fatty acid metabolism; KEGG:04114|Oocyte meiosis; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00565|Ether lipid metabolism
57564-91-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
615-53-2	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton
14635-75-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04010|MAPK signaling pathway; KEGG:05146|Amoebiasis; KEGG:04650|Natural killer cell mediated cytotoxicity
930-55-2	KEGG:00982|Drug metabolism - cytochrome P450
7782-77-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04140|Regulation of autophagy
10024-97-2	KEGG:05212|Pancreatic cancer; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04920|Adipocytokine signaling pathway; KEGG:04630|Jak-STAT signaling pathway
23282-20-4	KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
76963-41-2	KEGG:04080|Neuroactive ligand-receptor interaction
103818-46-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
27093-62-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:00983|Drug metabolism - other enzymes
673-50-7	KEGG:04080|Neuroactive ligand-receptor interaction
137915-12-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
35998-29-9	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
53177-12-1	KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05200|Pathways in cancer; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04672|Intestinal immune network for IgA production
5545-17-5	KEGG:05140|Leishmaniasis; KEGG:05146|Amoebiasis; KEGG:04640|Hematopoietic cell lineage; KEGG:04660|T cell receptor signaling pathway; KEGG:04514|Cell adhesion molecules (CAMs)
98774-23-3	KEGG:05416|Viral myocarditis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05144|Malaria; KEGG:05330|Allograft rejection; KEGG:04640|Hematopoietic cell lineage; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05340|Primary immunodeficiency
121-69-7	KEGG:00982|Drug metabolism - cytochrome P450
122314-67-4	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04360|Axon guidance
142720-24-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:04722|Neurotrophin signaling pathway
74-31-7	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis
37620-20-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
71267-22-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
621-64-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes
55557-02-3	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
59-89-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04722|Neurotrophin signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:00270|Cysteine and methionine metabolism; KEGG:00071|Fatty acid metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04145|Phagosome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00920|Sulfur metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:00910|Nitrogen metabolism; KEGG:00350|Tyrosine metabolism
80508-23-2	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00232|Caffeine metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00514|Other types of O-glycan biosynthesis
100-75-4	KEGG:00982|Drug metabolism - cytochrome P450
16858-02-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production
58479-52-0	KEGG:04080|Neuroactive ligand-receptor interaction
67383-44-2	KEGG:04080|Neuroactive ligand-receptor interaction
31430-18-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
118399-22-7	KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00140|Steroid hormone biosynthesis; KEGG:04010|MAPK signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:05320|Autoimmune thyroid disease
24526-64-5	KEGG:05012|Parkinson's disease
3734-49-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism
111-84-2	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis
618-92-8	KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05215|Prostate cancer
26027-38-3	KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles
25154-52-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:03050|Proteasome; KEGG:04810|Regulation of actin cytoskeleton
75970-99-9	KEGG:05323|Rheumatoid arthritis; KEGG:05144|Malaria; KEGG:05143|African trypanosomiasis; KEGG:04670|Leukocyte transendothelial migration; KEGG:04514|Cell adhesion molecules (CAMs)
3542-72-1	KEGG:03320|PPAR signaling pathway
105618-26-6	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis
78715-23-8	KEGG:00982|Drug metabolism - cytochrome P450
5442-12-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
6104-71-8	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04540|Gap junction
500-38-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:00590|Arachidonic acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:04672|Intestinal immune network for IgA production
51-41-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04260|Cardiac muscle contraction; KEGG:04144|Endocytosis; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00562|Inositol phosphate metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:04614|Renin-angiotensin system; KEGG:00350|Tyrosine metabolism
68-22-4	KEGG:04610|Complement and coagulation cascades
38673-38-0	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04610|Complement and coagulation cascades
68-23-5	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:00140|Steroid hormone biosynthesis; KEGG:05162|Measles; KEGG:04114|Oocyte meiosis
1886-26-6	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04540|Gap junction
70458-96-7	KEGG:05323|Rheumatoid arthritis
56161-73-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00983|Drug metabolism - other enzymes
35189-28-7	KEGG:00591|Linoleic acid metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:05150|Staphylococcus aureus infection
6533-00-2	KEGG:05215|Prostate cancer; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05144|Malaria; KEGG:04610|Complement and coagulation cascades; KEGG:05143|African trypanosomiasis; KEGG:05150|Staphylococcus aureus infection
797-63-7	KEGG:04115|p53 signaling pathway; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04610|Complement and coagulation cascades; KEGG:05150|Staphylococcus aureus infection
244-63-3	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:00590|Arachidonic acid metabolism
434-22-0	KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:04660|T cell receptor signaling pathway
72-69-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05016|Huntington's disease; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04940|Type I diabetes mellitus; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage
67018-85-3	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00983|Drug metabolism - other enzymes
128-62-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04150|mTOR signaling pathway; KEGG:04722|Neurotrophin signaling pathway
71-41-0	KEGG:04080|Neuroactive ligand-receptor interaction
103-65-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05016|Huntington's disease; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus
153587-01-0	KEGG:04270|Vascular smooth muscle contraction
629-59-4	KEGG:05200|Pathways in cancer; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04974|Protein digestion and absorption
88-12-0	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04530|Tight junction; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:04340|Hedgehog signaling pathway
39791-20-3	KEGG:05323|Rheumatoid arthritis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation
1400-61-9	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs)
19916-73-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:00380|Tryptophan metabolism; KEGG:04722|Neurotrophin signaling pathway; KEGG:03430|Mismatch repair
751-03-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04722|Neurotrophin signaling pathway
129298-91-5	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
303-47-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00030|Pentose phosphate pathway; KEGG:03420|Nucleotide excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:03015|mRNA surveillance pathway; KEGG:00190|Oxidative phosphorylation; KEGG:00430|Taurine and hypotaurine metabolism
5205-32-3	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04062|Chemokine signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04670|Leukocyte transendothelial migration; KEGG:04722|Neurotrophin signaling pathway; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton
29082-74-4	KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:00380|Tryptophan metabolism; KEGG:04623|Cytosolic DNA-sensing pathway
2197-37-7	KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:00590|Arachidonic acid metabolism; KEGG:04975|Fat digestion and absorption; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00061|Fatty acid biosynthesis
112-80-1	KEGG:05219|Bladder cancer; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04920|Adipocytokine signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption
124-07-2	KEGG:03320|PPAR signaling pathway
104-14-3	KEGG:05012|Parkinson's disease; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04144|Endocytosis
83150-76-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04350|TGF-beta signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:04972|Pancreatic secretion; KEGG:00480|Glutathione metabolism; KEGG:05320|Autoimmune thyroid disease
1034-01-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
82419-36-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:05146|Amoebiasis; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
78950-78-4	KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles
78111-17-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
132539-06-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04920|Adipocytokine signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00650|Butanoate metabolism; KEGG:00350|Tyrosine metabolism
23696-28-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
3922-90-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04976|Bile secretion; KEGG:00983|Drug metabolism - other enzymes
508-02-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00590|Arachidonic acid metabolism; KEGG:03410|Base excision repair
5429-85-6	KEGG:00564|Glycerophospholipid metabolism
1716-06-9	KEGG:03320|PPAR signaling pathway
484-49-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
8001-25-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:01100|Metabolic pathways; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:00480|Glutathione metabolism; KEGG:04975|Fat digestion and absorption; KEGG:05310|Asthma; KEGG:00561|Glycerolipid metabolism; KEGG:04974|Protein digestion and absorption
144689-24-7	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:05146|Amoebiasis
119615-63-3	KEGG:04910|Insulin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation
64224-21-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
58493-49-5	KEGG:04080|Neuroactive ligand-receptor interaction
92078-76-7	KEGG:04080|Neuroactive ligand-receptor interaction
73590-58-6	KEGG:05010|Alzheimer's disease; KEGG:05016|Huntington's disease; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:00071|Fatty acid metabolism; KEGG:03050|Proteasome; KEGG:00620|Pyruvate metabolism; KEGG:03010|Ribosome; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00640|Propanoate metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00350|Tyrosine metabolism
73590-85-9	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis
2312-35-8	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04610|Complement and coagulation cascades
96346-61-1	KEGG:05222|Small cell lung cancer; KEGG:01100|Metabolic pathways; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:00600|Sphingolipid metabolism
106956-32-5	KEGG:05010|Alzheimer's disease; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
99614-02-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation
5598-15-2	KEGG:05010|Alzheimer's disease; KEGG:05016|Huntington's disease; KEGG:05012|Parkinson's disease; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:04260|Cardiac muscle contraction; KEGG:04360|Axon guidance; KEGG:00983|Drug metabolism - other enzymes; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00190|Oxidative phosphorylation
76470-87-6	KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04140|Regulation of autophagy
789-02-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:03050|Proteasome; KEGG:03010|Ribosome; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
7659-29-2	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
148317-76-4	KEGG:00590|Arachidonic acid metabolism
118968-41-5	KEGG:05144|Malaria; KEGG:05143|African trypanosomiasis; KEGG:04670|Leukocyte transendothelial migration; KEGG:04514|Cell adhesion molecules (CAMs)
28957-04-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
96829-58-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05162|Measles; KEGG:04972|Pancreatic secretion; KEGG:04975|Fat digestion and absorption; KEGG:00561|Glycerolipid metabolism
65-86-1	KEGG:05160|Hepatitis C; KEGG:04920|Adipocytokine signaling pathway; KEGG:03320|PPAR signaling pathway
83-98-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
143-19-1	KEGG:04080|Neuroactive ligand-receptor interaction
484-12-8	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:00071|Fatty acid metabolism
9006-59-1	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00590|Arachidonic acid metabolism; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production; KEGG:04614|Renin-angiotensin system
66-79-5	KEGG:05416|Viral myocarditis; KEGG:05323|Rheumatoid arthritis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04976|Bile secretion; KEGG:05320|Autoimmune thyroid disease
19666-30-9	KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis
63121-00-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03420|Nucleotide excision repair; KEGG:00240|Pyrimidine metabolism; KEGG:04330|Notch signaling pathway
3687-15-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis
21256-18-8	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
60607-34-3	KEGG:00982|Drug metabolism - cytochrome P450
604-75-1	KEGG:05160|Hepatitis C; KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04520|Adherens junction; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
6801-81-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
15646-46-5	KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:03050|Proteasome; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
28721-07-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00983|Drug metabolism - other enzymes
53716-50-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism; KEGG:00480|Glutathione metabolism
20559-55-1	KEGG:05160|Hepatitis C; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction
937-13-3	KEGG:05219|Bladder cancer; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:01100|Metabolic pathways; KEGG:00983|Drug metabolism - other enzymes
637-03-6	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton
98-79-3	KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04380|Osteoclast differentiation
70-22-4	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
63939-65-1	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
6452-71-7	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:04144|Endocytosis
131-57-7	KEGG:04114|Oocyte meiosis
5633-20-5	KEGG:04080|Neuroactive ligand-receptor interaction
76-42-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00983|Drug metabolism - other enzymes
7782-44-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:00120|Primary bile acid biosynthesis; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production; KEGG:04742|Taste transduction; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00020|Citrate cycle (TCA cycle); KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:04974|Protein digestion and absorption
16837-52-8	KEGG:04110|Cell cycle; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04144|Endocytosis; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
1491-59-4	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction
434-07-1	KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway
79-57-2	KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04623|Cytosolic DNA-sensing pathway
50-56-6	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:05146|Amoebiasis; KEGG:04916|Melanogenesis; KEGG:05143|African trypanosomiasis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04972|Pancreatic secretion; KEGG:04971|Gastric acid secretion; KEGG:04070|Phosphatidylinositol signaling system; KEGG:00562|Inositol phosphate metabolism
82571-53-7	KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation
10028-15-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:03030|DNA replication; KEGG:00120|Primary bile acid biosynthesis; KEGG:05310|Asthma; KEGG:04742|Taste transduction; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00240|Pyrimidine metabolism; KEGG:04974|Protein digestion and absorption
33069-62-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:00983|Drug metabolism - other enzymes; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:03420|Nucleotide excision repair; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:00190|Oxidative phosphorylation; KEGG:04974|Protein digestion and absorption
552-41-0	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00340|Histidine metabolism; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism
3486-67-7	KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04623|Cytosolic DNA-sensing pathway
544-31-0	KEGG:04080|Neuroactive ligand-receptor interaction
57-10-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04950|Maturity onset diabetes of the young; KEGG:00061|Fatty acid biosynthesis
2091-29-4	KEGG:03320|PPAR signaling pathway; KEGG:04975|Fat digestion and absorption
1763-10-6	KEGG:04920|Adipocytokine signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:00071|Fatty acid metabolism
8002-75-3	KEGG:05010|Alzheimer's disease; KEGG:04110|Cell cycle; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:00100|Steroid biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00410|beta-Alanine metabolism; KEGG:04710|Circadian rhythm - mammal; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:00640|Propanoate metabolism; KEGG:00650|Butanoate metabolism; KEGG:04974|Protein digestion and absorption
11077-03-5	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton
40391-99-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:04510|Focal adhesion; KEGG:04670|Leukocyte transendothelial migration; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
130-85-8	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04360|Axon guidance
72800-72-7	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05215|Prostate cancer; KEGG:04350|TGF-beta signaling pathway; KEGG:04722|Neurotrophin signaling pathway
1977-33-9	KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04010|MAPK signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04146|Peroxisome; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04972|Pancreatic secretion; KEGG:04976|Bile secretion; KEGG:00071|Fatty acid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00564|Glycerophospholipid metabolism; KEGG:00770|Pantothenate and CoA biosynthesis
102625-70-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:04976|Bile secretion; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters
58-74-2	KEGG:05160|Hepatitis C; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage
311-45-5	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00983|Drug metabolism - other enzymes
4685-14-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05110|Vibrio cholerae infection; KEGG:04360|Axon guidance; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04614|Renin-angiotensin system; KEGG:04974|Protein digestion and absorption
56-38-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:00380|Tryptophan metabolism; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:05310|Asthma
555-57-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00340|Histidine metabolism; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism
131918-61-1	KEGG:04210|Apoptosis; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:04512|ECM-receptor interaction; KEGG:04974|Protein digestion and absorption
61869-08-7	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04810|Regulation of actin cytoskeleton
29552-41-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00590|Arachidonic acid metabolism; KEGG:05320|Autoimmune thyroid disease
149-29-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04530|Tight junction; KEGG:05310|Asthma; KEGG:04514|Cell adhesion molecules (CAMs)
57186-25-1	KEGG:04210|Apoptosis; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation
35065-29-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis
130663-39-7	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04614|Renin-angiotensin system
143037-36-9	KEGG:04080|Neuroactive ligand-receptor interaction
153049-49-1	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction
132861-87-1	KEGG:04080|Neuroactive ligand-receptor interaction
112-05-0	KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
7690-51-9	KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:05146|Amoebiasis
137281-23-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05216|Thyroid cancer; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:00670|One carbon pool by folate; KEGG:00790|Folate biosynthesis
52-67-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04145|Phagosome; KEGG:05150|Staphylococcus aureus infection; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
87-53-6	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage
61-33-6	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05146|Amoebiasis; KEGG:05332|Graft-versus-host disease; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
88373-73-3	KEGG:04080|Neuroactive ligand-receptor interaction
49776-64-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway
32534-81-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:00140|Steroid hormone biosynthesis; KEGG:04010|MAPK signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04916|Melanogenesis; KEGG:04722|Neurotrophin signaling pathway; KEGG:04976|Bile secretion; KEGG:04114|Oocyte meiosis; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:04710|Circadian rhythm - mammal
608-93-5	KEGG:05200|Pathways in cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis
87-86-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:00071|Fatty acid metabolism; KEGG:03420|Nucleotide excision repair; KEGG:00350|Tyrosine metabolism
78-11-5	KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00330|Arginine and proline metabolism
5534-95-2	KEGG:04080|Neuroactive ligand-receptor interaction
100-33-4	KEGG:05145|Toxoplasmosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
110-62-3	KEGG:05160|Hepatitis C; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway
359-83-1	KEGG:04080|Neuroactive ligand-receptor interaction
67-43-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04672|Intestinal immune network for IgA production
76-74-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04672|Intestinal immune network for IgA production
37300-21-3	KEGG:04610|Complement and coagulation cascades
6493-05-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:03050|Proteasome
54-95-5	KEGG:01100|Metabolic pathways; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:03010|Ribosome; KEGG:03013|RNA transport
23180-57-6	KEGG:05144|Malaria; KEGG:05143|African trypanosomiasis; KEGG:04670|Leukocyte transendothelial migration; KEGG:04514|Cell adhesion molecules (CAMs)
39324-30-6	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05212|Pancreatic cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis
84-97-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism
7601-90-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05211|Renal cell carcinoma; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:03030|DNA replication; KEGG:00910|Nitrogen metabolism
375-22-4	KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:03320|PPAR signaling pathway; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00061|Fatty acid biosynthesis
335-76-2	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion
355-46-4	KEGG:01100|Metabolic pathways; KEGG:04920|Adipocytokine signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04976|Bile secretion; KEGG:00071|Fatty acid metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00120|Primary bile acid biosynthesis; KEGG:00561|Glycerolipid metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism; KEGG:00650|Butanoate metabolism; KEGG:00072|Synthesis and degradation of ketone bodies
375-85-9	KEGG:03320|PPAR signaling pathway
375-95-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04973|Carbohydrate digestion and absorption; KEGG:05150|Staphylococcus aureus infection; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
754-91-6	KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway
1763-23-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:03050|Proteasome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00983|Drug metabolism - other enzymes; KEGG:00120|Primary bile acid biosynthesis; KEGG:00500|Starch and sucrose metabolism; KEGG:05320|Autoimmune thyroid disease; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism; KEGG:00052|Galactose metabolism; KEGG:00650|Butanoate metabolism; KEGG:04974|Protein digestion and absorption; KEGG:00062|Fatty acid elongation in mitochondria
335-67-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:05150|Staphylococcus aureus infection; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00120|Primary bile acid biosynthesis; KEGG:00500|Starch and sucrose metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:04977|Vitamin digestion and absorption; KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:00640|Propanoate metabolism; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:00910|Nitrogen metabolism; KEGG:00072|Synthesis and degradation of ketone bodies; KEGG:00565|Ether lipid metabolism; KEGG:00430|Taurine and hypotaurine metabolism
39800-16-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05416|Viral myocarditis; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04722|Neurotrophin signaling pathway; KEGG:00071|Fatty acid metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00340|Histidine metabolism; KEGG:05217|Basal cell carcinoma; KEGG:00410|beta-Alanine metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism
66104-22-1	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05152|Tuberculosis; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04540|Gap junction; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway
6621-47-2	KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:03013|RNA transport
536-59-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
2111-75-3	KEGG:04062|Chemokine signaling pathway
68132-21-8	KEGG:03320|PPAR signaling pathway
82834-16-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04672|Intestinal immune network for IgA production; KEGG:04614|Renin-angiotensin system; KEGG:04974|Protein digestion and absorption
34240-05-6	KEGG:04210|Apoptosis; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:01100|Metabolic pathways; KEGG:04724|Glutamatergic synapse; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:00071|Fatty acid metabolism; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00120|Primary bile acid biosynthesis; KEGG:00330|Arginine and proline metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism; KEGG:00650|Butanoate metabolism; KEGG:00910|Nitrogen metabolism; KEGG:00471|D-Glutamine and D-glutamate metabolism
10450-60-9	KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00910|Nitrogen metabolism
52645-53-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:05140|Leishmaniasis; KEGG:00380|Tryptophan metabolism; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00983|Drug metabolism - other enzymes
78371-63-8	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05322|Systemic lupus erythematosus; KEGG:04610|Complement and coagulation cascades; KEGG:05150|Staphylococcus aureus infection
129273-38-7	KEGG:04080|Neuroactive ligand-receptor interaction
14691-52-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00232|Caffeine metabolism; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04722|Neurotrophin signaling pathway; KEGG:00480|Glutathione metabolism
58-39-9	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway
198-55-0	KEGG:05219|Bladder cancer; KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
745-65-3	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04614|Renin-angiotensin system
42935-17-1	KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04640|Hematopoietic cell lineage; KEGG:00590|Arachidonic acid metabolism; KEGG:04962|Vasopressin-regulated water reabsorption
163251-41-0	KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04145|Phagosome; KEGG:05310|Asthma
108351-35-5	KEGG:04080|Neuroactive ligand-receptor interaction
17466-45-4	KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
15323-35-0	KEGG:04114|Oocyte meiosis
62-44-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04612|Antigen processing and presentation; KEGG:00590|Arachidonic acid metabolism
85-01-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:03010|Ribosome; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
1015-89-0	KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
77-10-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05214|Glioma; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04916|Melanogenesis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:00590|Arachidonic acid metabolism
51-71-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:04730|Long-term depression
64-04-0	KEGG:05012|Parkinson's disease
2257-09-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:03013|RNA transport; KEGG:05130|Pathogenic Escherichia coli infection
114-86-3	KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04150|mTOR signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04660|T cell receptor signaling pathway
92-43-3	KEGG:00590|Arachidonic acid metabolism
86-21-5	KEGG:04976|Bile secretion
50-06-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00120|Primary bile acid biosynthesis; KEGG:00500|Starch and sucrose metabolism; KEGG:00920|Sulfur metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:00561|Glycerolipid metabolism; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04977|Vitamin digestion and absorption; KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:04710|Circadian rhythm - mammal; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:00640|Propanoate metabolism; KEGG:00600|Sphingolipid metabolism; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:00510|N-Glycan biosynthesis; KEGG:00910|Nitrogen metabolism; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism; KEGG:00790|Folate biosynthesis; KEGG:00450|Selenocompound metabolism; KEGG:04974|Protein digestion and absorption; KEGG:00430|Taurine and hypotaurine metabolism; KEGG:00062|Fatty acid elongation in mitochondria
1400-48-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04940|Type I diabetes mellitus; KEGG:04976|Bile secretion; KEGG:00410|beta-Alanine metabolism; KEGG:00650|Butanoate metabolism; KEGG:00430|Taurine and hypotaurine metabolism
108-95-2	KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04145|Phagosome
77-09-8	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
15265-26-6	KEGG:04976|Bile secretion
143-74-8	KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04976|Bile secretion
92-84-2	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer
122-59-8	KEGG:03430|Mismatch repair
59-96-1	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction
2597-03-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
900-95-8	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer
50-60-2	KEGG:05010|Alzheimer's disease; KEGG:05160|Hepatitis C; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:00920|Sulfur metabolism
122-78-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05416|Viral myocarditis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease
103-82-2	KEGG:01100|Metabolic pathways
103429-31-8	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
71142-71-7	KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:04010|MAPK signaling pathway
2038-35-9	KEGG:04920|Adipocytokine signaling pathway; KEGG:03320|PPAR signaling pathway
50-33-9	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00590|Arachidonic acid metabolism
59-42-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00072|Synthesis and degradation of ketone bodies; KEGG:04614|Renin-angiotensin system
60-12-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05414|Dilated cardiomyopathy
1074-12-0	KEGG:01100|Metabolic pathways; KEGG:00561|Glycerolipid metabolism
100-63-0	KEGG:04978|Mineral absorption; KEGG:04640|Hematopoietic cell lineage; KEGG:04612|Antigen processing and presentation
1079-21-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS)
62-38-4	KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:04670|Leukocyte transendothelial migration
89-25-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs)
329-98-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:00983|Drug metabolism - other enzymes
3376-24-7	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton
14838-15-4	KEGG:05016|Huntington's disease; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04920|Adipocytokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:04145|Phagosome; KEGG:05110|Vibrio cholerae infection; KEGG:00190|Oxidative phosphorylation; KEGG:00360|Phenylalanine metabolism; KEGG:04966|Collecting duct acid secretion
2010-15-3	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer
103-85-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:04920|Adipocytokine signaling pathway; KEGG:00380|Tryptophan metabolism
57-41-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04977|Vitamin digestion and absorption; KEGG:04974|Protein digestion and absorption
60-82-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04972|Pancreatic secretion; KEGG:04976|Bile secretion; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
60-81-1	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:00071|Fatty acid metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:03050|Proteasome; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00410|beta-Alanine metabolism; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:00062|Fatty acid elongation in mitochondria
128129-56-6	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
108-73-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:05146|Amoebiasis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04976|Bile secretion; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:04340|Hedgehog signaling pathway
6441-77-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04976|Bile secretion; KEGG:00983|Drug metabolism - other enzymes
298-02-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:04010|MAPK signaling pathway
20839-06-9	KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
37558-16-0	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:04360|Axon guidance
56937-68-9	KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04070|Phosphatidylinositol signaling system; KEGG:00562|Inositol phosphate metabolism
504-20-1	KEGG:05210|Colorectal cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04978|Mineral absorption; KEGG:04380|Osteoclast differentiation; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:03013|RNA transport
75-44-5	KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:04670|Leukocyte transendothelial migration; KEGG:00480|Glutathione metabolism; KEGG:04144|Endocytosis
732-11-6	KEGG:05323|Rheumatoid arthritis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05310|Asthma
13171-21-6	KEGG:00564|Glycerophospholipid metabolism
482-67-7	KEGG:00920|Sulfur metabolism
142-10-9	KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways
36357-77-4	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04614|Renin-angiotensin system
7723-14-0	KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04512|ECM-receptor interaction
107-73-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton
643-79-8	KEGG:04110|Cell cycle; KEGG:04115|p53 signaling pathway; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
85-44-9	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
11016-15-2	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
57-47-6	KEGG:05210|Colorectal cancer; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04662|B cell receptor signaling pathway
14721-66-5	KEGG:04920|Adipocytokine signaling pathway; KEGG:03320|PPAR signaling pathway
83-86-3	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04062|Chemokine signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
150-86-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:03013|RNA transport; KEGG:00100|Steroid biosynthesis; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:04975|Fat digestion and absorption; KEGG:03030|DNA replication; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00640|Propanoate metabolism; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:03040|Spliceosome
554-62-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
98-98-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05323|Rheumatoid arthritis; KEGG:04940|Type I diabetes mellitus
124-87-8	KEGG:05010|Alzheimer's disease; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:04930|Type II diabetes mellitus; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:03050|Proteasome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:04360|Axon guidance
17617-45-7	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04360|Axon guidance
92-13-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04971|Gastric acid secretion; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:04672|Intestinal immune network for IgA production; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:03420|Nucleotide excision repair; KEGG:03410|Base excision repair
79-17-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
74150-27-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism
2062-78-4	KEGG:05210|Colorectal cancer; KEGG:04080|Neuroactive ligand-receptor interaction
85371-64-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04930|Type II diabetes mellitus; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis
13523-86-9	KEGG:05219|Bladder cancer; KEGG:05020|Prion diseases; KEGG:04930|Type II diabetes mellitus; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05216|Thyroid cancer; KEGG:04320|Dorso-ventral axis formation; KEGG:04540|Gap junction; KEGG:04144|Endocytosis; KEGG:04614|Renin-angiotensin system
484-68-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
480-39-7	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:00920|Sulfur metabolism
111025-46-8	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04114|Oocyte meiosis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04975|Fat digestion and absorption; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production; KEGG:04614|Renin-angiotensin system
68399-58-6	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
61477-96-1	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage
110-89-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04940|Type I diabetes mellitus; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease
7780-20-3	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
71627-22-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450
51-03-6	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:00270|Cysteine and methionine metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:03050|Proteasome; KEGG:03010|Ribosome; KEGG:00330|Arginine and proline metabolism
7491-74-9	KEGG:00140|Steroid hormone biosynthesis; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters; KEGG:05414|Dilated cardiomyopathy
28797-61-7	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
53179-13-8	KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05211|Renal cell carcinoma; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04380|Osteoclast differentiation; KEGG:04912|GnRH signaling pathway
3605-01-4	KEGG:04080|Neuroactive ligand-receptor interaction
23103-98-2	KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05020|Prion diseases; KEGG:05162|Measles; KEGG:04612|Antigen processing and presentation; KEGG:03040|Spliceosome
29232-93-7	KEGG:04142|Lysosome
50892-23-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00120|Primary bile acid biosynthesis; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:04672|Intestinal immune network for IgA production; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04977|Vitamin digestion and absorption; KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03022|Basal transcription factors; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:04710|Circadian rhythm - mammal; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:03440|Homologous recombination; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:03015|mRNA surveillance pathway; KEGG:00670|One carbon pool by folate; KEGG:00770|Pantothenate and CoA biosynthesis; KEGG:00640|Propanoate metabolism; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:00600|Sphingolipid metabolism; KEGG:03040|Spliceosome; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:00760|Nicotinate and nicotinamide metabolism; KEGG:04330|Notch signaling pathway; KEGG:00072|Synthesis and degradation of ketone bodies; KEGG:04340|Hedgehog signaling pathway; KEGG:04614|Renin-angiotensin system; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism; KEGG:00790|Folate biosynthesis; KEGG:03450|Non-homologous end-joining; KEGG:00450|Selenocompound metabolism; KEGG:04974|Protein digestion and absorption; KEGG:00565|Ether lipid metabolism; KEGG:00511|Other glycan degradation; KEGG:05340|Primary immunodeficiency; KEGG:04744|Phototransduction; KEGG:04966|Collecting duct acid secretion; KEGG:00062|Fatty acid elongation in mitochondria; KEGG:00603|Glycosphingolipid biosynthesis - globo series; KEGG:00604|Glycosphingolipid biosynthesis - ganglio series; KEGG:00290|Valine, leucine and isoleucine biosynthesis
65089-17-0	KEGG:04976|Bile secretion
36322-90-4	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:04010|MAPK signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04310|Wnt signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:03013|RNA transport; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04360|Axon guidance; KEGG:03030|DNA replication; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:03420|Nucleotide excision repair; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:03430|Mismatch repair; KEGG:03040|Spliceosome
147511-69-1	KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
122110-53-6	KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04310|Wnt signaling pathway
85340-56-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
4382-43-8	KEGG:05219|Bladder cancer; KEGG:05213|Endometrial cancer; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04930|Type II diabetes mellitus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04370|VEGF signaling pathway; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:00983|Drug metabolism - other enzymes
7440-06-4	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05020|Prion diseases; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04320|Dorso-ventral axis formation; KEGG:03410|Base excision repair
64218-02-6	KEGG:05152|Tuberculosis; KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:04514|Cell adhesion molecules (CAMs)
18378-89-7	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:04370|VEGF signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05162|Measles; KEGG:05100|Bacterial invasion of epithelial cells
481-42-5	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:05216|Thyroid cancer; KEGG:04320|Dorso-ventral axis formation; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
107023-41-6	KEGG:04020|Calcium signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction
518-28-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00100|Steroid biosynthesis; KEGG:02010|ABC transporters; KEGG:04360|Axon guidance
107667-60-7	KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:04010|MAPK signaling pathway; KEGG:05162|Measles; KEGG:04612|Antigen processing and presentation; KEGG:04144|Endocytosis; KEGG:03040|Spliceosome
9003-11-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
24937-83-5	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
25067-58-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04010|MAPK signaling pathway; KEGG:04722|Neurotrophin signaling pathway
26063-13-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
24936-38-7	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
30811-80-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04672|Intestinal immune network for IgA production
65914-17-2	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
9002-88-4	KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04660|T cell receptor signaling pathway
9002-98-6	KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway
25249-22-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
24939-03-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
9006-42-2	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04610|Complement and coagulation cascades
1404-26-8	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
82441-98-3	KEGG:00533|Glycosaminoglycan biosynthesis - keratan sulfate
102667-59-4	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
27416-86-0	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
72702-95-5	KEGG:00561|Glycerolipid metabolism
13408-56-5	KEGG:05222|Small cell lung cancer
129069-19-8	KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04630|Jak-STAT signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma
7440-09-7	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04971|Gastric acid secretion
7758-01-2	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis
7447-40-7	KEGG:05010|Alzheimer's disease; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04260|Cardiac muscle contraction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05414|Dilated cardiomyopathy; KEGG:00052|Galactose metabolism
7789-00-6	KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04070|Phosphatidylinositol signaling system; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:03018|RNA degradation; KEGG:00970|Aminoacyl-tRNA biosynthesis; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:03015|mRNA surveillance pathway; KEGG:03008|Ribosome biogenesis in eukaryotes
151-50-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05140|Leishmaniasis; KEGG:04146|Peroxisome
7778-50-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters; KEGG:03040|Spliceosome; KEGG:00740|Riboflavin metabolism
7681-11-0	KEGG:04370|VEGF signaling pathway
7757-79-1	KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:03410|Base excision repair
7790-21-8	KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00910|Nitrogen metabolism
7790-58-1	KEGG:00240|Pyrimidine metabolism; KEGG:00450|Selenocompound metabolism
9003-39-8	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
6673-35-4	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04360|Axon guidance
83382-71-2	KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles
78478-28-1	KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles
6735-59-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00380|Tryptophan metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00340|Histidine metabolism; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism
104632-26-0	KEGG:04080|Neuroactive ligand-receptor interaction
81093-37-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
55268-74-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:00983|Drug metabolism - other enzymes
19216-56-9	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04260|Cardiac muscle contraction; KEGG:04070|Phosphatidylinositol signaling system; KEGG:00562|Inositol phosphate metabolism; KEGG:05414|Dilated cardiomyopathy
50-24-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04710|Circadian rhythm - mammal
53-03-2	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production
95975-55-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion
128-20-1	KEGG:05010|Alzheimer's disease; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:04012|ErbB signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04916|Melanogenesis; KEGG:04730|Long-term depression
145-13-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:00071|Fatty acid metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00620|Pyruvate metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00120|Primary bile acid biosynthesis; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism; KEGG:00650|Butanoate metabolism; KEGG:00910|Nitrogen metabolism
1434-54-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:00071|Fatty acid metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00620|Pyruvate metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00120|Primary bile acid biosynthesis; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism; KEGG:00650|Butanoate metabolism; KEGG:00910|Nitrogen metabolism
1247-64-9	KEGG:04080|Neuroactive ligand-receptor interaction
90-34-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:04976|Bile secretion; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters
1921-70-6	KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:05146|Amoebiasis
302-33-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:00232|Caffeine metabolism
18206-61-6	KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04144|Endocytosis
57-66-9	KEGG:05012|Parkinson's disease; KEGG:00591|Linoleic acid metabolism; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters; KEGG:04977|Vitamin digestion and absorption
23288-49-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:05143|African trypanosomiasis; KEGG:04670|Leukocyte transendothelial migration; KEGG:05150|Staphylococcus aureus infection; KEGG:04975|Fat digestion and absorption; KEGG:04514|Cell adhesion molecules (CAMs)
51-06-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
59-46-1	KEGG:04270|Vascular smooth muscle contraction
671-16-9	KEGG:01100|Metabolic pathways; KEGG:04912|GnRH signaling pathway; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism
72332-33-3	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway
67747-09-5	KEGG:05215|Prostate cancer; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
4852-22-6	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer
29106-49-8	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04360|Axon guidance
32809-16-8	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04912|GnRH signaling pathway
82-89-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation
41198-08-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
57-83-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:03030|DNA replication; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:05217|Basal cell carcinoma; KEGG:03410|Base excision repair; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:04340|Hedgehog signaling pathway; KEGG:00350|Tyrosine metabolism; KEGG:04974|Protein digestion and absorption
500-92-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism
135467-92-4	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
60-87-7	KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04623|Cytosolic DNA-sensing pathway
66796-54-1	KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway
1918-16-7	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
54063-53-5	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04540|Gap junction
24579-73-5	KEGG:05016|Huntington's disease; KEGG:04146|Peroxisome
74-98-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:04010|MAPK signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:00480|Glutathione metabolism
57-55-6	KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
709-98-8	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04672|Intestinal immune network for IgA production
67-63-0	KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:00071|Fatty acid metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00350|Tyrosine metabolism
71-23-8	KEGG:04080|Neuroactive ligand-receptor interaction
64165-64-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05016|Huntington's disease; KEGG:05020|Prion diseases; KEGG:04978|Mineral absorption; KEGG:04146|Peroxisome; KEGG:04612|Antigen processing and presentation
60207-90-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:00270|Cysteine and methionine metabolism; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00920|Sulfur metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:03018|RNA degradation; KEGG:00340|Histidine metabolism; KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:00240|Pyrimidine metabolism; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:00600|Sphingolipid metabolism; KEGG:03040|Spliceosome; KEGG:00510|N-Glycan biosynthesis; KEGG:04330|Notch signaling pathway; KEGG:03060|Protein export
36015-30-2	KEGG:05219|Bladder cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04623|Cytosolic DNA-sensing pathway
123-38-6	KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:00071|Fatty acid metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism
79-09-4	KEGG:05212|Pancreatic cancer; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04370|VEGF signaling pathway
60569-19-9	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04540|Gap junction
2078-54-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00514|Other types of O-glycan biosynthesis
9009-62-5	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway
114-26-1	KEGG:04080|Neuroactive ligand-receptor interaction
469-62-5	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00983|Drug metabolism - other enzymes
525-66-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:05414|Dilated cardiomyopathy
78-87-5	KEGG:01100|Metabolic pathways
121-79-9	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
51-52-5	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04370|VEGF signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00071|Fatty acid metabolism; KEGG:03050|Proteasome; KEGG:00620|Pyruvate metabolism; KEGG:03010|Ribosome; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00500|Starch and sucrose metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00020|Citrate cycle (TCA cycle); KEGG:03420|Nucleotide excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00640|Propanoate metabolism; KEGG:00190|Oxidative phosphorylation
466-06-8	KEGG:05219|Bladder cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04623|Cytosolic DNA-sensing pathway
14152-28-4	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04520|Adherens junction; KEGG:04612|Antigen processing and presentation; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC)
13345-50-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
13345-51-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
71902-47-1	KEGG:05140|Leishmaniasis
363-24-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00591|Linoleic acid metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00590|Arachidonic acid metabolism; KEGG:04975|Fat digestion and absorption; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00564|Glycerophospholipid metabolism; KEGG:00565|Ether lipid metabolism; KEGG:00592|alpha-Linolenic acid metabolism
802-31-3	KEGG:05140|Leishmaniasis
551-11-1	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis
51982-36-6	KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
35121-78-9	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis
68794-57-0	KEGG:05140|Leishmaniasis
19716-69-9	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04730|Long-term depression; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis
139-85-5	KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04350|TGF-beta signaling pathway; KEGG:04520|Adherens junction; KEGG:04310|Wnt signaling pathway; KEGG:04144|Endocytosis
99-50-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:05140|Leishmaniasis; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:05131|Shigellosis; KEGG:04722|Neurotrophin signaling pathway
1448-96-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05020|Prion diseases; KEGG:05146|Amoebiasis; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway
130-86-9	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
553-12-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis
7412-77-3	KEGG:00860|Porphyrin and chlorophyll metabolism
123447-62-1	KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
95-63-6	KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:00071|Fatty acid metabolism; KEGG:03050|Proteasome; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:04142|Lysosome
87625-62-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04110|Cell cycle; KEGG:04115|p53 signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:03440|Homologous recombination
537-42-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
3681-99-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion
15932-80-6	KEGG:05160|Hepatitis C; KEGG:05145|Toxoplasmosis
53-79-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04977|Vitamin digestion and absorption; KEGG:04614|Renin-angiotensin system; KEGG:04974|Protein digestion and absorption
58-60-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04977|Vitamin digestion and absorption; KEGG:04614|Renin-angiotensin system; KEGG:04974|Protein digestion and absorption
110-60-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04970|Salivary secretion; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04530|Tight junction; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy
62251-11-0	KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis
52549-17-4	KEGG:05200|Pathways in cancer
15686-83-6	KEGG:00982|Drug metabolism - cytochrome P450
98-96-4	KEGG:05160|Hepatitis C; KEGG:04920|Adipocytokine signaling pathway; KEGG:03320|PPAR signaling pathway
288-13-1	KEGG:04210|Apoptosis; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04010|MAPK signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:03050|Proteasome; KEGG:00120|Primary bile acid biosynthesis; KEGG:00500|Starch and sucrose metabolism; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00030|Pentose phosphate pathway; KEGG:03410|Base excision repair; KEGG:00052|Galactose metabolism
271-80-7	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC)
129-00-0	KEGG:05010|Alzheimer's disease; KEGG:05016|Huntington's disease; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:05144|Malaria; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04612|Antigen processing and presentation; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00190|Oxidative phosphorylation
96489-71-3	KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04510|Focal adhesion
110-86-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism
71145-03-4	KEGG:04010|MAPK signaling pathway
694-59-7	KEGG:00980|Metabolism of xenobiotics by cytochrome P450
101-26-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:00564|Glycerophospholipid metabolism
66-72-8	KEGG:01100|Metabolic pathways; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00650|Butanoate metabolism; KEGG:00430|Taurine and hypotaurine metabolism
737-86-0	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
54-47-7	KEGG:01100|Metabolic pathways; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00650|Butanoate metabolism; KEGG:00430|Taurine and hypotaurine metabolism
149017-66-3	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04270|Vascular smooth muscle contraction; KEGG:04962|Vasopressin-regulated water reabsorption
85-87-0	KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:00590|Arachidonic acid metabolism; KEGG:05414|Dilated cardiomyopathy
91-84-9	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
58-14-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04146|Peroxisome
3690-10-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04612|Antigen processing and presentation
1121-30-8	KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04916|Melanogenesis; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04660|T cell receptor signaling pathway; KEGG:05217|Basal cell carcinoma
87-66-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis
945-32-4	KEGG:01100|Metabolic pathways; KEGG:04916|Melanogenesis; KEGG:00350|Tyrosine metabolism
25769-03-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05320|Autoimmune thyroid disease
116057-75-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
78-98-8	KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:00620|Pyruvate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism
127-17-3	KEGG:05020|Prion diseases; KEGG:04920|Adipocytokine signaling pathway; KEGG:04330|Notch signaling pathway
7187-62-4	KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05200|Pathways in cancer; KEGG:05323|Rheumatoid arthritis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04310|Wnt signaling pathway
146999-93-1	KEGG:04080|Neuroactive ligand-receptor interaction
14808-60-7	KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04145|Phagosome; KEGG:05150|Staphylococcus aureus infection
117-39-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00920|Sulfur metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:03440|Homologous recombination; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:00670|One carbon pool by folate; KEGG:00770|Pantothenate and CoA biosynthesis; KEGG:00640|Propanoate metabolism; KEGG:00052|Galactose metabolism; KEGG:00650|Butanoate metabolism; KEGG:00510|N-Glycan biosynthesis; KEGG:00910|Nitrogen metabolism; KEGG:00072|Synthesis and degradation of ketone bodies; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism; KEGG:04974|Protein digestion and absorption; KEGG:00532|Glycosaminoglycan biosynthesis - chondroitin sulfate; KEGG:00471|D-Glutamine and D-glutamate metabolism; KEGG:00740|Riboflavin metabolism
522-12-3	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
66594-14-7	KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
83-89-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05020|Prion diseases
82586-55-8	KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04614|Renin-angiotensin system
97466-90-5	KEGG:04080|Neuroactive ligand-receptor interaction
77-95-2	KEGG:05010|Alzheimer's disease; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
56-54-2	KEGG:05219|Bladder cancer; KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:00410|beta-Alanine metabolism
130-95-0	KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05323|Rheumatoid arthritis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04976|Bile secretion
91-22-5	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:01100|Metabolic pathways; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04510|Focal adhesion; KEGG:00270|Cysteine and methionine metabolism; KEGG:03050|Proteasome; KEGG:05414|Dilated cardiomyopathy
89-00-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:01100|Metabolic pathways; KEGG:04010|MAPK signaling pathway; KEGG:00380|Tryptophan metabolism
148-24-3	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04976|Bile secretion; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC)
85760-74-3	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04380|Osteoclast differentiation
6581-06-2	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
126602-89-9	KEGG:05144|Malaria; KEGG:05143|African trypanosomiasis; KEGG:04670|Leukocyte transendothelial migration; KEGG:04514|Cell adhesion molecules (CAMs)
52809-07-1	KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction
120166-69-0	KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma
117976-90-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
84225-95-6	KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04270|Vascular smooth muscle contraction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
22662-39-1	KEGG:04080|Neuroactive ligand-receptor interaction
84449-90-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00910|Nitrogen metabolism; KEGG:04974|Protein digestion and absorption
112887-68-0	KEGG:04210|Apoptosis; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05162|Measles
87333-19-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05211|Renal cell carcinoma; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04350|TGF-beta signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04510|Focal adhesion; KEGG:04670|Leukocyte transendothelial migration; KEGG:04614|Renin-angiotensin system
87269-97-4	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04610|Complement and coagulation cascades
66357-35-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion
128345-62-0	KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation
110445-25-5	KEGG:04020|Calcium signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04260|Cardiac muscle contraction; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC)
8002-13-9	KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:01040|Biosynthesis of unsaturated fatty acids
21416-87-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton
111911-87-6	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:00590|Arachidonic acid metabolism
98769-81-4	KEGG:04614|Renin-angiotensin system
132875-61-7	KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation
80125-14-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04080|Neuroactive ligand-receptor interaction
135062-02-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:04976|Bile secretion
151308-34-8	KEGG:04080|Neuroactive ligand-receptor interaction
50-55-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04970|Salivary secretion; KEGG:00380|Tryptophan metabolism; KEGG:04916|Melanogenesis; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:04976|Bile secretion; KEGG:04971|Gastric acid secretion; KEGG:00350|Tyrosine metabolism
57444-62-9	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
10453-86-8	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04610|Complement and coagulation cascades
108-46-3	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer
501-36-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:03410|Base excision repair
116-31-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:04012|ErbB signaling pathway; KEGG:00071|Fatty acid metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism
4759-48-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04145|Phagosome; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00983|Drug metabolism - other enzymes; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00030|Pentose phosphate pathway; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:04142|Lysosome; KEGG:00640|Propanoate metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:04974|Protein digestion and absorption
127-47-9	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:04672|Intestinal immune network for IgA production; KEGG:05217|Basal cell carcinoma; KEGG:04330|Notch signaling pathway; KEGG:04340|Hedgehog signaling pathway
79-81-2	KEGG:05200|Pathways in cancer; KEGG:04975|Fat digestion and absorption
43219-27-8	KEGG:00830|Retinol metabolism; KEGG:04744|Phototransduction
480-54-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism
10485-94-6	KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:01100|Metabolic pathways; KEGG:05140|Leishmaniasis; KEGG:00330|Arginine and proline metabolism
478-43-3	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04510|Focal adhesion; KEGG:04623|Cytosolic DNA-sensing pathway
127829-86-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis
36791-04-5	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
141-22-0	KEGG:04080|Neuroactive ligand-receptor interaction
23246-96-0	KEGG:04210|Apoptosis; KEGG:05214|Glioma; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05323|Rheumatoid arthritis; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04530|Tight junction; KEGG:02010|ABC transporters; KEGG:04672|Intestinal immune network for IgA production
72559-06-9	KEGG:04976|Bile secretion
13292-46-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04621|NOD-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:00983|Drug metabolism - other enzymes; KEGG:00120|Primary bile acid biosynthesis; KEGG:03450|Non-homologous end-joining
6998-60-3	KEGG:04976|Bile secretion
1744-22-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04650|Natural killer cell mediated cytotoxicity
49697-38-3	KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
158681-13-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00061|Fatty acid biosynthesis
105462-24-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04660|T cell receptor signaling pathway; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells
106266-06-2	KEGG:05200|Pathways in cancer; KEGG:04910|Insulin signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04920|Adipocytokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:04722|Neurotrophin signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04976|Bile secretion; KEGG:04114|Oocyte meiosis; KEGG:05217|Basal cell carcinoma; KEGG:00350|Tyrosine metabolism
87051-43-2	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04540|Gap junction
123441-03-2	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00564|Glycerophospholipid metabolism
145202-66-0	KEGG:04080|Neuroactive ligand-receptor interaction
82985-31-7	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04912|GnRH signaling pathway
91917-65-6	KEGG:04080|Neuroactive ligand-receptor interaction
125314-64-9	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway
131848-97-0	KEGG:05219|Bladder cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04612|Antigen processing and presentation
151342-35-7	KEGG:05212|Pancreatic cancer; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:04540|Gap junction
125628-97-9	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05216|Thyroid cancer; KEGG:05162|Measles; KEGG:03410|Base excision repair
144092-31-9	KEGG:04110|Cell cycle; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway
161582-11-2	KEGG:01100|Metabolic pathways
490-31-3	KEGG:02010|ABC transporters
143558-00-3	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
61413-54-5	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma
128517-07-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04013|MAPK signaling pathway - fly
91374-21-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
84057-95-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05140|Leishmaniasis; KEGG:05146|Amoebiasis; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:00920|Sulfur metabolism; KEGG:04514|Cell adhesion molecules (CAMs)
84088-42-6	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
14729-29-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway
11121-48-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:04976|Bile secretion; KEGG:00983|Drug metabolism - other enzymes
8000-25-7	KEGG:05323|Rheumatoid arthritis; KEGG:05144|Malaria; KEGG:05143|African trypanosomiasis; KEGG:04650|Natural killer cell mediated cytotoxicity
122320-73-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00120|Primary bile acid biosynthesis; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00020|Citrate cycle (TCA cycle); KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:05217|Basal cell carcinoma; KEGG:00410|beta-Alanine metabolism; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:04974|Protein digestion and absorption; KEGG:00062|Fatty acid elongation in mitochondria
287714-41-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption
83-79-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04260|Cardiac muscle contraction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03440|Homologous recombination; KEGG:00190|Oxidative phosphorylation; KEGG:00760|Nicotinate and nicotinamide metabolism
82-08-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:04013|MAPK signaling pathway - fly
121-19-7	KEGG:04060|Cytokine-cytokine receptor interaction
80214-83-1	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
135911-02-3	KEGG:04080|Neuroactive ligand-receptor interaction
136959-96-1	KEGG:04210|Apoptosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04380|Osteoclast differentiation; KEGG:04623|Cytosolic DNA-sensing pathway
151555-47-4	KEGG:05215|Prostate cancer; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis
117-02-2	KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04380|Osteoclast differentiation
7440-17-7	KEGG:00190|Oxidative phosphorylation
55481-88-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis
169939-94-0	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04971|Gastric acid secretion; KEGG:04070|Phosphatidylinositol signaling system; KEGG:05110|Vibrio cholerae infection
472-11-7	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway
14882-94-1	KEGG:05223|Non-small cell lung cancer; KEGG:05222|Small cell lung cancer; KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04920|Adipocytokine signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04520|Adherens junction
84-26-4	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
7440-18-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
11103-72-3	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis
153-18-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00590|Arachidonic acid metabolism
73257-80-4	KEGG:05160|Hepatitis C
15662-33-6	KEGG:04020|Calcium signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05414|Dilated cardiomyopathy
94840-66-1	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:04010|MAPK signaling pathway; KEGG:05221|Acute myeloid leukemia; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:00480|Glutathione metabolism; KEGG:04114|Oocyte meiosis
627-72-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05216|Thyroid cancer; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway
104713-70-4	KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction
150863-82-4	KEGG:05219|Bladder cancer; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:01100|Metabolic pathways; KEGG:00983|Drug metabolism - other enzymes
138112-76-2	KEGG:04080|Neuroactive ligand-receptor interaction
26289-39-4	KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
81-07-2	KEGG:04110|Cell cycle; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05211|Renal cell carcinoma; KEGG:04380|Osteoclast differentiation; KEGG:04973|Carbohydrate digestion and absorption
8001-23-8	KEGG:05200|Pathways in cancer; KEGG:03320|PPAR signaling pathway
94-59-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00232|Caffeine metabolism
20874-52-6	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04672|Intestinal immune network for IgA production
65-45-2	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
69-72-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05310|Asthma
53003-10-4	KEGG:05200|Pathways in cancer; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04310|Wnt signaling pathway; KEGG:05130|Pathogenic Escherichia coli infection
21593-77-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05146|Amoebiasis; KEGG:04142|Lysosome; KEGG:00531|Glycosaminoglycan degradation
89365-50-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04970|Salivary secretion; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04640|Hematopoietic cell lineage; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
525-72-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04722|Neurotrophin signaling pathway
96574-01-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04623|Cytosolic DNA-sensing pathway
115939-25-8	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04144|Endocytosis; KEGG:04145|Phagosome
3650-09-7	KEGG:04978|Mineral absorption
129981-36-8	KEGG:04270|Vascular smooth muscle contraction
2447-54-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04530|Tight junction; KEGG:04514|Cell adhesion molecules (CAMs)
94344-54-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
127779-20-8	KEGG:04930|Type II diabetes mellitus; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:03320|PPAR signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
34273-10-4	KEGG:05146|Amoebiasis; KEGG:04510|Focal adhesion; KEGG:04512|ECM-receptor interaction; KEGG:04974|Protein digestion and absorption
107-44-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05016|Huntington's disease; KEGG:05012|Parkinson's disease; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:00030|Pentose phosphate pathway; KEGG:00564|Glycerophospholipid metabolism; KEGG:00062|Fatty acid elongation in mitochondria
177975-08-5	KEGG:04080|Neuroactive ligand-receptor interaction
86819-20-7	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction
53126-63-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles
157659-79-5	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction
174636-32-9	KEGG:04080|Neuroactive ligand-receptor interaction
53527-28-9	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage
76081-98-6	KEGG:00190|Oxidative phosphorylation
112108-01-7	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction
64121-95-5	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:05020|Prion diseases; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04370|VEGF signaling pathway; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion
120-08-1	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00350|Tyrosine metabolism
51-34-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton
92-61-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
529-53-3	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
27740-01-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04010|MAPK signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:00330|Arginine and proline metabolism
91456-99-4	KEGG:03010|Ribosome
137424-80-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05016|Huntington's disease; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus
115055-59-9	KEGG:05140|Leishmaniasis
76-73-3	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
148244-82-0	KEGG:05219|Bladder cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04012|ErbB signaling pathway; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion
149146-12-3	KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04630|Jak-STAT signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
14611-51-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
7782-49-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04260|Cardiac muscle contraction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:03050|Proteasome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:04142|Lysosome; KEGG:03015|mRNA surveillance pathway; KEGG:03040|Spliceosome; KEGG:00190|Oxidative phosphorylation
12640-89-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway
10236-58-5	KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05146|Amoebiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04114|Oocyte meiosis; KEGG:04710|Circadian rhythm - mammal; KEGG:04974|Protein digestion and absorption
1464-42-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04144|Endocytosis; KEGG:04974|Protein digestion and absorption
2574-71-2	KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05146|Amoebiasis; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:00480|Glutathione metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04114|Oocyte meiosis; KEGG:04710|Circadian rhythm - mammal; KEGG:04974|Protein digestion and absorption
134404-52-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05020|Prion diseases; KEGG:04012|ErbB signaling pathway; KEGG:05221|Acute myeloid leukemia; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis
9012-36-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
17094-01-8	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:05146|Amoebiasis; KEGG:04650|Natural killer cell mediated cytotoxicity
106516-24-9	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction
79617-96-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00590|Arachidonic acid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00350|Tyrosine metabolism
51-14-9	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
24425-52-3	KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production
28523-86-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04976|Bile secretion; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:04710|Circadian rhythm - mammal
69772-83-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
75757-64-1	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
138-59-0	KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:04150|mTOR signaling pathway; KEGG:04510|Focal adhesion
54952-43-1	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05162|Measles
555-66-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
168482-23-3	KEGG:04080|Neuroactive ligand-receptor interaction
139755-83-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05221|Acute myeloid leukemia; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:00330|Arginine and proline metabolism
1343-98-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:04360|Axon guidance; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04742|Taste transduction; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05414|Dilated cardiomyopathy; KEGG:04330|Notch signaling pathway; KEGG:04740|Olfactory transduction
7440-21-3	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage
7631-86-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00562|Inositol phosphate metabolism; KEGG:04742|Taste transduction; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05414|Dilated cardiomyopathy; KEGG:00600|Sphingolipid metabolism; KEGG:04740|Olfactory transduction
7440-22-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05310|Asthma; KEGG:00450|Selenocompound metabolism
7761-88-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04978|Mineral absorption; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04672|Intestinal immune network for IgA production
22888-70-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:05146|Amoebiasis; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04976|Bile secretion; KEGG:00590|Arachidonic acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
122-34-9	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:00330|Arginine and proline metabolism
131741-08-7	KEGG:04020|Calcium signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:04260|Cardiac muscle contraction; KEGG:05414|Dilated cardiomyopathy
79902-63-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:00100|Steroid biosynthesis; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:05217|Basal cell carcinoma; KEGG:04974|Protein digestion and absorption
530-59-6	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
2306-27-6	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism
53123-88-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04140|Regulation of autophagy
163253-35-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
5779-62-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis
9050-67-3	KEGG:05323|Rheumatoid arthritis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04640|Hematopoietic cell lineage
126053-71-2	KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04510|Focal adhesion; KEGG:04640|Hematopoietic cell lineage; KEGG:04512|ECM-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC)
71636-61-8	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:04660|T cell receptor signaling pathway
80751-65-1	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04976|Bile secretion; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:00230|Purine metabolism; KEGG:04742|Taste transduction; KEGG:05414|Dilated cardiomyopathy; KEGG:04962|Vasopressin-regulated water reabsorption
80751-85-5	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction
2986-19-8	KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04660|T cell receptor signaling pathway
51209-75-7	KEGG:04062|Chemokine signaling pathway; KEGG:04144|Endocytosis
7440-23-5	KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:04972|Pancreatic secretion; KEGG:04976|Bile secretion; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04974|Protein digestion and absorption
7631-89-2	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:02010|ABC transporters; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00310|Lysine degradation; KEGG:04962|Vasopressin-regulated water reabsorption
13768-07-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:03050|Proteasome; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:04530|Tight junction; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04977|Vitamin digestion and absorption; KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:03410|Base excision repair; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:04330|Notch signaling pathway; KEGG:04340|Hedgehog signaling pathway; KEGG:04974|Protein digestion and absorption; KEGG:00531|Glycosaminoglycan degradation
532-32-1	KEGG:05214|Glioma
144-55-8	KEGG:05146|Amoebiasis
10588-01-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:00230|Purine metabolism; KEGG:03010|Ribosome; KEGG:05150|Staphylococcus aureus infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:03030|DNA replication; KEGG:00561|Glycerolipid metabolism; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00340|Histidine metabolism; KEGG:04977|Vitamin digestion and absorption; KEGG:03420|Nucleotide excision repair; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:03440|Homologous recombination; KEGG:03430|Mismatch repair; KEGG:00350|Tyrosine metabolism; KEGG:04974|Protein digestion and absorption
16721-80-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation; KEGG:04650|Natural killer cell mediated cytotoxicity
7631-90-5	KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
7775-09-9	KEGG:05200|Pathways in cancer
7647-14-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:04144|Endocytosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:02010|ABC transporters; KEGG:05414|Dilated cardiomyopathy; KEGG:04614|Renin-angiotensin system
361-09-1	KEGG:00983|Drug metabolism - other enzymes
956-48-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04612|Antigen processing and presentation; KEGG:03040|Spliceosome
151-21-3	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
7681-49-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00590|Arachidonic acid metabolism
6834-92-0	KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00910|Nitrogen metabolism
7632-00-0	KEGG:04110|Cell cycle; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04623|Cytosolic DNA-sensing pathway
54-21-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production
13410-01-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
10102-18-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04260|Cardiac muscle contraction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:03050|Proteasome; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:00590|Arachidonic acid metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00240|Pyrimidine metabolism; KEGG:03440|Homologous recombination; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:03040|Spliceosome; KEGG:00190|Oxidative phosphorylation
7757-83-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
96-64-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:04672|Intestinal immune network for IgA production; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03015|mRNA surveillance pathway; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:04330|Notch signaling pathway; KEGG:00511|Other glycan degradation; KEGG:00604|Glycosphingolipid biosynthesis - ganglio series
51110-01-1	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
6483-15-4	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
68367-52-2	KEGG:04210|Apoptosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:00620|Pyruvate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00561|Glycerolipid metabolism; KEGG:00052|Galactose metabolism
50-70-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04722|Neurotrophin signaling pathway
3930-20-9	KEGG:04976|Bile secretion
8001-22-7	KEGG:00380|Tryptophan metabolism; KEGG:04976|Bile secretion; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:02010|ABC transporters
129176-97-2	KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04623|Cytosolic DNA-sensing pathway
124-20-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04970|Salivary secretion; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04530|Tight junction; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy
71-44-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04530|Tight junction; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy
136587-13-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:04010|MAPK signaling pathway; KEGG:05330|Allograft rejection; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity
4775-80-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
123-78-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04360|Axon guidance
26993-30-6	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04730|Long-term depression; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04114|Oocyte meiosis
10216-23-6	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton
749-02-0	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04540|Gap junction
52-01-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04810|Regulation of actin cytoskeleton; KEGG:02010|ABC transporters; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:04672|Intestinal immune network for IgA production; KEGG:00330|Arginine and proline metabolism; KEGG:04614|Renin-angiotensin system
142561-96-4	KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00120|Primary bile acid biosynthesis
146670-40-8	KEGG:05200|Pathways in cancer
153050-21-6	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05162|Measles
136468-36-5	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05150|Staphylococcus aureus infection; KEGG:04514|Cell adhesion molecules (CAMs)
146362-70-1	KEGG:04080|Neuroactive ligand-receptor interaction
142001-63-6	KEGG:04080|Neuroactive ligand-receptor interaction
121524-09-2	KEGG:04080|Neuroactive ligand-receptor interaction
636-47-5	KEGG:01100|Metabolic pathways; KEGG:00670|One carbon pool by folate
7772-99-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05211|Renal cell carcinoma; KEGG:04976|Bile secretion
9005-25-8	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04530|Tight junction
62996-74-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:04710|Circadian rhythm - mammal; KEGG:00670|One carbon pool by folate; KEGG:04140|Regulation of autophagy; KEGG:04974|Protein digestion and absorption
97161-97-2	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00410|beta-Alanine metabolism; KEGG:00430|Taurine and hypotaurine metabolism
57-11-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05016|Huntington's disease; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction
362-66-3	KEGG:03320|PPAR signaling pathway
22108-99-2	KEGG:05150|Staphylococcus aureus infection
16562-13-3	KEGG:04080|Neuroactive ligand-receptor interaction
10048-13-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production
3130-72-1	KEGG:03320|PPAR signaling pathway
17619-97-5	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
49763-96-4	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways
18883-66-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04145|Phagosome; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04672|Intestinal immune network for IgA production; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00640|Propanoate metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:04614|Renin-angiotensin system; KEGG:04974|Protein digestion and absorption
7440-24-6	KEGG:04020|Calcium signaling pathway; KEGG:04730|Long-term depression
630-60-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:01100|Metabolic pathways; KEGG:05211|Renal cell carcinoma; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05221|Acute myeloid leukemia; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:04971|Gastric acid secretion; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:04614|Renin-angiotensin system; KEGG:04974|Protein digestion and absorption; KEGG:00062|Fatty acid elongation in mitochondria
57-24-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00591|Linoleic acid metabolism; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
100-42-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:05150|Staphylococcus aureus infection; KEGG:04975|Fat digestion and absorption; KEGG:05310|Asthma; KEGG:04977|Vitamin digestion and absorption
96-09-3	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:04010|MAPK signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism
9003-53-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05140|Leishmaniasis; KEGG:04610|Complement and coagulation cascades; KEGG:05150|Staphylococcus aureus infection
210644-62-5	KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04010|MAPK signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04810|Regulation of actin cytoskeleton
3810-71-7	KEGG:04080|Neuroactive ligand-receptor interaction
33507-63-0	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
110880-55-2	KEGG:04080|Neuroactive ligand-receptor interaction
304-55-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:03018|RNA degradation; KEGG:05340|Primary immunodeficiency
692-29-5	KEGG:01100|Metabolic pathways
51568-18-4	KEGG:01100|Metabolic pathways
306-40-1	KEGG:04080|Neuroactive ligand-receptor interaction
54182-58-0	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:05146|Amoebiasis; KEGG:04640|Hematopoietic cell lineage
57-50-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
85-86-9	KEGG:05160|Hepatitis C; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:04920|Adipocytokine signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway
103538-03-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04370|VEGF signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity
68-35-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
122-11-2	KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
57-68-1	KEGG:01100|Metabolic pathways; KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
723-46-6	KEGG:05215|Prostate cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04630|Jak-STAT signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:05310|Asthma; KEGG:04140|Regulation of autophagy
114438-33-4	KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05020|Prion diseases; KEGG:04612|Antigen processing and presentation
5329-14-6	KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00910|Nitrogen metabolism
103-12-8	KEGG:00910|Nitrogen metabolism
526-08-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism
144-83-2	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04612|Antigen processing and presentation
599-79-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05150|Staphylococcus aureus infection; KEGG:04514|Cell adhesion molecules (CAMs)
57-96-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters
297-83-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04977|Vitamin digestion and absorption
4478-93-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:05130|Pathogenic Escherichia coli infection
7704-34-9	KEGG:01100|Metabolic pathways
7446-09-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00190|Oxidative phosphorylation
54182-59-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05146|Amoebiasis; KEGG:04650|Natural killer cell mediated cytotoxicity
38194-50-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:05217|Basal cell carcinoma; KEGG:04142|Lysosome
32004-67-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05130|Pathogenic Escherichia coli infection
59864-04-9	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
15676-16-1	KEGG:00140|Steroid hormone biosynthesis; KEGG:04930|Type II diabetes mellitus; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04630|Jak-STAT signaling pathway; KEGG:04976|Bile secretion; KEGG:04971|Gastric acid secretion
60325-46-4	KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04020|Calcium signaling pathway
53583-79-2	KEGG:04080|Neuroactive ligand-receptor interaction
103628-46-2	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:05414|Dilated cardiomyopathy
11062-77-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy
40828-46-4	KEGG:01100|Metabolic pathways; KEGG:00480|Glutathione metabolism
145-63-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton
24730-31-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
99-35-4	KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
123663-49-0	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway
93-76-5	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:04146|Peroxisome; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
6893-02-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04260|Cardiac muscle contraction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:03420|Nucleotide excision repair; KEGG:04340|Hedgehog signaling pathway
7488-70-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04114|Oocyte meiosis; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04340|Hedgehog signaling pathway; KEGG:04614|Renin-angiotensin system
21259-20-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
77-81-6	KEGG:00564|Glycerophospholipid metabolism
321-64-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis
109581-93-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04144|Endocytosis; KEGG:04145|Phagosome; KEGG:05150|Staphylococcus aureus infection; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs)
157380-72-8	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction
229005-80-5	KEGG:05145|Toxoplasmosis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction
14807-96-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04623|Cytosolic DNA-sensing pathway
38649-73-9	KEGG:04976|Bile secretion
36085-73-1	KEGG:04080|Neuroactive ligand-receptor interaction
61789-97-7	KEGG:04110|Cell cycle; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:03320|PPAR signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04975|Fat digestion and absorption; KEGG:01040|Biosynthesis of unsaturated fatty acids
10540-29-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00120|Primary bile acid biosynthesis; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:04710|Circadian rhythm - mammal; KEGG:04142|Lysosome; KEGG:03015|mRNA surveillance pathway; KEGG:00640|Propanoate metabolism; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:00600|Sphingolipid metabolism; KEGG:03040|Spliceosome; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:00910|Nitrogen metabolism; KEGG:04340|Hedgehog signaling pathway; KEGG:03450|Non-homologous end-joining; KEGG:04974|Protein digestion and absorption; KEGG:00565|Ether lipid metabolism; KEGG:00511|Other glycan degradation; KEGG:05340|Primary immunodeficiency
106133-20-4	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction
481-53-8	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
568-73-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:05216|Thyroid cancer; KEGG:04510|Focal adhesion; KEGG:04310|Wnt signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04145|Phagosome; KEGG:00330|Arginine and proline metabolism
69659-80-9	KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04660|T cell receptor signaling pathway
514-07-8	KEGG:00380|Tryptophan metabolism
107-35-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04114|Oocyte meiosis; KEGG:02010|ABC transporters; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00120|Primary bile acid biosynthesis; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:04977|Vitamin digestion and absorption; KEGG:00350|Tyrosine metabolism; KEGG:00061|Fatty acid biosynthesis
516-35-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:00120|Primary bile acid biosynthesis; KEGG:00330|Arginine and proline metabolism
81-24-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters; KEGG:00120|Primary bile acid biosynthesis; KEGG:00330|Arginine and proline metabolism; KEGG:04977|Vitamin digestion and absorption
516-50-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:00120|Primary bile acid biosynthesis; KEGG:00330|Arginine and proline metabolism
516-90-5	KEGG:05210|Colorectal cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
25696-60-0	KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
14605-22-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04920|Adipocytokine signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04976|Bile secretion; KEGG:00120|Primary bile acid biosynthesis; KEGG:00330|Arginine and proline metabolism
109946-35-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:04720|Long-term potentiation; KEGG:04270|Vascular smooth muscle contraction
1605-68-1	KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
480-18-2	KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04975|Fat digestion and absorption; KEGG:04977|Vitamin digestion and absorption
118292-40-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05020|Prion diseases; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05216|Thyroid cancer; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04810|Regulation of actin cytoskeleton
93528-38-2	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage
67247-12-5	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation
109581-73-9	KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
107534-96-3	KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis
112410-23-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00983|Drug metabolism - other enzymes
611-40-5	KEGG:01100|Metabolic pathways; KEGG:04920|Adipocytokine signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:00071|Fatty acid metabolism; KEGG:04975|Fat digestion and absorption; KEGG:00561|Glycerolipid metabolism
17902-23-7	KEGG:05219|Bladder cancer; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:01100|Metabolic pathways; KEGG:04010|MAPK signaling pathway; KEGG:05216|Thyroid cancer; KEGG:00983|Drug metabolism - other enzymes; KEGG:00240|Pyrimidine metabolism
145158-71-0	KEGG:00982|Drug metabolism - cytochrome P450
501-75-7	KEGG:00380|Tryptophan metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00340|Histidine metabolism
79786-08-6	KEGG:04640|Hematopoietic cell lineage
13494-80-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:03010|Ribosome; KEGG:00450|Selenocompound metabolism
144701-48-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04145|Phagosome; KEGG:04614|Renin-angiotensin system
85622-93-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:03410|Base excision repair
2564-83-2	KEGG:05160|Hepatitis C; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis
2226-96-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00330|Arginine and proline metabolism
29767-20-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00983|Drug metabolism - other enzymes
76-80-2	KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis
103475-41-8	KEGG:05323|Rheumatoid arthritis; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:05150|Staphylococcus aureus infection; KEGG:00590|Arachidonic acid metabolism; KEGG:04514|Cell adhesion molecules (CAMs)
5701-82-6	KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
63590-64-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04722|Neurotrophin signaling pathway
91161-71-6	KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:04062|Chemokine signaling pathway; KEGG:05330|Allograft rejection; KEGG:04510|Focal adhesion; KEGG:04670|Leukocyte transendothelial migration; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
23031-25-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04540|Gap junction; KEGG:05332|Graft-versus-host disease; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:04971|Gastric acid secretion; KEGG:04742|Taste transduction
886-50-0	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
5915-41-3	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05222|Small cell lung cancer; KEGG:05216|Thyroid cancer; KEGG:04310|Wnt signaling pathway
100-21-0	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer
50679-08-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00591|Linoleic acid metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
83688-84-0	KEGG:04080|Neuroactive ligand-receptor interaction
75-65-0	KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04270|Vascular smooth muscle contraction; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04530|Tight junction
98774-24-4	KEGG:04080|Neuroactive ligand-receptor interaction
70636-86-1	KEGG:04080|Neuroactive ligand-receptor interaction
27213-78-1	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:04660|T cell receptor signaling pathway
58-22-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00120|Primary bile acid biosynthesis; KEGG:00500|Starch and sucrose metabolism; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:04710|Circadian rhythm - mammal; KEGG:03440|Homologous recombination; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:00640|Propanoate metabolism; KEGG:00600|Sphingolipid metabolism; KEGG:03040|Spliceosome; KEGG:00052|Galactose metabolism; KEGG:00760|Nicotinate and nicotinamide metabolism; KEGG:04340|Hedgehog signaling pathway; KEGG:04974|Protein digestion and absorption
315-37-7	KEGG:04110|Cell cycle; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04012|ErbB signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04610|Complement and coagulation cascades; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04512|ECM-receptor interaction; KEGG:04145|Phagosome; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:03040|Spliceosome; KEGG:04974|Protein digestion and absorption
1180-25-2	KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism
57-85-2	KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease
5949-44-0	KEGG:04110|Cell cycle
58-46-8	KEGG:05012|Parkinson's disease; KEGG:00350|Tyrosine metabolism
79-94-7	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04114|Oocyte meiosis
1461-25-2	KEGG:00140|Steroid hormone biosynthesis
94-24-6	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
79-95-8	KEGG:04114|Oocyte meiosis
1746-01-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00120|Primary bile acid biosynthesis; KEGG:00500|Starch and sucrose metabolism; KEGG:00920|Sulfur metabolism; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00970|Aminoacyl-tRNA biosynthesis; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04977|Vitamin digestion and absorption; KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03022|Basal transcription factors; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:04710|Circadian rhythm - mammal; KEGG:00563|Glycosylphosphatidylinositol(GPI)-anchor biosynthesis; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:03440|Homologous recombination; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:03015|mRNA surveillance pathway; KEGG:00670|One carbon pool by folate; KEGG:00770|Pantothenate and CoA biosynthesis; KEGG:00640|Propanoate metabolism; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:03020|RNA polymerase; KEGG:00600|Sphingolipid metabolism; KEGG:03040|Spliceosome; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:00510|N-Glycan biosynthesis; KEGG:00760|Nicotinate and nicotinamide metabolism; KEGG:00910|Nitrogen metabolism; KEGG:04330|Notch signaling pathway; KEGG:00072|Synthesis and degradation of ketone bodies; KEGG:04340|Hedgehog signaling pathway; KEGG:00533|Glycosaminoglycan biosynthesis - keratan sulfate; KEGG:04614|Renin-angiotensin system; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism; KEGG:00790|Folate biosynthesis; KEGG:04140|Regulation of autophagy; KEGG:03060|Protein export; KEGG:03450|Non-homologous end-joining; KEGG:00450|Selenocompound metabolism; KEGG:04974|Protein digestion and absorption; KEGG:00565|Ether lipid metabolism; KEGG:00532|Glycosaminoglycan biosynthesis - chondroitin sulfate; KEGG:00511|Other glycan degradation; KEGG:05340|Primary immunodeficiency; KEGG:04130|SNARE interactions in vesicular transport; KEGG:04122|Sulfur relay system; KEGG:00430|Taurine and hypotaurine metabolism; KEGG:04966|Collecting duct acid secretion; KEGG:00592|alpha-Linolenic acid metabolism; KEGG:00603|Glycosphingolipid biosynthesis - globo series; KEGG:00534|Glycosaminoglycan biosynthesis - heparan sulfate; KEGG:00604|Glycosphingolipid biosynthesis - ganglio series; KEGG:00601|Glycosphingolipid biosynthesis - lacto and neolacto series; KEGG:00512|Mucin type O-Glycan biosynthesis; KEGG:00290|Valine, leucine and isoleucine biosynthesis; KEGG:00531|Glycosaminoglycan degradation; KEGG:00740|Riboflavin metabolism; KEGG:00130|Ubiquinone and other terpenoid-quinone biosynthesis; KEGG:00460|Cyanoamino acid metabolism
127-18-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:05330|Allograft rejection; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00590|Arachidonic acid metabolism
1897-45-6	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04610|Complement and coagulation cascades
13965-91-8	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
60-54-8	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05211|Renal cell carcinoma; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:00071|Fatty acid metabolism; KEGG:04070|Phosphatidylinositol signaling system; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00120|Primary bile acid biosynthesis; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00564|Glycerophospholipid metabolism; KEGG:00600|Sphingolipid metabolism
16561-29-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:03410|Base excision repair; KEGG:04974|Protein digestion and absorption
66-40-0	KEGG:04970|Salivary secretion; KEGG:04976|Bile secretion
36062-04-1	KEGG:05010|Alzheimer's disease
567-03-3	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
67287-49-4	KEGG:04210|Apoptosis; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:04540|Gap junction
10097-84-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04012|ErbB signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05221|Acute myeloid leukemia; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03040|Spliceosome; KEGG:03060|Protein export
4747-99-3	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway
67-30-1	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04370|VEGF signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04810|Regulation of actin cytoskeleton
70649-54-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
530-91-6	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
7696-12-0	KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer
1124-11-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
2782-91-4	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis
14769-73-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05140|Leishmaniasis; KEGG:04722|Neurotrophin signaling pathway
518-34-3	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05414|Dilated cardiomyopathy
509-14-8	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:04910|Insulin signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04370|VEGF signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:04360|Axon guidance
16330-92-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04672|Intestinal immune network for IgA production; KEGG:05414|Dilated cardiomyopathy
4368-28-9	KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway
50-35-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00591|Linoleic acid metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05414|Dilated cardiomyopathy
7440-28-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis
563-68-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04012|ErbB signaling pathway; KEGG:04722|Neurotrophin signaling pathway
10102-45-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis
67526-95-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04114|Oocyte meiosis; KEGG:04120|Ubiquitin mediated proteolysis
4670-05-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
326-91-0	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
83-67-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis; KEGG:03050|Proteasome
58-55-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:03050|Proteasome; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:04360|Axon guidance; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04742|Taste transduction; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:04140|Regulation of autophagy
35891-70-4	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:04010|MAPK signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity
148-79-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:04010|MAPK signaling pathway; KEGG:00480|Glutathione metabolism
77-27-0	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04360|Axon guidance
298-93-1	KEGG:04210|Apoptosis; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis
54-64-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production
62-55-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04114|Oocyte meiosis; KEGG:03050|Proteasome; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00330|Arginine and proline metabolism; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00410|beta-Alanine metabolism; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism; KEGG:00190|Oxidative phosphorylation
625-00-3	KEGG:04080|Neuroactive ligand-receptor interaction
62-46-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04672|Intestinal immune network for IgA production
302-04-5	KEGG:00270|Cysteine and methionine metabolism; KEGG:04122|Sulfur relay system
59669-26-0	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04610|Complement and coagulation cascades
111-17-1	KEGG:04010|MAPK signaling pathway
154-42-7	KEGG:00230|Purine metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:03430|Mismatch repair
76-75-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
106243-16-7	KEGG:04080|Neuroactive ligand-receptor interaction
23564-05-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:04920|Adipocytokine signaling pathway; KEGG:00380|Tryptophan metabolism
50-52-2	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00232|Caffeine metabolism; KEGG:00590|Arachidonic acid metabolism; KEGG:00983|Drug metabolism - other enzymes
76721-89-6	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04614|Renin-angiotensin system
52-24-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:04722|Neurotrophin signaling pathway; KEGG:03410|Base excision repair
141-90-2	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04370|VEGF signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00071|Fatty acid metabolism; KEGG:03050|Proteasome; KEGG:00620|Pyruvate metabolism; KEGG:03010|Ribosome; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00500|Starch and sucrose metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00020|Citrate cycle (TCA cycle); KEGG:03420|Nucleotide excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00640|Propanoate metabolism; KEGG:00190|Oxidative phosphorylation
62-56-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:03410|Base excision repair
137-26-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03010|Ribosome; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:00640|Propanoate metabolism
57576-52-0	KEGG:05140|Leishmaniasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:00590|Arachidonic acid metabolism
73543-47-2	KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation
54397-85-2	KEGG:00590|Arachidonic acid metabolism
78922-62-0	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04810|Regulation of actin cytoskeleton
50-89-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:00071|Fatty acid metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00983|Drug metabolism - other enzymes; KEGG:00020|Citrate cycle (TCA cycle); KEGG:03420|Nucleotide excision repair; KEGG:00670|One carbon pool by folate; KEGG:00640|Propanoate metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00061|Fatty acid biosynthesis
65-71-4	KEGG:05219|Bladder cancer; KEGG:05323|Rheumatoid arthritis; KEGG:00983|Drug metabolism - other enzymes; KEGG:00240|Pyrimidine metabolism
89-83-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
490-91-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production
24305-27-9	KEGG:04080|Neuroactive ligand-receptor interaction
115103-54-3	KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
5630-53-5	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04010|MAPK signaling pathway; KEGG:05144|Malaria; KEGG:05216|Thyroid cancer; KEGG:05143|African trypanosomiasis; KEGG:04320|Dorso-ventral axis formation; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis; KEGG:04514|Cell adhesion molecules (CAMs)
55142-85-3	KEGG:05219|Bladder cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00590|Arachidonic acid metabolism; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05414|Dilated cardiomyopathy
40180-04-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00860|Porphyrin and chlorophyll metabolism
26839-75-8	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:04360|Axon guidance
106344-20-1	KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway
14325-05-4	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton
1953-02-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease
69014-14-8	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05340|Primary immunodeficiency
192185-72-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:04360|Axon guidance
27314-97-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00590|Arachidonic acid metabolism
7440-32-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:04145|Phagosome; KEGG:05150|Staphylococcus aureus infection; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:05130|Pathogenic Escherichia coli infection
12743-70-3	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway
13463-67-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04145|Phagosome; KEGG:05150|Staphylococcus aureus infection; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
11116-16-8	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles
32986-56-4	KEGG:04612|Antigen processing and presentation
1406-66-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04114|Oocyte meiosis; KEGG:00620|Pyruvate metabolism
1721-51-3	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:04976|Bile secretion; KEGG:00983|Drug metabolism - other enzymes
490-23-3	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00140|Steroid hormone biosynthesis; KEGG:04976|Bile secretion; KEGG:00983|Drug metabolism - other enzymes
25612-59-3	KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05200|Pathways in cancer; KEGG:00140|Steroid hormone biosynthesis; KEGG:05216|Thyroid cancer; KEGG:04510|Focal adhesion; KEGG:04310|Wnt signaling pathway; KEGG:00983|Drug metabolism - other enzymes; KEGG:05217|Basal cell carcinoma
64-77-7	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:04910|Insulin signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04310|Wnt signaling pathway; KEGG:00590|Arachidonic acid metabolism; KEGG:00500|Starch and sucrose metabolism
134308-13-7	KEGG:05010|Alzheimer's disease; KEGG:05016|Huntington's disease; KEGG:05012|Parkinson's disease; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:00071|Fatty acid metabolism; KEGG:03010|Ribosome; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00330|Arginine and proline metabolism; KEGG:00310|Lysine degradation; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:00190|Oxidative phosphorylation
13710-19-5	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00590|Arachidonic acid metabolism
26171-23-3	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis; KEGG:04920|Adipocytokine signaling pathway; KEGG:03320|PPAR signaling pathway
2398-96-1	KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
124937-51-5	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
108-88-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04360|Axon guidance; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00360|Phenylalanine metabolism; KEGG:00450|Selenocompound metabolism
584-84-9	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04144|Endocytosis; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
97240-79-4	KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04920|Adipocytokine signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04976|Bile secretion; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:02010|ABC transporters; KEGG:00330|Arginine and proline metabolism; KEGG:00564|Glycerophospholipid metabolism; KEGG:00910|Nitrogen metabolism
123948-87-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04510|Focal adhesion; KEGG:04512|ECM-receptor interaction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:02010|ABC transporters; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:03410|Base excision repair
89778-26-7	KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis
56211-40-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:00590|Arachidonic acid metabolism; KEGG:04614|Renin-angiotensin system
2104-86-1	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05320|Autoimmune thyroid disease; KEGG:04514|Cell adhesion molecules (CAMs)
402-71-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04975|Fat digestion and absorption
8001-35-2	KEGG:05215|Prostate cancer; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:00270|Cysteine and methionine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00640|Propanoate metabolism
302-30-7	KEGG:04080|Neuroactive ligand-receptor interaction
114899-77-3	KEGG:04110|Cell cycle; KEGG:05214|Glioma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04612|Antigen processing and presentation; KEGG:04114|Oocyte meiosis
27203-92-5	KEGG:04930|Type II diabetes mellitus; KEGG:04080|Neuroactive ligand-receptor interaction
87679-37-6	KEGG:05140|Leishmaniasis; KEGG:04614|Renin-angiotensin system
1197-18-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
366-93-8	KEGG:04940|Type I diabetes mellitus; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:00100|Steroid biosynthesis
14913-33-8	KEGG:05200|Pathways in cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:03410|Base excision repair
155-09-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:04010|MAPK signaling pathway; KEGG:00232|Caffeine metabolism; KEGG:04722|Neurotrophin signaling pathway; KEGG:00590|Arachidonic acid metabolism
15421-84-8	KEGG:04974|Protein digestion and absorption
19794-93-5	KEGG:05222|Small cell lung cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04146|Peroxisome; KEGG:04540|Gap junction; KEGG:00983|Drug metabolism - other enzymes
79855-88-2	KEGG:04910|Insulin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:00230|Purine metabolism
302-79-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00562|Inositol phosphate metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03022|Basal transcription factors; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:04710|Circadian rhythm - mammal; KEGG:03440|Homologous recombination; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:03015|mRNA surveillance pathway; KEGG:03040|Spliceosome; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:00190|Oxidative phosphorylation; KEGG:00910|Nitrogen metabolism; KEGG:04330|Notch signaling pathway; KEGG:04340|Hedgehog signaling pathway; KEGG:00533|Glycosaminoglycan biosynthesis - keratan sulfate; KEGG:00350|Tyrosine metabolism; KEGG:04974|Protein digestion and absorption; KEGG:00565|Ether lipid metabolism; KEGG:05340|Primary immunodeficiency; KEGG:00601|Glycosphingolipid biosynthesis - lacto and neolacto series
76896-80-5	KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:01100|Metabolic pathways; KEGG:04010|MAPK signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:04722|Neurotrophin signaling pathway; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis
43121-43-3	KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04010|MAPK signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04350|TGF-beta signaling pathway; KEGG:04520|Adherens junction; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:02010|ABC transporters; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00514|Other types of O-glycan biosynthesis
124-94-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis
76-25-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis)
28911-01-5	KEGG:04080|Neuroactive ligand-receptor interaction
1329-86-8	KEGG:04210|Apoptosis; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease
84788-92-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00380|Tryptophan metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00340|Histidine metabolism; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism
688-73-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:00140|Steroid hormone biosynthesis; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis
60-01-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:05146|Amoebiasis
52-68-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:04141|Protein processing in endoplasmic reticulum
76-03-9	KEGG:05010|Alzheimer's disease; KEGG:04010|MAPK signaling pathway
3083-23-6	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:00380|Tryptophan metabolism
79-01-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04114|Oocyte meiosis; KEGG:03050|Proteasome; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:04360|Axon guidance; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05340|Primary immunodeficiency
56038-13-2	KEGG:04973|Carbohydrate digestion and absorption; KEGG:04742|Taste transduction
58880-19-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05217|Basal cell carcinoma; KEGG:04330|Notch signaling pathway; KEGG:04974|Protein digestion and absorption; KEGG:04966|Collecting duct acid secretion
35943-35-2	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04530|Tight junction
101-20-2	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
3380-34-5	KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:05310|Asthma
83373-60-8	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton
629-50-5	KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles
58138-08-2	KEGG:04146|Peroxisome
112-24-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04510|Focal adhesion; KEGG:00480|Glutathione metabolism; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00620|Pyruvate metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00330|Arginine and proline metabolism; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:04974|Protein digestion and absorption
109-16-0	KEGG:05140|Leishmaniasis
545-55-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:04722|Neurotrophin signaling pathway; KEGG:03410|Base excision repair
5224-23-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
68694-11-1	KEGG:05323|Rheumatoid arthritis; KEGG:04610|Complement and coagulation cascades; KEGG:04710|Circadian rhythm - mammal
117-89-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis
75-89-8	KEGG:04080|Neuroactive ligand-receptor interaction
1582-09-8	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
70-00-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis
322-79-2	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
5817-39-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00920|Sulfur metabolism
537-40-6	KEGG:04976|Bile secretion; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption
14465-68-0	KEGG:04976|Bile secretion; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption
13647-35-3	KEGG:04610|Complement and coagulation cascades
552-30-7	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:03050|Proteasome; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:04360|Axon guidance; KEGG:03030|DNA replication; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:03420|Nucleotide excision repair; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:03440|Homologous recombination; KEGG:03430|Mismatch repair; KEGG:00670|One carbon pool by folate; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:03040|Spliceosome; KEGG:04614|Renin-angiotensin system; KEGG:04974|Protein digestion and absorption; KEGG:05340|Primary immunodeficiency; KEGG:00460|Cyanoamino acid metabolism
7187-66-8	KEGG:00250|Alanine, aspartate and glutamate metabolism
4964-14-1	KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:02010|ABC transporters; KEGG:05130|Pathogenic Escherichia coli infection
109-76-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis
1184-78-7	KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction
1631-73-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton
1066-45-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
56-24-6	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04360|Axon guidance
2508-19-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:04145|Phagosome; KEGG:05150|Staphylococcus aureus infection; KEGG:04975|Fat digestion and absorption; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:04974|Protein digestion and absorption
88-88-0	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04145|Phagosome; KEGG:05310|Asthma; KEGG:04672|Intestinal immune network for IgA production
118-96-7	KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:00140|Steroid hormone biosynthesis; KEGG:00380|Tryptophan metabolism; KEGG:00480|Glutathione metabolism; KEGG:00071|Fatty acid metabolism; KEGG:03010|Ribosome; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00330|Arginine and proline metabolism; KEGG:00970|Aminoacyl-tRNA biosynthesis; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00450|Selenocompound metabolism; KEGG:00062|Fatty acid elongation in mitochondria
78-30-8	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:00564|Glycerophospholipid metabolism
122-32-7	KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00061|Fatty acid biosynthesis
3902-71-4	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:04660|T cell receptor signaling pathway
132368-08-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
115-86-6	KEGG:04080|Neuroactive ligand-receptor interaction
892-20-6	KEGG:05152|Tuberculosis; KEGG:05323|Rheumatoid arthritis; KEGG:05140|Leishmaniasis; KEGG:04062|Chemokine signaling pathway; KEGG:04380|Osteoclast differentiation; KEGG:04670|Leukocyte transendothelial migration; KEGG:04145|Phagosome
639-58-7	KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage
76-87-9	KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:00140|Steroid hormone biosynthesis; KEGG:04920|Adipocytokine signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:05216|Thyroid cancer
486-12-4	KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05144|Malaria; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05340|Primary immunodeficiency
34157-83-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation
38748-32-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
126-72-7	KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00480|Glutathione metabolism
59247-13-1	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00603|Glycosphingolipid biosynthesis - globo series; KEGG:00604|Glycosphingolipid biosynthesis - ganglio series
97322-87-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04114|Oocyte meiosis; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:03420|Nucleotide excision repair; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:03440|Homologous recombination; KEGG:00310|Lysine degradation; KEGG:03430|Mismatch repair; KEGG:00640|Propanoate metabolism; KEGG:00650|Butanoate metabolism; KEGG:00072|Synthesis and degradation of ketone bodies; KEGG:00350|Tyrosine metabolism; KEGG:00062|Fatty acid elongation in mitochondria
2751-09-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04976|Bile secretion; KEGG:00983|Drug metabolism - other enzymes
1508-75-4	KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00330|Arginine and proline metabolism
533-75-5	KEGG:05010|Alzheimer's disease; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05211|Renal cell carcinoma; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:04062|Chemokine signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:03010|Ribosome; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05130|Pathogenic Escherichia coli infection; KEGG:04142|Lysosome
146836-84-2	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04144|Endocytosis; KEGG:03013|RNA transport; KEGG:04120|Ubiquitin mediated proteolysis
57773-63-4	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04912|GnRH signaling pathway; KEGG:00230|Purine metabolism
62450-06-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:00340|Histidine metabolism; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism
62450-07-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:01100|Metabolic pathways; KEGG:00380|Tryptophan metabolism; KEGG:00340|Histidine metabolism; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism
61-54-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00232|Caffeine metabolism; KEGG:00983|Drug metabolism - other enzymes
147159-51-1	KEGG:04080|Neuroactive ligand-receptor interaction
102040-03-9	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
57-95-4	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
51682-10-1	KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00910|Nitrogen metabolism
7440-33-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway
11130-73-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
11089-65-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04114|Oocyte meiosis; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:04360|Axon guidance; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00770|Pantothenate and CoA biosynthesis; KEGG:04340|Hedgehog signaling pathway; KEGG:00061|Fatty acid biosynthesis; KEGG:04744|Phototransduction
8024-37-1	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04976|Bile secretion; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
8006-64-2	KEGG:01100|Metabolic pathways; KEGG:04920|Adipocytokine signaling pathway; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
482-20-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04114|Oocyte meiosis
51-67-2	KEGG:05219|Bladder cancer; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04970|Salivary secretion; KEGG:05216|Thyroid cancer; KEGG:04320|Dorso-ventral axis formation; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway
170449-18-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05100|Bacterial invasion of epithelial cells
96744-75-1	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04320|Dorso-ventral axis formation; KEGG:04730|Long-term depression
119477-85-9	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04630|Jak-STAT signaling pathway
133681-84-2	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
1339-63-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00190|Oxidative phosphorylation
268203-93-6	KEGG:05200|Pathways in cancer; KEGG:05211|Renal cell carcinoma; KEGG:04020|Calcium signaling pathway; KEGG:00330|Arginine and proline metabolism
95999-11-4	KEGG:04080|Neuroactive ligand-receptor interaction
1120-21-4	KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04976|Bile secretion; KEGG:04971|Gastric acid secretion
66-22-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:03050|Proteasome; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:00100|Steroid biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:02010|ABC transporters; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:05320|Autoimmune thyroid disease; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:03440|Homologous recombination; KEGG:03430|Mismatch repair; KEGG:00640|Propanoate metabolism; KEGG:03040|Spliceosome; KEGG:00190|Oxidative phosphorylation; KEGG:04340|Hedgehog signaling pathway; KEGG:00350|Tyrosine metabolism; KEGG:03450|Non-homologous end-joining; KEGG:04974|Protein digestion and absorption
7440-61-1	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04978|Mineral absorption; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04144|Endocytosis; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03410|Base excision repair
541-09-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:05200|Pathways in cancer; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:01100|Metabolic pathways; KEGG:04012|ErbB signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion; KEGG:04722|Neurotrophin signaling pathway; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03410|Base excision repair; KEGG:03015|mRNA surveillance pathway
10102-06-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis
34661-75-1	KEGG:04080|Neuroactive ligand-receptor interaction
57-13-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:00232|Caffeine metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:05150|Staphylococcus aureus infection; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00020|Citrate cycle (TCA cycle); KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:05217|Basal cell carcinoma; KEGG:03410|Base excision repair; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:00640|Propanoate metabolism; KEGG:00600|Sphingolipid metabolism; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:00190|Oxidative phosphorylation; KEGG:04340|Hedgehog signaling pathway; KEGG:04614|Renin-angiotensin system; KEGG:00360|Phenylalanine metabolism; KEGG:00350|Tyrosine metabolism; KEGG:04974|Protein digestion and absorption
51-79-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:04672|Intestinal immune network for IgA production; KEGG:05414|Dilated cardiomyopathy
69-93-2	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00232|Caffeine metabolism; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04976|Bile secretion
58-96-8	KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:01100|Metabolic pathways; KEGG:04010|MAPK signaling pathway; KEGG:05144|Malaria; KEGG:04350|TGF-beta signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:00983|Drug metabolism - other enzymes; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:03430|Mismatch repair
58-98-0	KEGG:05219|Bladder cancer; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04320|Dorso-ventral axis formation; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00040|Pentose and glucuronate interconversions
2616-64-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
63-39-8	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04270|Vascular smooth muscle contraction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04520|Adherens junction; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04810|Regulation of actin cytoskeleton
104-98-3	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:05332|Graft-versus-host disease; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04612|Antigen processing and presentation
128-13-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04144|Endocytosis; KEGG:04950|Maturity onset diabetes of the young; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:04530|Tight junction; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:04672|Intestinal immune network for IgA production; KEGG:00061|Fatty acid biosynthesis
77-52-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:04670|Leukocyte transendothelial migration
125-46-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:04722|Neurotrophin signaling pathway
2001-95-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis
99-66-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:00100|Steroid biosynthesis; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:01040|Biosynthesis of unsaturated fatty acids; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00120|Primary bile acid biosynthesis; KEGG:00500|Starch and sucrose metabolism; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00970|Aminoacyl-tRNA biosynthesis; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00340|Histidine metabolism; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:04977|Vitamin digestion and absorption; KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:04710|Circadian rhythm - mammal; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03015|mRNA surveillance pathway; KEGG:00670|One carbon pool by folate; KEGG:00770|Pantothenate and CoA biosynthesis; KEGG:00640|Propanoate metabolism; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:03020|RNA polymerase; KEGG:00600|Sphingolipid metabolism; KEGG:03040|Spliceosome; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:00190|Oxidative phosphorylation; KEGG:00650|Butanoate metabolism; KEGG:04330|Notch signaling pathway; KEGG:04340|Hedgehog signaling pathway; KEGG:00350|Tyrosine metabolism; KEGG:03060|Protein export; KEGG:00450|Selenocompound metabolism; KEGG:04974|Protein digestion and absorption; KEGG:04130|SNARE interactions in vesicular transport; KEGG:04744|Phototransduction; KEGG:04966|Collecting duct acid secretion; KEGG:00062|Fatty acid elongation in mitochondria; KEGG:00531|Glycosaminoglycan degradation; KEGG:00740|Riboflavin metabolism
137862-53-4	KEGG:05010|Alzheimer's disease; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04614|Renin-angiotensin system
7440-62-2	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04971|Gastric acid secretion; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05110|Vibrio cholerae infection; KEGG:04672|Intestinal immune network for IgA production; KEGG:05414|Dilated cardiomyopathy; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:04974|Protein digestion and absorption
1314-62-1	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04512|ECM-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
27774-13-6	KEGG:04210|Apoptosis; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
1404-90-6	KEGG:04110|Cell cycle; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:00480|Glutathione metabolism; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:03030|DNA replication; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00120|Primary bile acid biosynthesis; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:00340|Histidine metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00310|Lysine degradation; KEGG:00770|Pantothenate and CoA biosynthesis; KEGG:00640|Propanoate metabolism; KEGG:00650|Butanoate metabolism; KEGG:00072|Synthesis and degradation of ketone bodies; KEGG:00450|Selenocompound metabolism; KEGG:04974|Protein digestion and absorption
121-34-6	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04020|Calcium signaling pathway; KEGG:04970|Salivary secretion; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
121-33-5	KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04010|MAPK signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:00983|Drug metabolism - other enzymes; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00500|Starch and sucrose metabolism; KEGG:00514|Other types of O-glycan biosynthesis
67469-78-7	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00590|Arachidonic acid metabolism
37221-79-7	KEGG:04110|Cell cycle; KEGG:05212|Pancreatic cancer; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04060|Cytokine-cytokine receptor interaction
102805-45-8	KEGG:04110|Cell cycle; KEGG:05212|Pancreatic cancer; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04060|Cytokine-cytokine receptor interaction
73168-24-8	KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04270|Vascular smooth muscle contraction
11000-17-2	KEGG:04020|Calcium signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04270|Vascular smooth muscle contraction; KEGG:04510|Focal adhesion; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04962|Vasopressin-regulated water reabsorption
50700-72-6	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
93413-69-5	KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04722|Neurotrophin signaling pathway; KEGG:04360|Axon guidance
52-53-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:02010|ABC transporters; KEGG:05414|Dilated cardiomyopathy
80-57-9	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways
115104-28-4	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters; KEGG:05310|Asthma
88-29-9	KEGG:04114|Oocyte meiosis
5536-17-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03030|DNA replication; KEGG:03410|Base excision repair; KEGG:03440|Homologous recombination; KEGG:03430|Mismatch repair; KEGG:03450|Non-homologous end-joining
60643-86-9	KEGG:01100|Metabolic pathways; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:00380|Tryptophan metabolism; KEGG:03010|Ribosome
865-21-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04114|Oocyte meiosis; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00190|Oxidative phosphorylation
50471-44-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05150|Staphylococcus aureus infection; KEGG:00100|Steroid biosynthesis; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:04975|Fat digestion and absorption; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:00410|beta-Alanine metabolism; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03040|Spliceosome; KEGG:00360|Phenylalanine metabolism; KEGG:04974|Protein digestion and absorption; KEGG:00565|Ether lipid metabolism
57-22-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04610|Complement and coagulation cascades; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04145|Phagosome; KEGG:04810|Regulation of actin cytoskeleton; KEGG:02010|ABC transporters; KEGG:00983|Drug metabolism - other enzymes
53643-48-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
71486-22-1	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease
42971-12-0	KEGG:04270|Vascular smooth muscle contraction
15805-73-9	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:04012|ErbB signaling pathway; KEGG:04370|VEGF signaling pathway; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04530|Tight junction
75-01-4	KEGG:05215|Prostate cancer; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:05216|Thyroid cancer; KEGG:00480|Glutathione metabolism; KEGG:03420|Nucleotide excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:03440|Homologous recombination
75-02-5	KEGG:00140|Steroid hormone biosynthesis
75-35-4	KEGG:05152|Tuberculosis; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:05310|Asthma
548-54-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis
11006-76-1	KEGG:05144|Malaria; KEGG:05143|African trypanosomiasis; KEGG:04670|Leukocyte transendothelial migration; KEGG:04514|Cell adhesion molecules (CAMs)
11103-57-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04260|Cardiac muscle contraction; KEGG:00270|Cysteine and methionine metabolism; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:00260|Glycine, serine and threonine metabolism; KEGG:04950|Maturity onset diabetes of the young; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:05150|Staphylococcus aureus infection; KEGG:04530|Tight junction; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05110|Vibrio cholerae infection; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04975|Fat digestion and absorption; KEGG:00053|Ascorbate and aldarate metabolism; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:00040|Pentose and glucuronate interconversions; KEGG:00514|Other types of O-glycan biosynthesis; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:00330|Arginine and proline metabolism; KEGG:00030|Pentose phosphate pathway; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:00564|Glycerophospholipid metabolism; KEGG:00520|Amino sugar and nucleotide sugar metabolism; KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03022|Basal transcription factors; KEGG:03410|Base excision repair; KEGG:00410|beta-Alanine metabolism; KEGG:03440|Homologous recombination; KEGG:00310|Lysine degradation; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:03015|mRNA surveillance pathway; KEGG:04962|Vasopressin-regulated water reabsorption; KEGG:00052|Galactose metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00910|Nitrogen metabolism; KEGG:04330|Notch signaling pathway; KEGG:04340|Hedgehog signaling pathway; KEGG:00533|Glycosaminoglycan biosynthesis - keratan sulfate; KEGG:00350|Tyrosine metabolism; KEGG:04974|Protein digestion and absorption; KEGG:00565|Ether lipid metabolism; KEGG:05340|Primary immunodeficiency; KEGG:00601|Glycosphingolipid biosynthesis - lacto and neolacto series
59-43-8	KEGG:04977|Vitamin digestion and absorption
83-88-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:05217|Basal cell carcinoma
98-92-0	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04144|Endocytosis; KEGG:05150|Staphylococcus aureus infection; KEGG:00500|Starch and sucrose metabolism
73-24-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04140|Regulation of autophagy
79-83-4	KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04010|MAPK signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04972|Pancreatic secretion; KEGG:04976|Bile secretion; KEGG:00071|Fatty acid metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:05130|Pathogenic Escherichia coli infection; KEGG:00564|Glycerophospholipid metabolism; KEGG:00770|Pantothenate and CoA biosynthesis
8059-24-3	KEGG:05222|Small cell lung cancer; KEGG:01100|Metabolic pathways; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:00430|Taurine and hypotaurine metabolism
68-19-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:01100|Metabolic pathways; KEGG:05144|Malaria; KEGG:00380|Tryptophan metabolism; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis
1406-16-2	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:00230|Purine metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00562|Inositol phosphate metabolism; KEGG:00561|Glycerolipid metabolism; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:03440|Homologous recombination; KEGG:04142|Lysosome; KEGG:03430|Mismatch repair; KEGG:00910|Nitrogen metabolism; KEGG:04330|Notch signaling pathway; KEGG:04340|Hedgehog signaling pathway; KEGG:04974|Protein digestion and absorption; KEGG:00532|Glycosaminoglycan biosynthesis - chondroitin sulfate
67-97-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:04978|Mineral absorption; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03013|RNA transport; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:02010|ABC transporters; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:03030|DNA replication; KEGG:00983|Drug metabolism - other enzymes; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00330|Arginine and proline metabolism; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:03420|Nucleotide excision repair; KEGG:05217|Basal cell carcinoma; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:03440|Homologous recombination; KEGG:03430|Mismatch repair; KEGG:00910|Nitrogen metabolism; KEGG:04340|Hedgehog signaling pathway; KEGG:04974|Protein digestion and absorption
1406-18-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04961|Endocrine and other factor-regulated calcium reabsorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:04610|Complement and coagulation cascades; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04976|Bile secretion; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04971|Gastric acid secretion; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:04070|Phosphatidylinositol signaling system; KEGG:03050|Proteasome; KEGG:00620|Pyruvate metabolism; KEGG:04810|Regulation of actin cytoskeleton; KEGG:03010|Ribosome; KEGG:03013|RNA transport; KEGG:04530|Tight junction; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00562|Inositol phosphate metabolism; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03018|RNA degradation; KEGG:00020|Citrate cycle (TCA cycle); KEGG:03410|Base excision repair; KEGG:04142|Lysosome; KEGG:03015|mRNA surveillance pathway; KEGG:03040|Spliceosome; KEGG:04962|Vasopressin-regulated water reabsorption
12001-79-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:03013|RNA transport; KEGG:00100|Steroid biosynthesis; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00590|Arachidonic acid metabolism; KEGG:04975|Fat digestion and absorption; KEGG:03030|DNA replication; KEGG:00330|Arginine and proline metabolism; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00640|Propanoate metabolism; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:03040|Spliceosome
83-70-5	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer
84-80-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04810|Regulation of actin cytoskeleton
11032-49-8	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer
58-27-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:00860|Porphyrin and chlorophyll metabolism; KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:04520|Adherens junction; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04145|Phagosome; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:03013|RNA transport; KEGG:00100|Steroid biosynthesis; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:04975|Fat digestion and absorption; KEGG:03030|DNA replication; KEGG:00330|Arginine and proline metabolism; KEGG:00240|Pyrimidine metabolism; KEGG:03410|Base excision repair; KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00640|Propanoate metabolism; KEGG:03008|Ribosome biogenesis in eukaryotes; KEGG:03040|Spliceosome
1115-84-0	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:00270|Cysteine and methionine metabolism; KEGG:04114|Oocyte meiosis; KEGG:04360|Axon guidance
142449-89-6	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton
83480-29-9	KEGG:00500|Starch and sucrose metabolism
149647-78-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:04120|Ubiquitin mediated proteolysis; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:03450|Non-homologous end-joining
118949-22-7	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis
639089-54-6	KEGG:05220|Chronic myeloid leukemia; KEGG:05200|Pathways in cancer; KEGG:04972|Pancreatic secretion; KEGG:04974|Protein digestion and absorption
209409-98-3	KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage
65595-90-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04970|Salivary secretion; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
81-81-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:05146|Amoebiasis; KEGG:05143|African trypanosomiasis; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:00590|Arachidonic acid metabolism; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00983|Drug metabolism - other enzymes; KEGG:05130|Pathogenic Escherichia coli infection
7732-18-5	KEGG:04972|Pancreatic secretion; KEGG:04976|Bile secretion; KEGG:04964|Proximal tubule bicarbonate reclamation; KEGG:04962|Vasopressin-regulated water reabsorption
146714-97-8	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04916|Melanogenesis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway
105219-56-5	KEGG:04210|Apoptosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage
524-12-9	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
134959-51-6	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04360|Axon guidance
5119-48-2	KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04722|Neurotrophin signaling pathway
632-85-9	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00983|Drug metabolism - other enzymes; KEGG:00240|Pyrimidine metabolism
19545-26-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04973|Carbohydrate digestion and absorption; KEGG:04114|Oocyte meiosis; KEGG:04070|Phosphatidylinositol signaling system; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:00562|Inositol phosphate metabolism; KEGG:03450|Non-homologous end-joining
31098-42-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway
58205-87-1	KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
81801-12-9	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05215|Prostate cancer; KEGG:05152|Tuberculosis; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:04914|Progesterone-mediated oocyte maturation
131986-45-3	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton
26791-73-1	KEGG:04110|Cell cycle; KEGG:04115|p53 signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis
69-89-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05016|Huntington's disease; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:01100|Metabolic pathways; KEGG:04010|MAPK signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:00380|Tryptophan metabolism; KEGG:04146|Peroxisome; KEGG:05146|Amoebiasis; KEGG:00071|Fatty acid metabolism; KEGG:00230|Purine metabolism; KEGG:00620|Pyruvate metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:05414|Dilated cardiomyopathy; KEGG:00020|Citrate cycle (TCA cycle); KEGG:00630|Glyoxylate and dicarboxylate metabolism; KEGG:00310|Lysine degradation; KEGG:00640|Propanoate metabolism; KEGG:00650|Butanoate metabolism; KEGG:00072|Synthesis and degradation of ketone bodies; KEGG:00062|Fatty acid elongation in mitochondria
6754-58-1	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:01100|Metabolic pathways; KEGG:00232|Caffeine metabolism
7440-63-3	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04730|Long-term depression; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation
37294-28-3	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:05162|Measles; KEGG:04623|Cytosolic DNA-sensing pathway
138381-45-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04512|ECM-receptor interaction; KEGG:04810|Regulation of actin cytoskeleton; KEGG:04530|Tight junction; KEGG:04360|Axon guidance; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC); KEGG:03420|Nucleotide excision repair; KEGG:04974|Protein digestion and absorption
112514-54-2	KEGG:05200|Pathways in cancer
127657-42-5	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:04370|VEGF signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway
146-48-5	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05210|Colorectal cancer; KEGG:04115|p53 signaling pathway; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05140|Leishmaniasis; KEGG:04970|Salivary secretion; KEGG:00380|Tryptophan metabolism; KEGG:04916|Melanogenesis; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:04976|Bile secretion; KEGG:04971|Gastric acid secretion; KEGG:00330|Arginine and proline metabolism; KEGG:00350|Tyrosine metabolism
7440-64-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05210|Colorectal cancer; KEGG:05016|Huntington's disease; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:04722|Neurotrophin signaling pathway
107753-78-6	KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05332|Graft-versus-host disease; KEGG:00590|Arachidonic acid metabolism; KEGG:05310|Asthma
151319-34-5	KEGG:04080|Neuroactive ligand-receptor interaction
37762-06-4	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05223|Non-small cell lung cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:00230|Purine metabolism
101975-10-4	KEGG:04540|Gap junction; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC)
144-68-3	KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05145|Toxoplasmosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04012|ErbB signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04270|Vascular smooth muscle contraction; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04730|Long-term depression; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04114|Oocyte meiosis; KEGG:04360|Axon guidance
181494-14-4	KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer
26538-44-3	KEGG:05210|Colorectal cancer; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00982|Drug metabolism - cytochrome P450; KEGG:04976|Bile secretion; KEGG:02010|ABC transporters
471-05-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:04062|Chemokine signaling pathway; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04120|Ubiquitin mediated proteolysis
30516-87-1	KEGG:05010|Alzheimer's disease; KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:00380|Tryptophan metabolism; KEGG:03320|PPAR signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04260|Cardiac muscle contraction; KEGG:00071|Fatty acid metabolism; KEGG:00280|Valine, leucine and isoleucine degradation; KEGG:00983|Drug metabolism - other enzymes; KEGG:00020|Citrate cycle (TCA cycle); KEGG:03420|Nucleotide excision repair; KEGG:00240|Pyrimidine metabolism; KEGG:00640|Propanoate metabolism; KEGG:00190|Oxidative phosphorylation; KEGG:00061|Fatty acid biosynthesis; KEGG:00062|Fatty acid elongation in mitochondria
132880-11-6	KEGG:05010|Alzheimer's disease; KEGG:05219|Bladder cancer; KEGG:05160|Hepatitis C; KEGG:05200|Pathways in cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:00140|Steroid hormone biosynthesis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04660|T cell receptor signaling pathway; KEGG:04145|Phagosome; KEGG:05150|Staphylococcus aureus infection; KEGG:05310|Asthma; KEGG:04514|Cell adhesion molecules (CAMs)
56775-88-3	KEGG:04142|Lysosome
7440-66-6	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:04960|Aldosterone-regulated sodium reabsorption; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04976|Bile secretion; KEGG:04260|Cardiac muscle contraction; KEGG:04512|ECM-receptor interaction; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00590|Arachidonic acid metabolism; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:05414|Dilated cardiomyopathy; KEGG:04140|Regulation of autophagy; KEGG:00061|Fatty acid biosynthesis
5970-45-6	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05211|Renal cell carcinoma; KEGG:04010|MAPK signaling pathway; KEGG:04978|Mineral absorption; KEGG:05162|Measles; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04114|Oocyte meiosis; KEGG:04120|Ubiquitin mediated proteolysis
7646-85-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:00010|Glycolysis / Gluconeogenesis; KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04662|B cell receptor signaling pathway; KEGG:04320|Dorso-ventral axis formation; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04144|Endocytosis; KEGG:03010|Ribosome; KEGG:00030|Pentose phosphate pathway
13530-65-9	KEGG:04115|p53 signaling pathway; KEGG:05200|Pathways in cancer; KEGG:04621|NOD-like receptor signaling pathway
1314-13-2	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:04972|Pancreatic secretion; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04672|Intestinal immune network for IgA production
15442-64-5	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway
13463-41-7	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05020|Prion diseases; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04146|Peroxisome; KEGG:05162|Measles; KEGG:04722|Neurotrophin signaling pathway; KEGG:00480|Glutathione metabolism; KEGG:04612|Antigen processing and presentation; KEGG:04144|Endocytosis; KEGG:03040|Spliceosome
7733-02-0	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:01100|Metabolic pathways; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04020|Calcium signaling pathway; KEGG:04724|Glutamatergic synapse; KEGG:04720|Long-term potentiation; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04978|Mineral absorption; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:04916|Melanogenesis; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04612|Antigen processing and presentation; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04144|Endocytosis; KEGG:00071|Fatty acid metabolism; KEGG:04971|Gastric acid secretion; KEGG:04530|Tight junction; KEGG:05414|Dilated cardiomyopathy
1314-98-3	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04672|Intestinal immune network for IgA production
12122-67-7	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:01100|Metabolic pathways; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:00250|Alanine, aspartate and glutamate metabolism; KEGG:05140|Leishmaniasis; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04510|Focal adhesion; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00330|Arginine and proline metabolism
146939-27-7	KEGG:04020|Calcium signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:04540|Gap junction; KEGG:00900|Terpenoid backbone biosynthesis
137-30-4	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05160|Hepatitis C; KEGG:05016|Huntington's disease; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05012|Parkinson's disease; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:04010|MAPK signaling pathway; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04666|Fc gamma R-mediated phagocytosis; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04660|T cell receptor signaling pathway; KEGG:05320|Autoimmune thyroid disease
7440-67-7	KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:05416|Viral myocarditis; KEGG:05131|Shigellosis; KEGG:04510|Focal adhesion; KEGG:04670|Leukocyte transendothelial migration; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC)
1314-23-4	KEGG:05219|Bladder cancer; KEGG:05200|Pathways in cancer; KEGG:05222|Small cell lung cancer; KEGG:05416|Viral myocarditis; KEGG:05410|Hypertrophic cardiomyopathy (HCM); KEGG:05131|Shigellosis; KEGG:04510|Focal adhesion; KEGG:04670|Leukocyte transendothelial migration; KEGG:04512|ECM-receptor interaction; KEGG:05100|Bacterial invasion of epithelial cells; KEGG:05414|Dilated cardiomyopathy; KEGG:05130|Pathogenic Escherichia coli infection; KEGG:05412|Arrhythmogenic right ventricular cardiomyopathy (ARVC)
155944-23-3	KEGG:05145|Toxoplasmosis
118072-93-8	KEGG:05010|Alzheimer's disease; KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:04110|Cell cycle; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05213|Endometrial cancer; KEGG:05214|Glioma; KEGG:05160|Hepatitis C; KEGG:05218|Melanoma; KEGG:05223|Non-small cell lung cancer; KEGG:04115|p53 signaling pathway; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:04141|Protein processing in endoplasmic reticulum; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:04150|mTOR signaling pathway; KEGG:05020|Prion diseases; KEGG:05211|Renal cell carcinoma; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04012|ErbB signaling pathway; KEGG:04010|MAPK signaling pathway; KEGG:04720|Long-term potentiation; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:04520|Adherens junction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04540|Gap junction; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04310|Wnt signaling pathway; KEGG:04144|Endocytosis; KEGG:04114|Oocyte meiosis; KEGG:04810|Regulation of actin cytoskeleton; KEGG:00900|Terpenoid backbone biosynthesis; KEGG:04360|Axon guidance; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production
139264-17-8	KEGG:04080|Neuroactive ligand-receptor interaction
82626-48-0	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00830|Retinol metabolism; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:00380|Tryptophan metabolism
33369-31-2	KEGG:00980|Metabolism of xenobiotics by cytochrome P450; KEGG:00140|Steroid hormone biosynthesis
68291-97-4	KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:05140|Leishmaniasis; KEGG:00910|Nitrogen metabolism; KEGG:00350|Tyrosine metabolism
110703-94-1	KEGG:05145|Toxoplasmosis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:00051|Fructose and mannose metabolism; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:05140|Leishmaniasis; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:05162|Measles; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:00620|Pyruvate metabolism; KEGG:00040|Pentose and glucuronate interconversions; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:00052|Galactose metabolism
61-80-3	KEGG:00982|Drug metabolism - cytochrome P450; KEGG:00591|Linoleic acid metabolism; KEGG:00980|Metabolism of xenobiotics by cytochrome P450
9010-72-4	KEGG:05014|Amyotrophic lateral sclerosis (ALS); KEGG:04210|Apoptosis; KEGG:05219|Bladder cancer; KEGG:05220|Chronic myeloid leukemia; KEGG:05210|Colorectal cancer; KEGG:05160|Hepatitis C; KEGG:05212|Pancreatic cancer; KEGG:05200|Pathways in cancer; KEGG:05215|Prostate cancer; KEGG:05222|Small cell lung cancer; KEGG:05145|Toxoplasmosis; KEGG:05416|Viral myocarditis; KEGG:05152|Tuberculosis; KEGG:05142|Chagas disease (American trypanosomiasis); KEGG:04910|Insulin signaling pathway; KEGG:05020|Prion diseases; KEGG:05323|Rheumatoid arthritis; KEGG:04620|Toll-like receptor signaling pathway; KEGG:04930|Type II diabetes mellitus; KEGG:05120|Epithelial cell signaling in Helicobacter pylori infection; KEGG:04010|MAPK signaling pathway; KEGG:04080|Neuroactive ligand-receptor interaction; KEGG:05322|Systemic lupus erythematosus; KEGG:05140|Leishmaniasis; KEGG:04370|VEGF signaling pathway; KEGG:04920|Adipocytokine signaling pathway; KEGG:04940|Type I diabetes mellitus; KEGG:04270|Vascular smooth muscle contraction; KEGG:05144|Malaria; KEGG:04621|NOD-like receptor signaling pathway; KEGG:04622|RIG-I-like receptor signaling pathway; KEGG:04610|Complement and coagulation cascades; KEGG:03320|PPAR signaling pathway; KEGG:04350|TGF-beta signaling pathway; KEGG:05146|Amoebiasis; KEGG:04062|Chemokine signaling pathway; KEGG:04060|Cytokine-cytokine receptor interaction; KEGG:05131|Shigellosis; KEGG:05216|Thyroid cancer; KEGG:04380|Osteoclast differentiation; KEGG:05221|Acute myeloid leukemia; KEGG:05143|African trypanosomiasis; KEGG:05330|Allograft rejection; KEGG:04662|B cell receptor signaling pathway; KEGG:04664|Fc epsilon RI signaling pathway; KEGG:04510|Focal adhesion; KEGG:04912|GnRH signaling pathway; KEGG:05332|Graft-versus-host disease; KEGG:04640|Hematopoietic cell lineage; KEGG:04630|Jak-STAT signaling pathway; KEGG:04670|Leukocyte transendothelial migration; KEGG:04730|Long-term depression; KEGG:05162|Measles; KEGG:04650|Natural killer cell mediated cytotoxicity; KEGG:04722|Neurotrophin signaling pathway; KEGG:04914|Progesterone-mediated oocyte maturation; KEGG:04660|T cell receptor signaling pathway; KEGG:04623|Cytosolic DNA-sensing pathway; KEGG:04145|Phagosome; KEGG:05150|Staphylococcus aureus infection; KEGG:00590|Arachidonic acid metabolism; KEGG:05310|Asthma; KEGG:05320|Autoimmune thyroid disease; KEGG:04672|Intestinal immune network for IgA production; KEGG:04514|Cell adhesion molecules (CAMs); KEGG:00565|Ether lipid metabolism
